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SUMMARY 
Neuronal cell death caused by excitotoxicity accompanies neurodegenerative disorders, such 
as Alzheimer’s disease (AD) and Huntington’s disease (HD), epilepsy and ischaemia. 
Glutamate is the major excitotoxin in the CNS and causes activation of glutamate receptors. 
Ionotropic glutamate receptors can directly cause calcium influx that further enables 
activation of cell death pathways. Kainic acid (KA) is a specific agonist for ionotropic non-
NMDA glutamate receptors, namely KA and AMPA receptors. KA induces epiletic activity 
in rodents and causes hippocampal sclerosis, similar to human temporal epilepsy. HD, a 
neurodegenerative disease characterized by accumulation of mutant huntingtin protein, and 
causing cell death in the striatum of affected individuals, has also been shown to involve 
excitotoxic cell death. Intracellular organelles have been implicated in stress sensing and 
contribute to cell death signaling. Mitochondria have been closely linked to apoptotic 
pathways and recent research has also implicated other organelles, such as the endoplasmic 
reticulum (ER), lysosomes and Golgi apparatus in cell death.  
In this thesis, the involvement of ER stress was shown to accompany hippocampal cell death 
caused by KA in vivo and in vitro as well as in a cell model of HD. KA induced activation of 
ER stress sensors that aim to restore homeostasis via activation of the unfolded protein 
response (UPR). In prolonged stressful conditions, the UPR activates apoptotic pathways. 
Treatment with an ER stress inhibitor, Salubrinal (Sal), significantly attenuated cell death in 
hippocampal neurons in vivo and in vitro. ER stress was also activated in a cell model of HD 
and treatment with Sal reduced cell death and mutant hungtingtin aggregation. These data 
indicated for the first time the involvement of the ER in cell death pathways caused by 
excitotoxicity, and that inhibition of ER stress could be a potential treatment against neuronal 
cell death in HD and other disorders involving excitotoxicity. 
In search of other cell death mediators we focused on Cdk5 that has been implicated 
deregulated in excitotoxicity. Involved in multiple signaling pathways, Cdk5, has been 
implicated, for instance, in regulation of synaptic proteins, ER stress and cell death. In this 
thesis, a KA receptor important for mediating cell death in the hippocampus, GluR6, was 
shown to be regulated by Cdk5. Inhibition of Cdk5 reduced GluR6 downregulation by KA as 
well as cell death caused by KA in vitro. These data indicated Cdk5 involvement in KA 
excitotoxicity and could also present a potential drug target in neurological disorders. 





AD Alzheimer’s disease 
ADP Adenosine diphosphate 
ALS Amyotrophic lateral sclerosis (Lou Gehrig’s disease) 
AMP Adenosine monophosphate 
AMPA 2-amino-3-(5-methyl-3-oxo-1,2- oxazol-4-yl)propanoic acid 
ATF Activating transcription factor 
ATP Adenosine triphosphate 
Aβ Amyloid beta peptide 
Bcl-2 B-cell lymphoma 2 
BH Bcl-2 homology  
BiP Binding immunoglobulin protein (BiP); 78 kDa glucose-regulated protein 
(GRP-78); heat shock 70 kDa protein 5 (HSPA5)  
BIR Baculovirus IAP repeat –domain 
CARD Caspase recruitment domain 
Cdk5 Cyclin-dependent kinase 5 
CED Cell death abnormal 
CNS Central nervous system 
DED Dead effector domain 
ER Endoplasmic reticulum 
ERAD ER associated degradation 
ERSE ER stress element 
GluK Glutamate receptor, kainate subtype 
GluR Glutamate receptor 
Grik Glutamate receptor, ionotropic, kainate (gene) 
GRP Glucose regulated protein 
GTP Guanine triphosphate 
HD Huntington’s disease 
iGluR Ionotropic glutamate receptor 
IAP Inhibitor of apoptosis –protein  
KA Kainic acid, kainate 
KAR Kainate receptor 
KO Knockout 
mGluR Metabotropic glutamate receptor 
mRNA Messenger RNA 
NMDA N-methyl-D-aspartic acid 
PD Parkinson’s disease 
PDZ Postsynaptic density-95/Discs large/Zona occludens-1 
PSD Postsynaptic density 
Sal Salubrinal 
TLE Temporal lobe epilepsy 
TNF Tumor necrosis factor 
TRAF2 TNF receptor associated factor 2 
TUNEL  Terminal deoxynucleotidyl transferase dUTP nick end labelling 
UPR Unfolded protein response 
UPS Ubiquitin proteasome system 
WB Western blotting 
 1 
Review of the Literature 
1.1 Cell death 
1.1.1 Classification of cell death  
Cell death has classically been divided to apoptosis and necrosis. While apoptosis is a 
controlled, active form of cell death, necrosis is characterized by uncontrolled, passive 
breakdown of cellular contents to the surroundings, often leading to spread of inflammation 
in nearby cells. In addition, morphological classification of cell death by Schweichel and 
Merker adds autophagy to the list of cell death mechanisms (Schweichel, Merker 1973, 
Kroemer et al. 2009). Nowadays, several other types of cell death or subtypes of apoptosis 
are proposed; however, the characteristics can be overlapping making the distinction 
challenging.  
1.1.2 Necrosis 
Necrosis (from Greek νεκρός, "dead") is considered as uncontrolled death of cells in 
unbearable conditions. Necrosis is often caused by external factors that can occur after 
sudden trauma, hyperthermia, infection, or toxin. Morphologically, necrotic cell death 
involves clumping of chromatin, swelling of mitochondria, disruption of cellular membranes 
and disintegration of organelles. For a long time necrosis was thought to be a passive process. 
Recently, certain cell types have been shown to undergo so called “programmed necrosis” or 
“necroptosis” that has been shown to involve specific molecular machinery (Bizik et al. 
2004).  
Necroptosis was described as a form of ordered cellular explosion (Vandenabeele et al. 2010). 
As early as in 1988 it was noted that stimulation of certain cell types with tumor necrosis 
factor (TNF) could result both in apoptotic-like cell death without DNA fragmentation or 
necrosis-like cell death (Laster, Wood & Gooding 1988). The dying cells exhibited either 
classical apoptotic or balloon like morphology without nuclear condensation, characteristics 
of necrotic and apoptotic cell death, respectively (Laster, Wood & Gooding 1988). Nowadays, 
many proteins are known to contribute to necroptosis, including TNF receptors, receptor 
interacting proteins 1 and 3 (RIP1, -3) and caspase inhibitors, among others (Vandenabeele et 
al. 2010). Caspase inhibitors expressed in some cell lines and primary cells, including cIAP, 
as well as pharmacological caspase inhibitors can block the apoptotic pathways and thus 
favor necroptotic cell death pathway (Fiers et al. 1995, Vercammen et al. 1998).  
1.1.3 Apoptosis  
Apoptosis is a genetically programmed form of cell death required for embryonic and 
postnatal development as well as for tissue homeostasis, aging and removal of unwanted cells. 
Especially, during development an excess number of cells are produced that later are 
removed by apoptosis. In addition, a large number of diseases are associated with 
disturbances in apoptotic cell death pathways, including deregulation of the pathways in 
cancers and autoimmune diseases, as well as excessive cell death seen e.g. in 
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neurodegenerative diseases, AIDS (Acquired Immune Deficiency Syndrome), and ischaemic 
injuries (Agostini, Tucci & Melino 2011). 
Apoptosis is characterized by cell shrinking, membrane blebbing, nuclear chromatin 
condensation and fragmentation while integrity of the membranes and organelles are 
sustained (Kroemer et al. 2009, Kerr, Wyllie & Currie 1972, Williams, Little & Shipley 
1974). More detailed biochemical criteria nowadays define apoptosis including caspase 
activation, energy consumption (ATP), and exposure of phosphatidylserine on the cell outer 
membrane. Definite criteria of apoptotic characteristics, however, remain to be fully 
described, since they are overlapping with other forms of cell death (Kroemer et al. 2009, 
Kroemer et al. 2005, Galluzzi et al. 2011). 
1.1.4 Non-apoptotic cell death 
Cell death is a growing area of research and since the first descriptions of programmed cell 
death (PCD) non-apoptotic types of cell demise have been proposed (Kroemer et al. 2009, 
Kroemer et al. 2005, Galluzzi et al. 2011). Certain tentative definitions of atypical cell death 
include mitotic catastrophe, anoikis, paraptosis, pyroptosis, pyronecrosis, and entosis. Anoikis, 
for instance, is cell death of adherent cells caused by loss of cell-to-matrix interaction. 
However, anoikis is mostly executed by intrinsic apoptosis machinery (Frisch, Francis 1994). 
Another similar form of cell death is entosis that is characterized as a non-apoptotic cell death 
process. Entosis was found to occur in epithelial cells detached from the matrix, subsequently 
eaten by neighboring cells (Overholtzer et al. 2007). The peculiar finding was that the cells 
were alive and seemed normal by the time of engulfment, also the cell death was driven by 
lysosomal degradation machinery rather than apoptosis or autophagy (Overholtzer et al. 
2007). 
Autophagic cell death 
Autophagy, also called self-eating, is a catabolic pathway of cytoplasmic constituents and 
organelles by delivery to and fusion with the lysosome (Mizushima 2007). The lysosome 
contains hydrolases that require acidic environment (pH 4,8) and the organelle maintains this 
acidic environment by pumping protons from the cytosol via proton pumps and chloride ion 
channels. These hydrolases are able to proteolyse the constituents delivered to the lysosome 
and recycle basic materials such as amino acids and lipids. Autophagy is mediated by a 
specialized organelle, the autophagosome, that sequesters portions of cytosol in response to 
certain stimuli. Originally autophagy was found to be an adaptive response to nutrient 
deprivation but now it is also linked to clearance of damaged organelles and aggregated 
proteins and serves to protect cells from different stressors (Banerjee, Beal & Thomas 2010). 
Existence of autophagic vacuoles in dying cells has introduced the term “autophagic cell 
death” or more conveniently, “cell death with autophagy” (Mizushima 2005). Dysregulation 
of autophagy has emerged in numerous diseases, especially in neurodegenerative diseases 
where observation of increased amounts of autophagosomes have provoked discussion about 
their roles in neuronal cell death (Banerjee, Beal & Thomas 2010). However, in neurons it 
has been thought that defective rather than excessive autophagy results in cell death.  
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Autophagy can be divided into three types: macro-, micro- and chaperone-mediated 
autophagy (Mizushima 2007). Macroautophagy, which is usually referred to as bare 
autophagy, involves de novo formation of autophagosomes that sequester proteins targeted to 
lysosomes. Microautophagy is basically direct pinocytosis of cytosol by the lysosome and 
functions continuously in resting state (Banerjee, Beal & Thomas 2010). Chaperone-mediated 
autophagy (CMA) is a selective degradation pathway of proteins containing a pentapeptide 
motif (KFERQ) that is recognized by a cytosolic chaperone, heat-shock cognate 70 (HSC70), 
targeting the substrates to lysosomes. CMA can be induced for prolonged times, for instance, 
during nutritional deprivation (Kon, Cuervo 2010).  
The machinery of autophagy includes over 30 genes named autophagy-related genes (ATG) 
(Klionsky 2007). Classical pathway to autophagy involves mTOR (mammalian target of 
rapamycin), a kinase that negatively regulates autophagy. mTOR-mediated inhibition can be 
removed by e.g. starvation resulting in autophagosome formation. Furthermore, a protein 
involved in autophagy, Beclin-1 (Atg-6), is bound to Bcl-2 under normal conditions but 
released in response to starvation (Pattingre et al. 2005) emphasizing the roles of one cell 
death pathway beyond its borders. Another example of interconnections between cell death 
pathways comes from the finding that Atg5 and Beclin-1 deficient cells are unable to express 
phosphatidylserine (PS) on their surface and secrete less lysophosphatidylcholine (LPC), a 
signal for phagocytic clearance, during apoptosis (Qu et al. 2007). Thus, autophagy might 
also be needed for proper function of phagocytosis since PS exposure is a prerequisite for 
apoptotic cell engulfment by phagocytes (Marguet et al. 1999). Rapamycin has been shown 
to ameliorate amyloid and tau pathology in a mouse model of AD (Spilman et al. 2010). 
Moreover, autophagy has been linked to HD, where sequestration of mTOR as well as 
Beclin-1 to mutant huntingtin aggregates might both induce but also inhibit autophagy, 
respectively, resulting in inefficient clearance of aggregates (Ravikumar et al. 2004, Shibata 
et al. 2006, Hyrskyluoto et al. 2012). 
PARP-1 –dependent cell death 
Poly(ADP-ribose) polymerase 1 (PARP-1) is a nuclear DNA repair enzyme that modulates 
the activities of histones and topoisomerases by incorporating polymers of ADP-ribose in 
response to DNA damage. PARP-1 –dependent cell death divides opinions, some considering 
it as a form of necrosis (Duprez et al. 2009), others as a separate cell death mode, also termed 
parthanatos (Andrabi, Dawson & Dawson 2008). Regardless, early activation of PARP-1 
occurs during excitotoxicity, ischaemia, traumatic brain injury and several neurodegenerative 
disorders. The molecular determinants include accumulation of poly (ADP-ribosyl)ated 
proteins and translocation of AIF (Apoptosis inducing factor) to the nucleus (Yu et al. 2002). 
PARP-1 is also a substrate for caspases (Lazebnik et al. 1994). 
1.2 Mediators of apoptosis 
1.2.1 Apoptosis in the nematode Caenorhabditis elegans  
Pioneering work in the characterization of apoptotic proteins was conducted in the nematode 
Caenorhabditis elegans (C. elegans) during the 1990s. C. elegans has provided many 
advantages in cell death research mostly due to its small size and short generation time (3d). 
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The development of C. elegans hermaphrodite has been fully characterized: 1090 somatic 
nuclei are generated out of which 131 undergo programmed cell death to yield an adult worm 
with 959 somatic cells (Metzstein, Stanfield & Horvitz 1998). Furthermore, 116 of all dying 
cells are derived from the lineage forming the nervous system, highlighting the importance of 
cell death in formation of functional neuronal networks.  
Genetic studies on C. elegans have defined over 20 genes involved in programmed cell death 
(Lettre, Hengartner 2006). Apoptosis in C. elegans can be described by a linear model as 
shown in Figure 1. Genes involved in all these steps have been characterized and divided into 
four groups according to which phase they take part in: decision, execution, engulfment, and 
degradation. The decision-making is assumed to be controlled by several mechanisms. 
However, two neurosecretory motor (NSM) neurons that normally die during development 
are rescued by mutations in ces-1 (cell death specification abnormal) or ces-2 genes. Both 
ces-1 and ces-2 are transcription factors and ces-1 is thought to inhibit NSM sister cell death 
while ces-2 inhibits the pro-survival function of ces-1 thereby causing cell death (Lettre, 
Hengartner 2006) (Fig 1).  
 
Figure 1 Cell death in C. elegans. Mammalian homologs are circled. Abbreviations: ABCA: ATP-Binding Cassette, 
subfamily A; AIF: Apoptosis Inducing Factor; Apaf-1: Apoptotic Protease-Activating Factor-1; Bcl-2: B-Cell Lymphoma 2; 
BH3: Bcl-2 Homology-3; bZIP: basic region leucine-ZIPper; ced: CEll Death abnormal; ces: CEll death Specification 
abnormal; cps-6: CED-3 Protease Suppressor 6; crn-1: Cell death Realated Nuclease 1; DOCK1: Dedicator Of CytoKinesis 
1; egl-1: EGg-Laying abnormal; ELMO-2: Engulfment and celL Motility gene-2; FEN-1: Flap structure-specific 
EndoNuclease-1; GULP: phosphotyrosine-binding (PTB) domain-containing enGULfment adaptor Protein 1; LRP1: Low 
density lipoprotein receptor-Related Protein 1; nuc-1: NUClease abnormal; Rac1: RAs-related C3 botulinum toxin substrate 
1; wah-1: Worm AIF Homolog. 
Three apoptotic genes were found to be essential for the developmental PCD to occur, 
therefore called the “killer genes”. Loss-of-function in the egl-1 (egg-laying abnormal), ced-3 
(cell death abnormal) or ced-4 genes were found to resist the PCD of all 131 cells that 
normally are removed during wild-type development (Conradt, Horvitz 1998, Ellis, Horvitz 
1986). Egl-1 shares similarity to mammalian BH3-only proteins, Bax and Bid. The other two 
“killer genes”, ced-3 and ced-4, also have mammalian counterparts; caspase and Apaf-1, 
respectively. Loss-of-function mutations in these genes result in similar phenotype as seen in 
egl-1 mutant. Another gene involved in the execution phase of apoptosis is ced-9 that on the 
contrary to the “killer genes” is anti-apoptotic. Mutations in ced-9 gene lead to ectopic cell 
death and embryonic lethality (Hengartner, Ellis & Horvitz 1992). As a consequence, 
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overexpression of ced-9 or its mammalian homolog bcl-2 protects against cell death 
(Hengartner, Horvitz 1994). Normally, CED-9 resides in the outer mitochondrial surface and 
binds CED-4 in an inactive conformation. When destined to apoptosis, EGL-1 is produced 
that binds to CED-9 thereby releasing CED-4 dimer. CED-4 then forms a tetramer that recruit 
proCED-3 to an apoptosome. The apoptosome activates CED-3 by proteolysis and 
subsequently CED-3 continues to execute apoptosis by cleaving important cellular proteins 
(Lettre, Hengartner 2006) (Fig 1). The engulfment by neighboring cell is mediated by several 
ced –genes as shown in figure 1. These genes are involved i.e. in cytoskeletal rearrangements. 
Finally the degradation of the engulfed cell involves activation of several nucleases that 
degrade the DNA from the cell corpse (Fig 1).  
Mechanisms of apoptosis are evolutionarily conserved with much more complex variations in 
higher order animals as compared to C. elegans. Nonetheless, apoptosis in C. elegans is 
considered as a simplified model of mammalian apoptosis (Fig. 1).  
1.2.2 Caspase family proteins 
Apoptotic signaling often leads to activation of cysteine specific proteases called caspases 
(cysteinyl aspartate-specific proteinases) (Thornberry 1997, Cohen 1997).  Caspase activation 
is an important step in the cell’s commitment to apoptosis and can be regarded as a point of 
no return. Caspases are responsible for most of the visible characteristics of apoptosis, shown 
by deletion studies, and using inhibitors that block caspase activation and subsequent 
apoptosis (Earnshaw, Martins & Kaufmann 1999). Caspases are translated as inactive 
zymogens (pro-caspases) and they reside dormant in the cytosol waiting for a signal of 
activation. The apoptotic caspases are divided into upstream initiator caspases (caspase-2, -8, 
-9, -10, and -12) that upon apoptotic stimulus are activated via dimerization. Dimerization is 
brought about by interaction of apoptotic regulator proteins with the initiator caspase 
prodomains containing either caspase recruitment domain (CARD) or dead effector domain 
(DED). This interaction enables clustering of procaspases and subsequent caspase activation 
cascade (Creagh, Conroy & Martin 2003). Caspase-2 was initially considered as an initiator 
caspase since it is activated by dimerization, however, recent studies have indicated caspase-2 
also in other functions apart from apoptosis, including cell cycle arrest and in tumor 
suppression (Bouchier-Hayes, Green 2012). Thus caspase-2 has been designated as an 
“orphan” caspase (Bouchier-Hayes, Green 2012). 
Table 1 Caspase family proteins.  
Group  Members Prodomain Special  
Group I Pro-inflammatory 
caspases 
Caspase-1, -4, -5, -
12 (in humans), -
13, and -14 
Long  Involved in cytokine 
maturation, inflammatory 
response 
Group II Apoptotic 
initiator caspases 
Caspase-(2), -8, -9, 
-10, and -12 
(rodents) 
Long  Contain DED (8 and 10), or 





Caspase-3, -6, and -
7 
Short  Contain NED domain 
Abbreviations: CARD: Caspase Recruitment Domain; DED: Dead Effector Domain; NED: Non-Enzymatic Domain. 
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As the name implies, caspases are specific for substrate proteins that contain an aspartate 
(Asp/D) residue and use a conserved cysteine residue in their active site for catalyzing the 
peptide bond cleavage (Pop, Salvesen 2009). Caspases posses fairly conserved substrate 
pockets or amino acid recognition sites with slight variations (Chowdhury, Tharakan & Bhat 
2008). Caspase substrates usually contain a tetrapeptide that usually ends with the critical 
aspartate residue; however, variations in the tetrapeptide sequence are numerous for different 
caspases (Pop, Salvesen 2009). The means by which caspases exert the destruction occurs by 
either inactivation of the target protein, or by activation via cleavage of a regulatory domain 
(Hengartner 2000).  
Once initiator caspases are activated they cleave downstream effector caspases or “executors” 
(caspase-3, -6, and -7) in a cascade –like manner (Slee et al. 1999). These executors 
eventually perform the destructive work by cleaving the key enzymes and structural proteins 
resulting in the formation of apoptotic bodies. It is estimated that caspases have in the order 
of several hundred substrates, especially, cytoskeletal and nuclear proteins, as well as 
important signaling proteins (Chowdhury, Tharakan & Bhat 2008). Important caspase 
substrates include the nuclease responsible for the nucleosomal laddering, used to detect 
apoptosis (Wyllie 1980). Nowadays known as CAD, caspase-activated DNase, is translated 
with an inhibitory subunit (ICAD) that is released by activated caspase-3 (See fig 3). As a 
result, active CAD cuts DNA to fragments of approximately 180 base pair (Liu et al. 1997, 
Enari et al. 1998). Other downstream effects of caspase activation include cleavage of nuclear 
lamins, resulting in nuclear shrinking and budding (Rao, Perez & White 1996), cleavage of 
cytoskeletal proteins, such as spectrin, gelsolin and PARP (Wang et al. 1998, Kothakota et al. 
1997, Lazebnik et al. 1994) and constitutive activation of p21 activated kinase 2 (PAK2) by 
cleavage of the negative regulatory subunit (Rudel, Bokoch 1997).	  
Non-cell death related functions 
In addition to apoptosis, some caspases have roles beyond cell death. These include both 
proteolytic and non-proteolytic processes, involving their catalytic- and prodomains, 
respectively. A subset of caspases is involved in inflammation, specifically, in the maturation 
of lymphocytes. The first caspase to be described was interleukin-1 (IL-1) beta converting 
enzyme (ICE; caspase-1) that, as the name implies, converts the precursor of the pro-
inflammatory cytokine IL-1 beta to its mature form (Thornberry et al. 1992). Together with 
caspase-1, caspase-4 and -5 belong to the group I pro-inflammatory caspases involved in 
cytokine maturation. Moreover, certain bacteria have been shown to use caspase-1 to kill 
their host cells, and this caspase-1 –dependent cell death has been termed pyroptosis (Labbe, 
Saleh 2008). Other non-cell death related functions of caspases include regulation of cell 
survival, proliferation, and differentiation (Lamkanfi et al. 2007).  
In addition, it has been proposed that only caspase-14 might function as a true non-apoptotic 
caspase (Pop, Salvesen 2009). Caspase-14 is strictly expressed in suprabasal layers of 
epidermis and involved in keratinocyte differentiation and cornification, and is essential in 
protection against UVB photodamage (Denecker et al. 2007).  
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The activation of caspase-2 occurs via a signaling platform consisting of PIDD (p53-induced 
protein with a death domain) and RAIDD (Receptor interacting protein (RIP)-associated 
ICH1/CAD-3 homologous protein with a death domain), the PIDDosome (Tinel, Tschopp 
2004). Importantly, PIDD has been implicated in NFκB (Nuclear factor κB) activation in a 
signaling complex consisting of RIPK1 (Receptor interacting protein kinase 1) and NEMO 
(NFκB essential modulator)/IKKγ (Inhibitor of κB (IκB) kinase γ) (Janssens et al. 2005). 
Activation of PIDD occurs in response to DNA damage and which signaling module is 
assembled is determined dose-dependently and thus by the extent of damage. PIDD can be 
considered therefore as a molecular switch between cell death (caspase-2 activation) and 
survival (NFkB activation) (Bouchier-Hayes, Green 2012). 
Table 2 Phenotypic effects of caspase knock-out in mice (Earnshaw, Martins & Kaufmann 1999, Degterev, Boyce & 
Yuan 2003). 
Group Member Developmental 
effect in knock-
out mouse 





Caspase-1 Normal Defective production of IL 1 α, 1β, 18 
and IFNγ. Resistant to septic shock 
 Caspase-4, -5 - - 
 Caspase-11 Normal Defective production of IL 1 α, 1β, 18 
and IFNγ. Defective lymphocyte 





Caspase-2 Normal Reduced numbers of facial motor 
neurons at birth. Resistance to granzyme 
B + perforin induced B-lymphocyte cell 
death. Defective in developmental and 
doxorubin-induced apoptosis of oocytes. 
Accelerated aging (Zhang et al. 2007) 
 Caspase-8 Embryonic 
lethal 
Impaired development of cardiac 
muscles, abdominal hemorrhage. 
Defects in death—receptor activated 
apoptosis 
 Caspase-9 Embryonic/ 
neonatal lethal 
Abnormal brain development, neuronal 
hyperplasia 
 Caspase-10 - Deletion in humans cause systemic 
juvenile idiopathic arthritis (Tadaki et al. 
2011) 
 Caspase-12 Normal Resistance to ER stress-induced cell 
death and Aβ toxicity. Resistance to 






Defective brain development, neuronal 
hyperplasia. Defect in DNA 
fragmentation during apoptosis 
 Caspase-6  - 
 Caspase-7 Normal Appear normal, substituted by other 
caspases. 
Abbreviations: Aβ: Amyloid beta; IFNγ: Interferon gamma; IL: Interleukin. 
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Lessons from caspase knock-out mice – relevance for brain development 
While deletion of ced-3 gene in C.elegans resulted in almost total inability to developmental 
apoptosis, deficiency in mammalian caspases exert often tissue-specific defects in apoptosis 
due to wider selection of caspases. For instance, caspase-8 deficiency in mouse is embryonic 
lethal, impairs cardiac muscle development and blocks signaling through the death receptors 
TNFR1, Cd95/Fas/Apo1 and Dr3 (Varfolomeev et al. 1998). Knockout of either caspase-1 or 
-11 in mice produce viable animals that show resistance to ischaemic brain injury and 
lipopolysaccharide (LPS)-induced endotoxic shock (Li et al. 1995, Kang et al. 2000, Schielke 
et al. 1998). Caspase-3 and caspase-9 deletions have been shown to affect neuronal 
development, inducing neuronal hyperplasia and perinatal lethality (Kuida et al. 1996, Hakem 
et al. 1998).  
Caspase-3 
Caspase-3 is a major executor caspase that acts downstream of caspase cascade and has 
important substrates, such as, ICAD, PARP, sterol regulatory element-binding proteins 
(SREBPs), lamins, β-catenin and other caspases (Chowdhury, Tharakan & Bhat 2008). The 
activation of caspase-3 occurs by two sequential cleavages of the full initial 32kDa proform 
to yield a heterodimer of 20kDa and 12kDa subunits (Nicholson et al. 1995). Procaspase-3 
can be cleaved, for instance, by caspase-8 that is activated by APO-1 (Fas/CD95)-receptor 
pathway involving the DISC signaling complex formation (classically termed the extrinsic 
pathway) (Kischkel et al. 1995). In addition, apoptotic signaling from mitochondria, 
formation of the apoptosome and subsequent activation of caspase-9 results in procaspase-3 
cleavage (classically termed the intrinsic pathway) (Li et al. 1997).  
Caspase-12 
The murine caspase-12 is an ER resident caspase with most homology (48%) to human 
caspase-4. Human caspase-12 is a pseudogene with the exception of some populations of 
African heritage (Saleh et al. 2004, Kachapati et al. 2006). The human functional variant of 
caspase-12 has been linked to pro-inflammatory caspases and increased risk of sepsis (Saleh 
et al. 2004). For comparison, caspase-12 defective mice show resistance to septic shock 
(Saleh et al. 2006). The murine caspase-12, has been shown to promote apoptosis in ER 
stressed cells and caspase-12 deficient mice are resistant to ER stress-induced apoptosis 
(Nakagawa et al. 2000). In addition, caspase-12 was required for Aβ -mediated cell death in 
mouse cortical neurons but is not involved in other apoptotic pathways (Nakagawa et al. 
2000). Previously, caspase-12 activation has been closely linked to cell death involving ER 
stress, such as, transient ischaemic injury and oxygen/glucose deprivation (Osada et al. 2010, 
Badiola et al. 2011).  
The ER-mediated cell death pathway can be activated by means of accumulation of 
misfolded or unfolded proteins or by perturbation of calcium homeostasis (Kaufman 1999, 
Ferri, Kroemer 2001). Caspase-12 locates to the cytoplasmic side of the ER where stress –
induced translocation of cytosolic caspase-7 results in proximity-induced caspase-12 
cleavage and activation (Nakagawa et al. 2000, Rao et al. 2001). Caspase-12 subsequently 
activates procaspase-9 that in turn activates downstream effector caspases (Rao et al. 2002a). 
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1.2.3 The Bcl-2 family proteins 
As the caspase family proteins can be viewed as a group of true cell demolitioners, the Bcl-2 
(B-cell lymphoma 2) family proteins are a group of cell death regulators, including both anti- 
and pro-apoptotic members. This family consists of approximately 20 members, divided into 
three interacting groups according to which Bcl-2 Homology (BH) domains they exhibit (Fig 
2).  
 
Figure 2 The Bcl-2 family proteins. The three subfamilies of Bcl-2 family proteins, domains present in each subfamily and 
their members. Abbreviations: A1/Bfl-1: Bcl-2-related protein A1; Bad: Bcl-2 Antagonist of cell Death; Bak: Bcl-2 
antagonistic killer; Bax: Bcl-2-Associated X protein; Bcl-2: B cell lymphoma-2; Bcl-XL: Bcl-extra long; Bid: BH3 
interacting domain death agonist; Bik: Bcl-2 interacting killer; Bim: Bcl-2 interacting mediator of cell death; Bmf: Bcl-2 
modifying factor; Bok: Bcl-2 related ovarian killer; Hrk: hara-kiri; Mcl-1: myeloid cell leukemia 1; Noxa: named for 
“injury”; Puma: p53 promoter upregulated modulator of apoptosis; TM: transmembrane domain. 
Anti-apoptotic Bcl-2 family proteins 
The founding member, proto-oncogene Bcl-2, as well as Bcl-xL, Bcl-w/Bcl2L2, A1/Bfl-1, 
and Mcl-1 (Fig 2) promote cell survival by preventing mitochondrial permeabilization and 
cytochrome c release (Fig 3). These anti-apoptotic members of Bcl-2 family contain all of the 
four BH domains 1-4 with conserved homology among all members. Bcl-2 is an integral 
membrane protein residing at the mitochondria, the ER or the nucleus (Hockenbery et al. 
1990, Zhu et al. 1996). Expression of Bcl-2 can block apoptotic features such as membrane 
blebbing and nuclear condensation. Furthermore, mice lacking the bcl-2 gene show excessive 
cell death and Bcl-2 is required for kidney, lymphocyte and melanocyte stem cell survival 
(Veis et al. 1993, Ranger, Malynn & Korsmeyer 2001) (Table 3). In addition, deletion of Bcl-
XL in mice results in massive cell death of developing neurons (Motoyama et al. 1995) (See 
table 3). 
Pro-apoptotic Bcl-2 family proteins 
The pro-apoptotic Bcl-2 proteins are divided to the multidomain (BH 1-3) pro-apoptotic or 
effector proteins, e.g. Bak and Bax, and to BH3-only proteins, e.g. Bim, Bid, Bad, and Puma 
(Fig 2). Many pro-apoptotic members are cytosolic or in contact with the cytoskeleton in 
healthy cells while death signals induce their conformational changes and targeting to 
membranes, especially to the mitochondrial outer membrane (Korsmeyer et al. 2000) (Fig 3).  
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The multidomain pro-apoptotic Bak and Bax are crucial for the mitochondrial outer 
membrane permeabilization (MOMP) (Wei et al. 2001) (Fig 3). Bak and Bax are normally 
guarded by interaction with Bcl-2, ensuring neutralization and inhibition of Bak/Bax 
oligomerization (Youle, Strasser 2008). Apoptotic signals remove this interaction and allow 
pore formation through Bax/Bak oligomerization to release the mitochondrial cell death 
machinery. Bax and Bak are related to each other having overlapping functions. Knockout 
mice of either gene produce viable animals, although Bax deficient mice are sterile (Lindsten 
et al. 2000, Knudson et al. 1995) (Table 3). However, combined deletion of Bax and Bak, 
bax-/-/bak-/-, was shown to be mostly lethal and causing wide developmental disturbances 
underlining their importance in cell death during development (Lindsten et al. 2000) (Table 
3). 
BH3-only proteins 
The BH3-only proteins function mostly as the sensors of apoptotic signals and pass it on to 
other Bcl-2 members, for instance, by antagonizing their anti-apoptotic relatives (See fig 3). 
The BH3-only protein subfamily consists of over 12 members found from mice and humans, 
and given their highly specialized tasks, this subfamily provides a higher level of fine-tuning 
for apoptotic pathways.  
For instance, the BH3-only protein, Bid, can be cleaved by caspase-8 in response to APO-1 
(Fas/CD95)-receptor pathway resulting in formation of truncated Bid (tBid) that translocates 
to mitochondria (Li et al. 1998). At mitochondria, tBid inserts to the outer membrane where it 
induces Bak and/or Bax oligomerization and pore formation (Wei et al. 2001, Wei et al. 2000) 
resulting in MOMP (See fig 3).  
Table 3 Major phenotypes in certain Bcl-2 family knock-out mice (Ranger, Malynn & Korsmeyer 2001). 
Bcl-2 
subfamily 
Member Developmental effect 




Bcl-2 Death within a few 
months of birth 
Renal failure, apoptosis in thymus, spleen, 
melanocytes, postnatal neuronal death 
 Bcl-XL Embryonic lethal 
(E13) 
Extensive neuronal death, apoptosis of hematopoietic 
cells of liver 
 Mcl-1 Embryonic lethal 
(E3,5-4) 
 
 A1 Viable Accelerated neutrophil apoptosis 
 Bcl-w Viable Male infertility 
Pro-
apoptotic 
Bax Viable Modest lymphoid and neuronal hyperplasia, male 
infertility, increased oocyte lifespan 
 Bak Viable Fertile  
 Bax/Bak 90% perinatal lethal Persistence of interdigital webs, accumulatin of CNS 
neurons, splenomegaly, resistance to various cell 
death stimuli 
BH3-only Bid Viable Resistance to anti-Fas-induced hepatocellular 
apoptosis 
 Bim Partially embryonic 
lethal before E9,5 
Perturbation of thymic development, lymphadeno-
pathy, splenomegaly. Premature death due to 
vasculitis, cardiac infarction. 
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Abbreviations: A1: Bcl-2-related protein A1; Bak: Bcl-2 antagonistic killer; Bax: Bcl-2-Associated X protein; Bcl-2: B cell 
lymphoma-2; Bcl-XL: Bcl-extra long; Bid: BH3 interacting domain death agonist; Bim: Bcl-2 interacting mediator of cell 
death; CNS: central nervous system; KO: knock-out; Mcl-1: myeloid cell leukemia 1. 
1.2.4 Inhibitor of apoptosis –proteins 
The inhibitor of apoptosis (IAP) -proteins are a family of anti-apoptotic proteins. The first 
IAP genes were found from baculovirus where they are believed to prevent apoptotic 
response in the host insect cells (Harvey et al. 1997). The IAP family comprises of eight 
members: Neuronal apoptosis inhibitory protein (NAIP/BIRC1), cellular IAP1/human IAP2 
(c-IAP1/HIAP1/MIHB/BIRC2), cellular IAP2/human IAP1 (c-
IAP2/HIAP1/MIHC/API2/BIRC3), X-linked inhibitor of apoptosis 
(XIAP/MIHA/hILP/BIRC4/ILP-1), Survivin (TIAP/BIRC5), BIR-containing ubiquitin 
conjugating enzyme (BRUCE/Apollon/BIRC6), Livin (KIAP/ML-IAP/BIRC7) and testis-
specific IAP (Ts-IAP/hILP2/BIRC8/ILP-2).  
All IAPs are structurally characterized by one or more ~70-residue Baculovirus IAP Repeat 
(BIR) domains that are zinc-containing globular structures with a conserved cysteine and 
histidine core sequence (Miller 1999). The BIR domains are essential for the anti-apoptotic 
functions of IAPs since they enable association with certain caspases and can inhibit their 
actions (Ni, Li & Zou 2005) (Fig 3). As it turns out, all IAPs have been shown to inhibit the 
caspase cascade, however, physical interactions and direct caspase inhibition have been only 
shown for some (Salvesen, Duckett 2002). Taken their anti-apoptotic functions, it is not 
surprising that IAPs have been found upregulated in certain cancers and are studied as targets 
for cancer therapy (Hunter, LaCasse & Korneluk 2007). Furthermore, IAPs are a good 
example of how the ubiquitin-proteasomal system is linked to apoptotic signaling. Five of the 
IAPs contain a carboxy-terminal RING (Really Interesting New Gene) domain that targets 
both the IAPs themselves (autoregulation) as well as pro-apoptotic proteins, such as caspase-
3 and -7, for proteasomal degradation, thus enhancing their anti-apoptotic properties (Ni, Li 
& Zou 2005). 
The RING domain is characteristic for ubiquitin E3 ligases, a family of proteins that add 
ubiquitin to target proteins in a series of enzymatic reactions, collectively termed the 
‘ubiquitination’ (Ciechanover 1998). Other enzymes involved in ubiquitination include E1 
ubiquitin activating enzyme and E2 ubiquitin conjugating enzyme. The addition of ubiquitin 
protein to target protein at a lysine recidue signals most often for degradation of the target 
protein in the proteasome but can also be a sign for endocytosis, activation or other signaling 
mechanism (Ciechanover 1998). The ability to form isopeptide bonds between other ubiquitin 
polypeptides makes ubiquitin a versatile signal molecule. Seven lysine residues in the 
ubiquitin polypeptide enable multible different types of linkages. Of these a polyubiquitin 
chain formed via Lys48 has been shown to be the signal for proteasomal degradation. Others, 
like Lys63 linked polyubiquitin chains are involved in regulatory functions and Lys11 linked 
polyubiquitin chains have been shown to control cell division (Strieter, Korasick 2012).   
XIAP is ubiquitously expressed and might be a “housekeeping” IAP functioning in prevention 
of apoptosis induced by various extracellular stimuli such as UV light, chemotoxic drugs, and 
activation of the tumor necrosis factor (TNF) and Fas receptors (Duckett et al. 1996, Duckett 
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et al. 1998, Hunter, LaCasse & Korneluk 2007). XIAP mediates its protective effect 
downstream of mitochondrial cytochrome c release in contrast to Bcl-xL that protects 
mitochondrial integrity (Duckett et al. 1998). XIAP contains three BIR domains, the third of 
which (BIR3) inhibits caspase-9 activity by binding monomeric forms of mature caspase-9 
(Shiozaki et al. 2003). On the contrary, the linker region between BIR1 and BIR2 of XIAP 
inhibits cleaved caspase-3 and -7 (Riedl et al. 2001, Scott et al. 2005, Chai et al. 2001). 
Smac/DIABLO binds the same region as caspase-9 and can antagonize the inhibitory effect 
of XIAP on caspase-9 (Srinivasula et al. 2001). Ablation of XIAP in mice is viable and 
perhaps partially compensated by c-IAP-1 and c-IAP-2 (Harlin et al. 2001).  
Expression of XIAP has been detected during rat brain development and in adult rat brain 
(Korhonen, Belluardo & Lindholm 2001). Caspase-3 activation by kainic acid results in 
XIAP degradation in the rat hippocampus. In addition, it has been shown that caspase-3 
induces cleavage of XIAP BIR3 motif that releases caspase-9 inhibition and allows additional 
caspase activation (Zou et al. 2003). XIAP has been indicated protective for neuronal cells in 
several ways. Overexpression of XIAP reduced caspase-12 cleavage and calpain activation in 
a mouse model of ALS, carrying human mutant superoxide dismutase 1 (SOD1) (Wootz et al. 
2006). Furthermore, overexpression of XIAP induces brain neurotrophic factor (BDNF) 
(Kairisalo et al. 2009) and mitochondrial antioxidant SOD2 (Kairisalo et al. 2007) via nuclear 
factor-κB (NFκB) dependent mechanisms. Interestingly, resveratrol, an antioxidant 
polyphenol found in grapes and red wine was shown to increase XIAP levels and 
mitochondrial antioxidants in rat PC6.3-cells (Kairisalo et al. 2011) and provides an 
intriguing therapeutic agent in multiple disorders. 
c-IAP-1 and c-IAP-2, the two closest IAP family proteins to XIAP, have also been shown to 
bind to caspases, however, their capacity to inhibit caspases is poor as compared to XIAP 
(Eckelman, Salvesen 2006). Despite their poor caspase inhibition ability, c-IAPs may still 
contribute to apoptosis pathways via their ubiquitin ligase activity. Indeed, it was shown that 
c-IAP-1 and c-IAP-2 bind and ubiquitinate Smac/DIABLO (Hu, Yang 2003). In addition, c-
IAP-1 ubiquitinates TRAF2 in response to TNF receptor II activation (Li, Yang & Ashwell 
2002, Samuel et al. 2006). The rat inhibitor of apoptosis protein-2 (RIAP-2), homologue of 
human c-IAP-1, is expressed mainly by neurons in the adult rat brain and KA was shown to 
regulate RIAP-2 expression in vulnerable areas of the hippocampus (Belluardo et al. 2002). 
KA induced similar expression patterns for XIAP and RIAP-2 with initial increase in the 
levels in certain areas, including the CA3 area of the hippocampus, followed by a decrease in 
longer time-points (Korhonen, Belluardo & Lindholm 2001, Belluardo et al. 2002).   
The first mammalian IAP to be found was NAIP (Roy et al. 1995). Deletion of NAIP in 
patients with severe form of the neurodegenerative disease spinal muscular atrophy (SMA) 
was initially thought to be the gene responsible for the disease, however, later identified as a 
modifier of the severity of the disease (Roy et al. 1995, Scharf et al. 1998). NAIP has been 
shown to inhibit neuronal cell death in vitro and in vivo (Simons et al. 1999, Xu et al. 1997b). 
In addition, NAIP expression was shown to be elevated in response to ischaemia in surviving 
neurons (Xu et al. 1997a) and might have broad neuroprotective effects in disorders involving 
neuronal damage. The protective effect of NAIP has been linked to interaction with 
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hippocalcin, a neuronally expressed calcium-binding protein that increased the 
neuroprotective effect of NAIP BIR-domains against calcium-induced motor neuron death 
(Mercer et al. 2000). The fact that XIAP is considered the only true caspase inhibitor and 
many of the other IAPs likely use their ubiquitin ligase activity to inhibit apoptosis has raised 
the question how NAIP functions since it does not contain the RING domain. Recently, it 
was shown that NAIP binds and inhibits pro-caspase-9 via its BIR3 domain and has been 
evolved resistant to inhibition by Smac-type proteins (Davoodi et al. 2010).  
The giant 530kDa IAP, Bruce, contains a ubiquitin conjugating domain (UBC), characteristic 
for E2 ubiquitin conjugating enzymes, in its C-terminus, in addition to the BIR domain 
(Hauser et al. 1998). Apollon, the human homolog of Bruce, was first identified in human 
brain cancer cells, gliomas, showing resistance to chemotherapy (Chen et al. 1999). 
Interestingly, Bruce deletion is embryonic lethal in mouse and it was identified as 
indispensable for Smac ubiquitination and degradation (Hao et al. 2004). KA treatment in the 
rat decreased Bruce levels in the hippocampus in coordination with caspase-3 activation and 
cell death that was further increased by an antisense oligonucleotide for Bruce (Sokka et al. 
2005). Taken together, Bruce, as well as c-IAP-1/RIAP-2 and XIAP are downregulated in 
cells undergoing KA-induced apoptosis underlining their importance in cellular survival. 
In addition to Smac and Omi, another IAP inhibitor, XAF1 (XIAP-Associated Factor 1) has 
been characterized that inhibits most IAPs, including XIAP, c-IAP-1, c-IAP-2, Livin, TsIAP, 
and NAIP. XAF1 was also required for XIAP-mediated downregulation of Survivin via the 
ubiquitin-proteasome system (Arora et al. 2007). Downregulation of XAF1 has been linked to 
cancer with a coinciding IAP upregulation. Overexpression of XAF1 can sensitize cells for 
Apo2L/TRAIL-induced apoptosis and result in cancer cell death showing promise as a 
therapeutic target (Hunter, LaCasse & Korneluk 2007). 
1.2.5 Other cell death mediators 
Calpain 
Among other cell death mediators is the calcium-dependent neutral proteinase calpain that 
was identified in 1968 (Huston, Krebs 1968). The human genome encodes at least 13 
homologs of the large subunit of calpain superfamily (Dear, Boehm 2001). Only the major 
isoforms, m-calpain and µ-calpain have been found to be expressed in neuronal tissues (Wu, 
Lynch 2006). Calpains participate in numerous signaling pathways regulated by calcium. 
Calpain activation has been closely linked to neurotoxic insults often involving rises in 
intracellular calcium, occurring, for instance, during ischaemia, AD, PD, and HD (Bevers, 
Neumar 2008, Frederick et al. 2008, Yamashima 2000, Saito et al. 1993a, Bizat et al. 2003, 
Crocker et al. 2003). 
Calpains are activated in response to cytosolic calcium elevation. Threshold for half-maximal 
activation of m- and µ-calpains are 400-800µM and 3-50µM, respectively (Goll et al. 2003). 
Generally, calpains are composed of a distinct 80kDa catalytic subunit and a common 30kDa 
regulatory subunit, both of which can bind calcium. A natural inhibitor of calpain, calpastatin, 
binds the substrate binding site in calcium-dependent manner (Goll et al. 2003).  
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Neuronal calpain substrates include synaptic and post-synaptic density proteins, cytoskeletal 
proteins, and signaling proteins. In addition, calpain substrates important for cell death 
include AIF (Polster et al. 2005), Cdk5 cofactors, p35 and p39 (Kusakawa et al. 2000, Patzke, 
Tsai 2002), and spectrin (Harris, Morrow 1988, Czogalla, Sikorski 2005). Importantly, 
calpain can be activated by glutamate receptor stimulation and process also numerous 
glutamate receptors, including NMDA- and AMPA-receptor subunits, PSD95 and MAP2 
(microtubule-associated protein-2) that affect the levels, localization and stability of the 
proteins and synapses (Wu, Lynch 2006). Spectrin is an important substrate of calpain 
cleavage (Harris, Morrow 1988) and often used as a marker of calpain activation. Together 
with caspase-3, calpain cleaves at specific sites in spectrin polypeptide, and the breakdown 
product profiles can be used to distinguish the activation of these proteases.  
1.3 Organelle-specific initiation of cell death 
The initial discovery of apoptosis described it morphologically as controlled cell shrinking 
with sustained organelle and membrane integrity (Kerr, Wyllie & Currie 1972). Later on it 
was, however, recognized that intracellular organelles participate in cell death and are 
capable of sensing stressful conditions. Classic apoptotic signaling was divided to extrinsic or 
death receptor pathway and intrinsic or mitochondrial pathway characterized by MOMP and 
release of mitochondrial cell death mediators (See fig 3). 
The evolution of eukaryotes includes the formation of compartmentalized, highly specialized 
membrane-bound structures, organelles. This compartmentalization has provided evolvability 
through microenvironments that are maintained by controlled ion and small molecule flux 
across their membranes. Importantly, coupled to this is the vesicle transfer between 
organelles, which allows distribution of molecules to secretion or sites where they are needed 
in the cell. Organelle-specific responses that aim to adaptation and restoration of homeostasis 
or, after surpassing a threshold, lead to activation of cell death pathways are now 
acknowledged and under intense investigations. At the level of the whole cell, it should be 
noted that perturbations in any organelle could ultimately lead to activation of the common 
apoptotic pathway (Ferri, Kroemer 2001). 
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Figure 3 Intrinsic and extrinsic cell death pathways. The intrinsic or mitochondrial apoptotic pathway can be induced by 
DNA damage, free radicals or other stressors leading to activation of BH3-only proteins, release of anti-apoptotic Bcl2 
members from pro-apoptotic Bcl-2 members and Bax/Bak oligomerization. Bax/Bak oligomerization results in 
mitochondrial outer membrane permeabilization (MOMP) and release of mitochondrial cell death mediators. Cytochrome c 
forms part of the apoptosome with Apaf-1 and pro-caspase-9 that is a platform for activation of caspase-9. Active caspase-9 
can further activate the executioner caspase-3 that further cleaves major cellular substrates and executes apoptosis. AIF and 
Endo G, release from mitochondria results in their translocation to the nucleus where they take part in nuclear DNA 
degradation. Smac/DIABLO and Omi/HtrA are both inhibitors of IAP proteins and their release enables release of cell death 
molecules that are normally kept in guard by IAPs. Extrinsic or death receptor pathway can be activated by extracellular 
stimuli by binding of ligands to their cognate death receptor. Ligand binding induces receptor interaction with adapter 
proteins FADD or TRADD and formation of a caspase-activating platform for initiator caspases, such as caspase-8. Active 
caspase-8 can directly further activate the executioner caspases, such as caspase-3 but also activate Bid that in turn enhances 
the mitochondrial cell death pathway. Caspase-3 cleaves ICAD releasing CAD from the inhibitory subunit that allows its 
translocation to the nucleus for DNA degradation. Abbreviations: A1: Bcl-2-related protein A1; AIF: apoptosis inducing 
factor; Apaf-1: apoptotic protease-activating factor-1; Bak: Bcl-2 antagonistic killer; Bax: Bcl-2-Associated X protein; Bcl-2: 
B cell lymphoma-2; Bcl-XL: Bcl-extra long; Bid: BH3 interacting domain death agonist; Bruce/Apollon: BIR-containing 
ubiquitin-conjugating enzyme; c-IAP1/2: cellular IAP1/2; IAP: inhibitor of apoptosis –protein; DD: death domain; DED: 
death effector domain; Endo G: endonuclease G; FADD: Fas-associated death domain; ICAD: caspase-activated DNAse 
with inhibitory subunit; ILP-2: testis-specific IAP; Mcl-1: myeloid cell leukemia-1; NAIP: neuronal apoptosis inhibitory 
protein; Omi/HtrA2: high temperature requirement A2; Smac/DIABLO: second mitochondria-derived activator of caspases; 
TRADD: TNFR-1-associated death domain; XIAP: X-linked IAP.  
1.3.1 Extrinsic / death receptor pathway 
Some cells express cell surface receptors that upon binding their cognate ligands can form a 
platform for caspase activation. These, so called ‘death receptors’ belong to tumor necrosis 
factor receptor (TNFR) family and include CD95/Fas/Apo-1 (Cluster of differentiation 
95/Fas/apoptosis antigen 1) receptor that binds FasL, type 1 tumor necrosis factor α (TNFα) 
receptor that binds TNFα, death receptor 3 (DR3) that binds Apo3 ligand, and DR4 and DR5 
that bind Apo2/TRAIL (Degli-Esposti 1999, Pan et al. 1997, Friesen et al. 1996). Receptor 
activation follows interaction with specific adapter proteins, containing death domains (DD), 
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such as, Fas-associated death domain (FADD) and TNFR-1-associated death domain 
(TRADD) that initiate apoptosis by activating caspase-8 or caspase-10 via their death effector 
domain (DED) (Chinnaiyan et al. 1995, Boldin et al. 1995, Hsu, Xiong & Goeddel 1995) 
(See fig 3). 
For instance, binding of FasL to CD95/Fas/Apo-1 induces association with the adapter 
molecule FADD that has the ability to form oligomers when bound to receptor (Chinnaiyan et 
al. 1995, Boldin et al. 1995, Tourneur, Chiocchia 2010). Death effector domain (DED) motifs 
located in the N-terminal part of FADD activate pro-caspase-8 through homotypic interaction 
and this allows efficient activation of caspase-8 (Tourneur, Chiocchia 2010). Active caspase-
8 then directly cleaves caspase-3 and Bid, a pro-apoptotic protein that can translocate to 
mitochondria to release cytochrome c, leading to further enhancement of caspase activation 
(Luo et al. 1998, Budihardjo et al. 1999) (Fig 3).  
1.3.2 Mitochondrial cell death pathway 
Mitochondrial or intrinsic pathway can be triggered by various stressors, including DNA 
damage, free radicals or damage by toxins, leading to apoptotic signaling with central role 
played by mitochondria. Mitochondrial outer membrane permeabilization (MOMP) occurring 
after apoptotic stimulus promotes the release of several pro-apoptotic proteins to the cytosol. 
These include cytochrome c, Smac/DIABLO, AIF, EndoG and Omi/HtrA2. MOMP is thus 
the major driving force in cell death pathways initiated by mitochondria. In addition to Bak 
and Bax, mediating MOMP, it was previously shown that upon genotoxic DNA damage, 
release of histones promotes mitochondrial damage that occurs via a strong interaction 
between histones and mitochondria, and that this results in the permeabilization of the 
mitochondrial membranes (Cascone et al. 2012) (Fig 3). 
Cytochrome c 
Cytochrome c is an essential protein for cell life and death. It resides in mitochondria and 
involves in cellular respiration as part of the electron transport chain as well as scavenges 
reactive oxygen species (ROS) (Landes, Martinou 2011). In addition to supporting cell’s life 
and wellbeing it was recognized to take crucially part in apoptosis (Liu et al. 1996). Induction 
of MOMP allows cytochrome c to flow to the cytosol where it activates an adaptor protein, 
Apaf-1 (Fig 3).  
Apaf-1  
Apaf-1 (Apoptotic Protease-Activating Factor-1) is a multidomain protein containing 
caspase-recruitment domain (CARD), a nucleotide-binding and oligomerization domain 
(NOD) and a regulatory Y-domain composed of WD40 (named after their terminal 
tryptophan (W) and aspartic acid (D) dipeptide) repeats (WDRs) (Zou et al. 1997). In healthy 
cells, Apaf-1 exists in an inactive form as monomer while binding of cytochrome c to the 
WDRs after MOMP induces conformational changes in Apaf-1, including ATP hydrolysis of 
the NOD domain and subsequent nucleotide exchange (Kim et al. 2005). Through several 
steps of activation, Apaf-1 molecules are able to oligomerize into a heptameric apoptosome 
complex (Riedl, Salvesen 2007) (Fig 3). Oligomerization is coupled to procaspase-9 
recruitment via the CARD domains in both procaspase-9 and Apaf1 (Qin et al. 1999). Thus, 
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the apoptosome serves as a platform and greatly raises the local concentration of procaspase-
9 further allowing subsequent caspase cascade and caspase-3 activation (Bratton, Salvesen 
2010) (Fig 3).  
Omi/HtrA2 
HtrA2 (High temperature requirement A2), also known as Omi, is a serine protease located 
normally in the mitochondria (Suzuki et al. 2001). After translation, HtrA2 is delivered to 
mitochondria by mitochondrial targeting sequence (MTS) and inserted to the inner 
mitochondrial membrane. Maturation requires proteolysis and release of HtrA2 to the inner 
mitochondrial space (Vande Walle, Lamkanfi & Vandenabeele 2008). Apoptotic stimulus 
allows HtrA2 to relocate to the cytosol where it can bind and neutralize inhibitor of apoptosis 
(IAP)-proteins (Fig 3), such as the X-linked inhibitor of apoptosis protein (XIAP), and 
directly promote apoptosis with its proteolytic activity (van Loo et al. 2002). Deletion of 
HtrA2 gene in mice has been linked to parkinsonian, neurodegenerative phenotype and 
premature death (Jones et al. 2003). Consequently, mutations in the HtrA2 gene were 
associated to Parkinson’s disease (PD), altered mitochondrial morphology and susceptibility 
to stress-induced cell death (Strauss et al. 2005). In addition, Cdk5 was recently found to 
phosphorylate HtrA2 at S400 during p38 activation, increasing its protease activity and 
possibly neuroprotection by maintaining mitochondrial membrane potential (Fitzgerald et al. 
2011).  
AIF  
AIF (Apoptosis-inducing factor) was the first mitochondrial protein linked to cell death 
independent of caspases (Susin et al. 1996, Susin et al. 1999). Normally AIF resides in the 
mitochondrial intermembrane space (IMS) but can be proteolysed and released in response to 
MOMP. During cell death, AIF traverses from the mitochondria to the nucleus to condense 
and fragment DNA (Fig 3). Furthermore, AIF has functions as part of the respiratory chain 
and metabolic redox reactions (Joza et al. 2009). AIF is released after most proapoptotic 
signals inducing MOMP; however, certain signals can promote AIF release specifically, such 
as glutamate excitotoxicity and ischemic insults (Zhu et al. 2003, Wang et al. 2004). In 
addition, excessive DNA damage can activate the PARP-1 –dependent cell death pathway 
independent of caspases but dependent on AIF (Yu et al. 2002). The release of AIF without 
MOMP was proposed to involve calpain-mediated proteolysis (Polster et al. 2005). 
Interestingly, PARP-1-mediated cell death can be induced by excitotoxins, including NMDA 
and KA that are also linked to calcium-mediated calpain activation (Wang et al. 2004, Polster 
et al. 2005, Cheung et al. 2005). A mouse model with reduced AIF expression, the 
“Harlequin” (Hq), showed less neuronal damage in the hippocampus after KA treatment 
suggesting that AIF is an important mediator of excitotoxic cell death (Cheung et al. 2005). 
Smac/DIABLO  
Smac (Second Mitochondria-derived Activator of Caspases) is a natural inhibitor of IAP-
family proteins (Du et al. 2000). Mitochondrially located in healthy cells, Smac is cleaved 
and released into the cytosol in response to apoptotic stimulus (Shiozaki, Shi 2004) (Fig 3). 
EndoG  
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Endonuclease G released from mitochondria upon apoptosis is translocated to the nucleus 
where it cleaves chromatin DNA into nucleosomal fragments (Li, Luo & Wang 2001) (Fig 3). 
EndoG functions independently of caspases. 
1.3.3 Lysosomal initiation of cell death 
The lysosomes are involved in hydrolysis of intracellular macromolecules and filled with 
different types of hydrolytic enzymes such as proteases, lipases, nucleases, glycosidases, and 
phosphatases, among others, that are enzymatically active at low pH. Lysosomal membrane 
permebilization (LMP) might occur when uncharged lysosomotropic amines are taken by the 
lysosomes and accumulate in excess due to the their ability to become protonated in the 
acidic environment. These protonated forms then act as detergents to destabilize the 
lysosomal membranes (Boya, Kroemer 2008). In addition, ROS, Bax, as well as various other 
agents have been indicated in LMP (Terman et al. 2006). LMP usually results in cell death as 
it involves the release of proteases, cathepsins B, D and L that are active also in neutral pH 
and able to activate caspases and other apoptotic effectors (Boya, Kroemer 2008). Balance 
between complete and partial lysosomal breakdown determines the cell death pathway. 
Complete disruption usually induces necrosis while partial breakdown of a subset of 
lysosomes may cause apoptotic cell death. For instance, in mouse hepatocytes it was shown 
that TNF-α induces Bid-mediated LMP and subsequent activation of caspase-2 that further 
facilitated mitochondrial permeabilization (Guicciardi et al. 2005). Apart from LMP, 
deficiency in lysosomal function has been linked to neuronal cell death in certain disorders. 
For instance, deficiency in cathepsin B and L cause neurodegeneration in mice that is similar 
to human neuronal ceroid lipofuscinoses (Felbor et al. 2002, Siintola et al. 2006, Jalanko, 
Braulke 2009).  
1.3.4 Golgi apparatus and cell death 
The Golgi apparatus is an ancient organelle with a central function in the secretory pathway. 
In mammalian cells the Golgi is most often composed of a stack of flattened cisternal 
membranes arranged in a polarized fashion (cis-to-trans). On the contrary, plants, 
invertebrates and the fungi exhibit isolated Golgi stacks and, for instance, in the yeast 
Saccharomyces cerevisiae the Golgi cisternae are separate compartments distributed 
thorough the cell (Latijnhouwers, Hawes & Carvalho 2005, Preuss et al. 1992). Mammalian 
Golgi is dependent on and tightly associated with the microtubule network around the 
centrosome (Rios, Bornens 2003). The Golgi apparatus is structurally composed of a number 
of golgins and Golgi reassembly stacking proteins (GRASPs) that are mostly transmembrane 
proteins (Rios, Bornens 2003). The Golgi has been implicated in multiple functions, 
including transport and sorting, protein and lipid biosynthesis, microtubule nucleation centre 
formation, and calcium storage (Wilson et al. 2011). Neuronal Golgi is especially important 
for axoplasmic transport of proteins and macromolecules in ortho- and retrograde as well as 
transsynaptic routes and, therefore, dysfunction of Golgi could be detrimental for neuronal 
survival. At present, the role played by the Golgi in neurological disorders, however, remains 
controversial. 
The Golgi undergoes reversible structural disassembly/reassembly under different conditions, 
especially during mitosis and upon massive flow of cargo proteins or membranes. Also many 
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drugs can cause fragmentation of the Golgi with different morphologies. For instance, 
brefeldin A inhibits ER to Golgi transport and induces breakdown and redistribution of Golgi 
membranes with the ER (Klausner, Donaldson & Lippincott-Schwartz 1992). During 
apoptosis, the Golgi has been shown to undergo irreversible fragmentation as an early sign 
(Mukherjee et al. 2007). Importantly, several apoptotic factors are found at Golgi membranes, 
including caspase-2 (Mancini et al. 2000). Caspase-2 was found to have a unique role in the 
initiation of apoptosis at the Golgi where it cleaves Golgin-160 at a specific site not cleaved 
by other caspases (Mancini et al. 2000). Furthermore, preventing this cleavage delayed 
apoptotic Golgi fragmentation in Staurosporin-treated cells indicating that caspase-2 cleavage 
of golgin-160 is critical in fragmentation of the Golgi (Mancini et al. 2000). Following 
caspase-2 cleavage of golgin-160, caspase-3 cleaves golgin-160 at other sites and also other 
Golgi proteins, including GRASP65 and the vesicle tethering protein p115 (Chiu et al. 2002, 
Lane et al. 2002). Cleaved Golgi proteins often translocate to the nucleus to either block 
(golgin-160) or promote apoptosis (p115) (Chiu et al. 2002, Hicks, Machamer 2005).  
Induction of apoptosis by death receptor ligation has been shown to trigger a clustering of 
mitochondria, lysosomes and endosomes at the Golgi/microtubule organizing center (MTOC) 
site (Degli Esposti et al. 2009, Ouasti et al. 2007). It has been proposed that the Golgi might 
serve as a converging site during apoptosis and promote apoptosis via organellar cross talk 
(Aslan, Thomas 2009).  
Recently, Golgi fragmentation was shown to occur during neuronal injury caused by NMDA, 
reactive oxygen and nitrogen species as well as ER stress (Nakagomi et al. 2008). The study 
also pointed out that inhibition of Golgi fragmentation was at least partially preventive or 
delayed cell death implicating that the Golgi has an important role in apoptotic signaling 
(Nakagomi et al. 2008). Golgi fragmentation has been observed in several neurodegenerative 
diseases including amyotrophic lateral sclerosis (ALS), AD, corticobasal degeneration and 
Creutzfeldt-Jacob disease, among others (Gonatas, Stieber & Gonatas 2006). The relevance 
of Golgi fragmentation in dissecting cell death (the cause or the consequence) in these 
diseases, however, remains to be verified. 
1.4 ER stress and cell death 
The endoplasmic reticulum has a number of important functions: it is the first compartment in 
the secretory pathway, the site of secreted and membrane protein synthesis, an important 
intracellular calcium store (5mM versus cytosolic 0,1µM) (Sammels et al. 2010) and the site 
of lipid and sterol biosynthesis (Chang et al. 2006). Thus, perturbations of ER homeostasis in 
any of the functions mentioned can trigger stress reactions and signaling pathways called the 
unfolded protein response (UPR).  
In general, the folding of a typical secreted protein is driven by the hydrophobic effect to 
minimize the amount of hydrophobic amino acids on the surface of the protein, which also 
ensures the native conformation with the lowest free energy. Unfolded conformations are 
characterized by hydrophobic amino acids on the protein surface which leads to abnormal 
interactions and aggregation with other unfolded proteins. To ensure correct folding of 
proteins, ER and cytosolic chaperones catalyse rate-limiting folding reactions. The ER 
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harbors several chaperones from which at least three general folding systems can be 
distinguished: the HSP70 molecular chaperones BiP/GRP78/Kar2p (Gething 1999, Kleizen, 
Braakman 2004), and Lhs1p/GRP170/ORP150 (Saris et al. 1997), the HSP90 chaperone 
GRP94/HSP94 (Argon, Simen 1999), and the lectin chaperones calnexin and calreticulin 
(Williams 2006). In addition, the ER contains many other essential foldases, enzymes 
catalyzing steps that increase their folding rate. For instance, ER harbors the peptidyl prolyl 
isomerase (PPI) that catalyzes the cis-trans isomerization of peptidyl proline bonds, and the 
protein disulfide isomerase (PDI) catalyzing the formation of disulfide bonds. Furthermore, 
ER is the site of N-linked glycosylation system, which is part of the protein folding and 
maturation process in the ER.  
Translation of proteins destined for secretion and membranes is guided by a signal sequence 
that leads the ribosomes to the endoplasmic reticulum. A signal recognition particle (SRP) in 
the ribosome enables the binding of the ribosome to the rough endoplasmic reticulum (rER) 
(Lutcke 1995) and insertion of the growing peptide to the lumen of the ER via the Sec61p 
translocation channel. GRP78 (glucose-regulated protein 78kDa) also known as BiP 
(Immunoglobulin binding protein) is a major regulator of ER homeostasis and involved in 
binding of newly synthesized proteins and translocation of misfolded proteins out of the ER 
to the proteasomes, a process called ER associated degradation (ERAD). BiP binds the 
unfolded peptides with its peptide-binding domain to promote proper folding and to prevent 
aggregation (Kleizen, Braakman 2004). BiP has a low affinity to short hydrophobic peptides 
allowing a wide substrate spectrum (Flynn et al. 1991). Characteristic of HSP70 class 
chaperones is a conserved N-terminal ATPase domain and a C-terminal substrate-binding 
domain. Binding and release of substrates from BiP is catalyzed by ATP-ADP cycling. ATP 
hydrolysis releases the peptides from BiP in a reaction stimulated by DnaJ-like co-chaperones, 
such as MTJ1 (murine transmembrane protein) (Chevalier et al. 2000). GrpE co-chaperone 
Sil1p/BAP (BiP-associated protein), a nucleotide exchange factor, catalyzes the ADP-ATP 
exchange reaction (Chung, Shen & Hendershot 2002). ATP depletion inhibits protein folding 
and it has been suggested that protein folding capacity is limited by ATP import during active 
secretion and ER stress (Schroder 2008). Upregulation of BiP is a marker of accumulation of 
unfolded proteins in the ER. Functionally, BiP is also regulated at the level of 
oligomerization. In oligomeric state BiP is phosphorylated and ADP-ribosylated while the 
monomeric and unmodified form of BiP alone is able to associate with unfolded proteins 
(Freiden, Gaut & Hendershot 1992). The oligomeric pool has been suggested to present a BiP 
storage pool and during unfolded protein response BiP is released from the oligomeric pool to 
monomeric form (Freiden, Gaut & Hendershot 1992, Laitusis, Brostrom & Brostrom 1999). 
Other chaperones that bind partially folded peptides include, for instance, the GRP94 
chaperone that acts as a holdase, presenting unfolded substrate peptides to foldases, such as 
PDIs and PPIs. Unfavorable folding conditions, such as increased ATP consumption by 
HSP70 foldases induce the buffering activity of holdases (Winter, Jakob 2004). A common 
post-translational modification of ER-translated proteins is glycosylation that begins in the 
ER and continues in the Golgi apparatus. The lectin chaperones assist in the correct 
glycosylation reactions and retain the unfolded N-linked glycoproteins in the ER. The folding 
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protein is de- and reglycosylated a few cycles in reactions catalyzed by α-glucosidase and 
uridine diphosphate (UDP)-glucose:glycoprotein glycosyl transferase (UGGT), respectively. 
The lectins calnexin and calreticulin retain monoglycosylated proteins in the ER during the 
glycosylation cycle. UGGT acts preferentially on unfolded conformations to start the 
reglycosylation reaction and improperly folded proteins are finally transferred via calnexin to 
the Mn11p/Htm1p/EDEM (ER degradation-enhancing α-mannosidase-like protein) that 
induces retrotranslocation to the cytosol for proteasomal degradation (Molinari et al. 2003).  
1.4.1 Endoplasmic reticulum-associated degradation (ERAD) 
Only proteins that have been correctly folded are packaged to COPII (coatamer protein II) 
vesicles for ER exit. Failure to adopt a stable conformation is sensed by the chaperones in a 
process termed quality control resulting in dislocation of unfolded proteins from the ER 
through the retrotranslocon channel, composed of at least Sec61. Recently a ubiquitin-like 
domain (UBL) containing transmembrane protein homoCys -responsive ER resident protein 
(HERP) was implicated as a receptor for BiP substrates (Schulze et al. 2005). HERP is 
known to bind derlin, another protein implicated in retrotranslocation machinery (Okuda-
Shimizu, Hendershot 2007). Taken together, it is assumed that these factors link the unfolded 
proteins to cytosolic ubiquitin-proteasome system (Vembar, Brodsky 2008). In the cytosol 
unfolded proteins are ubiquitinated by cytosolic ubiquitin ligases for targeting to proteasomal 
degradation (Kopito 1997).  
1.4.2 ER stress 
Stress in general is a response of perturbation of the normal homeostasis or state in a system. 
In the ER, stress can be seen as loss of normal homeostasis due to accumulation of unfolded 
proteins, disturbance in calcium levels or lipid metabolism. If the cell is in threat it triggers a 
conserved tripartite transcriptional program called the unfolded protein response (UPR) (see 
fig 4) aiming to restore ER homeostasis (Schroder, Kaufman 2005).  
1.4.3 Unfolded protein response  
The UPR consists of activation of three transmembrane proteins at the ER membrane: 1) 
IRE1 (inositol-requiring 1)/ERN1 (ER to nucleus signaling 1), 2) PERK [double-stranded 
RNA-activated protein kinase (PKR)-like endoplasmic reticulum kinase] / PEK [pancreatic 
eukaryotic initiation factor 2α (eiF2α) kinase] and 3) ATF6 (activating transcription factor 6) 
(Fig 4). All these stress sensors are associated with BiP by their ER luminal domains in 
normal conditions (Bertolotti et al. 2000). Increase in the amount of unfolded proteins strips 
the ER membrane-bound BiP resulting in release of stress sensor proteins.  
PERK pathway 
During resting conditions, PERK is found as a monomer at the ER membrane bound by BiP 
via the ATPase binding region. Induction of the UPR results in the release of BiP allowing 
dimerization of PERK and subsequent trans-autophosphorylation (Sood et al. 2000). The 
activation mechanisms as well as the domain involved are very similar in PERK and IRE1. 
The most acknowledged function of activated PERK is transient phosphorylation of the α-
subunit of the eukaryotic translational initiation factor 2 α (eiF2α) that inhibits translation of 
most mRNAs (Sood et al. 2000) (Fig 4). Phosphorylation of eiF2α inhibits the GDP-GTP 
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exchange by the guanine nucleotide exchange factor (GEF) eIF2β that is necessary for the 
activity of eiF2α. This results in sequestration of tRNAmet needed for translation initiation 
(Bertolotti et al. 2000). Not all translation is, however, blocked. Certain mRNAs with specific 
upstream open reading frames (uORFs) in the 5’ leader are translated, among them the 
transcription factor ATF4 (Harding et al. 2000, Scheuner et al. 2001). ATF4 induces both 
pro-survival (early) and pro-apoptotic (late) gene expression, including the pro-apoptotic 
C/EBP (CCAAT/enhancer binding protein) homologous protein (CHOP) (Ma et al. 2002). 
IRE1α pathway 
Ire1α is the most conserved ER stress sensor. Like the other sensors, Ire1α is a 
transmembrane protein with an ER luminal domain and cytosolic kinase and RNase domains 
(Tirasophon, Welihinda & Kaufman 1998, Wang et al. 1998). During UPR, dissociation of 
BiP or direct binding of unfolded proteins induces the ER luminal domains of Ire1α to 
undergo homo-oligomerization (Hetz, Glimcher 2009). This results in conformational 
changes that enable trans-autophosphorylation of the cytosolic kinase domains and 
subsequent RNase activation. The endoribonuclease activity of Ire1α is responsible for 
excision of a 26-nucleotide fragment from XBP1 (X-box binding protein 1) mRNA (Fig 4). 
This modification yields a spliced form of XBP1 mRNA (XBP1s) that is translated into an 
active transcription factor (Yoshida et al. 2001, Calfon et al. 2002). Translated XBP1 binds to 
promoters containing the ERSE (ER stress element) consensus sequences and promote 
transcription of BiP/Grp78 as well as other chaperones (Yoshida et al. 2001) (Fig 4). In 
addition, XBP1 binds another cis acting element, UPRE, found specifically in genes involved 
in ERAD (Yamamoto et al. 2004).  
Alternatively, Ire1α can be phosphorylated and serve as platform for activation of TRAF2 
(Tumor necrosis factor (TNF)-receptor associated factor 2), ASK1 (Apoptosis signal-
regulating kinase 1) and the IκB (Inhibitor of kappa B) kinase IKK. These events lead to 
activation of stress-activated JNK, ASK1, ERK (Extracellular signal-regulated kinase) and 
p38 kinases (Hetz, Glimcher 2009). Subsequently, caspase-12 is released from ER 
membranes linking ER stress to JNK pathway and apoptosis (Yoneda et al. 2001).  
ATF6 pathway 
In basal conditions, ATF6 is localized to the ER and bound to the chaperone BiP (Shen et al. 
2002) (Fig 4). The interaction masks two Golgi localization signals that are exposed during 
accumulation of unfolded proteins and following BiP sequestration. The Golgi resident site-1 
and site-2 proteases (S1P and S2P) cleave ATF6 (p90ATF6), which generates a cytoplasmic 
basic leucine zipper (bZIP) transcription factor N-ATF6 (p50ATF6) (Shen et al. 2002) (Fig 4). 
N-ATF6 translocation to the nucleus induces transcription of genes containing the ERSE-I, -
II, or CRE consensus sequences. For instance, BiP, XBP1 and CHOP are target genes 
upregulated by ATF6 under stressed conditions (Haze et al. 1999, Yoshida et al. 2001). 
Additionally, ATF6 is bound by calreticulin, an ER calcium- and glycoprotein -binding 
chaperone (Hong et al. 2004b). In normal conditions, ATF6 is glycosylated and another 
mechanism to induce UPR is to sense underglycosylated forms of ATF6. Underglycosylation 
occurs, for instance, during calcium depletion from the ER (Hong et al. 2004b). Furthermore, 
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chemical inhibition of N-glycosylation by tunicamycin (Tu) results in ATF6 activation (Haze 
et al. 1999). Another ER stress inducer, thapsigargin (Tg), causing ER calcium depletion via 
inhibition of the SERCA pumps (sarcoplasmic/endoplasmic reticulum Ca2+-ATPase) also 
induces cleavage and underglycosylation of ATF6 (Hong et al. 2004b, Haze et al. 1999). In 
addition, Tg and Tu were shown to induce proteasomal degradation of ATF6 independently 
from S1P/S2P cleavage (Hong et al. 2004a). Consequently, inhibition of proteasomal activity 
was sufficient to prevent the decrease in the levels of ATF6 in response to ER stress but also 
stabilize ATF6 levels under normal conditions (Hong et al. 2004a). Rapid turnover of ATF6 
by UPS-dependent mechanism is thought to have evolved to keep ATF6 in guard from 
accidental triggering of the UPR. 
1.4.4 Pharmacological inducers of ER stress 
ER quality control is tightly linked in with the UPS. Thus it is not surprising that ER stress 
increases cytosolic UPS substrates (Menendez-Benito et al. 2005). Vice versa, proteasomal 
inhibition by lactacystin upregulated ER stress-associated genes (Choy et al. 2011). Thus, 
proteasomal dysfunction occurring during normal aging and in neurodegenerative diseases 
(Grune et al. 2004) might contribute to the level and vulnerability of the ER to cope with 
different stressors.  
Experimental ER stress can also be induced by pharmacological agents affecting different 
functions of the ER. Tunicamycin, for instance, disturbs N-linked glycosylation of proteins 
by inhibiting i.e. GlcNAc phosphotransferase (GPT) in the first step of glycoprotein synthesis 
(Breckenridge et al. 2003). Thapsigargin specifically inhibits the ER Ca2+ -ATPase and 
induces rapid release of stored Ca2+ with the disruption of calcium homeostasis (Thastrup et 
al. 1990). Furthermore, dithiotreitol (DTT) inhibits disulfide bond formation by its reducing 
properties and thus inhibits normal protein maturation in the ER (Breckenridge et al. 2003). 
Moreover, Brefeldin A (BFA) is an inhibitor of certain Arf1 GTP-exchange factors (GEFs; 
GBF1, BIG1 and BIG2) and inhibits the anterograde ER to Golgi transport of proteins 
without affecting retrograde transport resulting in accumulation of proteins in the ER 
(Breckenridge et al. 2003, Zhao, Lasell & Melancon 2002).  
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Figure 4 ER stress pathways.  See text for details. Abbreviations: ATF4/6: activating transcription factor 4/6; BiP: 
immunoglobulin binding protein; CHOP: C/EBP homologous protein CRE: cAMP response element; eIF2α; eukaryotic 
translational initiation factor 2α; ERSE: ER stress element; IRE1: inositol requiring 1; PERK: PKR-like endoplasmic 
reticulum kinase; S1P/S2P: site 1/2 protease; XBP1: X-box binding protein 1. 
1.4.5 Cell death induced by ER stress 
In case adaptive responses to ER stress fail, the UPR switches into apoptosis promoting mode. 
PERK and IRE1 signaling pathways have evolved mechanisms to trigger apoptotic pathways 
during irremediable ER stress. Apoptosis is triggered by at least three pathways, including 
activation of CHOP, JNK pathway, and caspase-12, that all promote activation of caspase-3 
(Oyadomari, Mori 2004). ATF6 and ATF4, downstream of PERK, and induce transcription 
of the CHOP/GADD153 transcription factor (Yoshida et al. 2001, Ma et al. 2002). CHOP can 
downregulate expression of the anti-apoptotic Bcl-2 and on the other hand upregulate 
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expression of ERO1α inducing oxidative reactions in the ER (McCullough et al. 2001, 
Marciniak et al. 2004). CHOP is ubiquitously expressed at low levels in the cytosol of non-
stressed cells. Induction of stress in the ER leads to CHOP expression and accumulation to 
the nucleus (Ron, Habener 1992). CHOP depleted mice exhibit reduced levels of ER stress-
induced apoptosis (Oyadomari et al. 2002). Vice versa, overexpression of CHOP leads to cell 
cycle arrest and/or apoptosis (Maytin et al. 2001, Barone et al. 1994).  
Apoptosis induced by ER stress has been proposed to consist of a combination of intrinsic 
and extrinsic apoptotic pathways with essential roles played by the Bcl-2 family proteins 
(Schroder, Kaufman 2005). Bcl-2, keeping the proapoptotic Bcl-2 family proteins at guard, 
localizes to the ER membranes in addition to the mitochondrial and nuclear membranes 
(Lithgow et al. 1994). Overexpression of Bcl-2 and Bcl-xL protect cells from thapsigargin-
induced cell death by inhibiting caspase-3 activation and the JNK pathway (Srivastava et al. 
1999). On the other hand, ER stress induces the activation of several BH3-only proteins; Bid, 
Bim, Noxa and Puma that further target Bax and Bak and signaling to the mitochondrial cell 
death machinery (Li, Lee & Lee 2006, Upton et al. 2008, Puthalakath et al. 2007). 
Furthermore, in addition to mitochondrial membrane localization, Bax and Bak have been 
shown to localize to the ER in response to ER stress (Zong et al. 2003). At ER membranes 
Bax and Bak oligomerize to form pores and induce progressive calcium depletion and 
caspase-12 cleavage leading to cell death. These findings are also supported by studies with 
bax-/-/bak-/- cells that are resistant to ER stress induced apoptosis (Zong et al. 2003, Zong et al. 
2001). In addition, IRE1 associates with the TNF receptor associated factor 2 (TRAF2) and 
apoptosis signal-regulating kinase 1 (ASK1) to form a complex that activates the c-Jun N-
terminal kinase (JNK) (Urano et al. 2000). JNK activates the proapoptotic Bim and inhibits 
the anti-apoptotic Bcl-2. 
Caspase-12 was shown to localize to the ER and be involved in ER stress-induced cell death 
(Nakagawa et al. 2000). Deletion of caspase-12 from mice results in inhibition of ER stress 
mediated cell death, although the mice are capable of other types of cell death pathways. 
Moreover, it was shown that inhibition of caspase-9 blocked this cell death pathway while 
caspase-8 was not involved (Rao et al. 2002b). Apart from Caspase-12, also caspase-2 was 
linked to ER stress-induced apoptosis in multiple myeloma cells treated with the 26S 
proteasome inhibitor, bortezomib (Gu et al. 2008). Caspase-2 is also involved in Bid cleavage 
contributing to apoptotic signaling downstream of ER stress, an event counteracted by 
inhibition of caspase-2 (Upton et al. 2008). 
1.4.6 ER stress in neurological disorders 
The very focal roles of the ER in cellular functions sets it vulnerable for a number of 
environmental and genetic factors. ER stress has been detected in numerous human diseases 
from diabetes to neurological disorders, such as AD, ALS, and generally in diseases with 
accumulation of mutant proteins (Schroder, Kaufman 2005, Lindholm, Wootz & Korhonen 
2006). Disruption of proteostasis occurs, for instance, in ALS and HD, where mutant proteins 
superoxide dismutase-1 (SOD1) and huntingtin, respectively, aggregate and result in 
proteasomal dysfunction and accumulation of proteins in the ER (Nishitoh et al. 2008, 
Nishitoh et al. 2002). Mutations in the presenilins were also linked to disruption of calcium 
 26 
homeostasis and oxidative stress in AD with implications in ER dysfunction (Guo et al. 1997, 
Mattson et al. 2000). Moreover, it was recently shown that presenilins actually form Ca2+ 
leak channels at ER membranes that when mutated, as in familial AD, disrupt Ca2+ signaling 
(Tu et al. 2006). In addition, as previously described, Aβ -mediated cell death involves 
caspase-12 and ER -specific apoptosis (Nakagawa et al. 2000). 
1.5 Excitotoxicity 
1.5.1 Glutamate and other excitatory amino acids 
The amino acid glutamic acid, or glutamate as it exists in physiological pH, is the major 
excitatory neurotransmitter in the mammalian central nervous system (CNS). It is essential 
for development, differentiation and synaptic plasticity of neurons. Toxicity of glutamate was 
recognized in 1957 by Lucas and Newhouse (Lucas, Newhouse 1957) with their observation 
that subcutaneous injection of glutamate to mouse retina resulted in neuronal degeneration. 
Later Olney coined the term “glutamate excitotoxicity” in studies characterizing brain lesions 
and neuronal necrosis after subcutaneous injections of glutamate in infant and adult mice as 
well as in an infant rhesus monkey (Olney 1969, Olney, Sharpe 1969). Association of 
glutamate excitotoxicity to acute brain damage, such as hypoxia and ischaemia, was noticed 
when Rothman used a post-synaptic blocker of excitatory transmitters, y-D-glutamylglycine 
(DGG), to inhibit the effects induced by anoxic atmosphere and exogenous glutamate 
(Rothman 1984). Since, it has been noted that glutamate excitotoxicity occurs in acute 
ischaemic injury and as secondary injury after traumatic brain injury as well as in epilepsy. 
Moreover, chronic over-excitation of glutamate receptors occurs in neurodegenerative 
diseases, such as ALS, AD, PD and HD.  
Although glutamate is by far the most important and potent excitotoxin in the CNS, also other 
natural and exogenous molecules can mediate excitotoxicity. The natural excitatory amino 
acids include aspartic acid/aspartate, quinolinic acid (QA), sulphur-containing excitatory 
amino acids, such as homocysteic acid and the dipeptide N-Acetylaspartylglutamic acid 
(NAAG) (Doble 1999). Exogenous excitatory molecules include N-methyl-D-aspartic acid 
(NMDA) and kainate (KA).  
1.5.2 Glutamate receptors 
Glutamate gates two main receptor types in the CNS: the ionotropic and metabotropic 
glutamate receptors. These receptors belong to the ligand-gated ion channel protein family 
sharing the common property of rapid activation by an agonist followed by desensitization, 
uncoupling of agonist from receptor, a process that inhibits unregulated ion flow and cell 
death in the continued presence of neurotransmitters (Jones, Westbrook 1996). Both receptor 
types are further divided to three families.  
1.5.2.1 Ionotropic glutamate receptors 
Ionotropic glutamate receptors (iGluRs) are named according to which specific agonist they 
bind. These are the N-Methyl-D-Aspartate (NMDA), α-amino-3-hydroxyl-5-methyl-4-
isoxazole-propionate (AMPA) and kainic acid (KA). Classically, AMPA and KA receptors 
have been categorized together as non-NMDA receptors. Ionotropic glutamate receptors 
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function as ligand-gated ion channels that upon binding of glutamate open and allow ion flux 
through the channel, more precisely, influx of sodium and/or calcium and efflux of potassium. 
The structure of iGluRs in general is a tetramer in which each monomer possesses its own 
ligand-binding site and a hydrophobic domain (M2) that contributes to the channel lumen 
formation (Madden 2002). Moreover, three additional transmembrane segments, M1, M3 and 
M4, contribute to the channel formation and are arranged so that the N-terminal part of the 
polypeptide lies extracellularly and C-terminus intracellularly. Specific residues distributed in 
the agonist-binding site, especially in the S2 loop contribute to the receptor sensitivity and 
agonist specificity (Stern-Bach et al. 1994). 
Excitotoxicity is most potently triggered via NMDA receptor overactivation, however, other 
glutamate receptors can induce excitotoxicity either directly (KARs, AMPARs) or indirectly 
(AMPARs, mGluRs) by activating calcium channels or NMDA receptors via sodium influx -
mediated depolarization of the cell membrane (Carriedo, Yin & Weiss 1996). 
1.5.2.2 NMDA receptors 
The most studied of ionotropic glutamate receptor subtypes are the NMDA receptors 
(NMDARs). The NMDARs form highly calcium permeable glutamate-gated ion channels 
from a combination of three different subunits GluN1-3 (formerly NR1-3). The GluN1 
subunit has eight splice variants (GluN1-1a-4a; GluN1-1b-4b), while GluN2 subunits include 
four (GluN2A-D) and GluN3 two isoforms (GluN3A-B) (Lau, Tymianski 2010).  Classically, 
gating of NMDARs require both binding of various ligands as well as cellular depolarization. 
In basal, unstimulated conditions the channel currents are inhibited by a magnesium ion in 
the pore that can be removed by activation of other ionotropic glutamate channels (AMPA; 
KA). The amino acid glycine is also an essential cofactor for NMDAR opening; very small 
concentrations (10nM) potentiate NMDAR activation (Johnson, Ascher 1987). In addition, 
changes in physiological pH can affect NMDAR functions, for instance, after an injury or 
ischaemia.  NMDA receptor signaling can be coupled to another calcium-permeable channel, 
the acid-sensing ion channel (ASIC) enhancing calcium signaling and acidotoxicity in 
ischaemia (Gao et al. 2005).  
1.5.2.3 AMPA receptors 
AMPA receptors include four subunits GluA1-4 that make up heteromeric channels. Their 
calcium permeability varies between subtypes; for instance, GluR1 and GluR3 are permeable 
while GluR2 containing channels are impermeable to calcium (Hollmann, Hartley & 
Heinemann 1991). AMPARs mediate most of the low frequency glutamatergic 
neurotransmission. In addition, AMPARs are thought to regulate NMDAR excitation by 
removing the magnesium block via postsynaptic depolarization.  
1.5.2.4 Kainate receptors 
KA was originally isolated from the seaweed Kainin-sou (or Makuri) in Japan. Before the 
characterization of KARs, KA was known as an agonist for non-NMDA receptors. However, 
cloning of KARs enabled the differentiation of KARs from AMPARs and their functional 
separation (Hollmann, Heinemann 1994, Bettler, Mulle 1995). KA has high affinity to KARs; 
5-15nM for KA1 and KA2 and 70-100nM for GluR5-7. AMPARs can also be activated by 
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KA, but exhibit much lower affinity for KA (1000 fold lower as for KARs) (Hollmann, 
Heinemann 1994). 
The KA receptor family comprises of five subunits, that have been renamed as GluK1-5 
(encoded by the genes Grik1-5); GluR5 (GluK1/Grik1), GluR6 (GluK2/Grik2), GluR7 
(GluK3/Grik3), KA1 (GluK4/Grik4) and KA2 (GluK5/Grik5) (Contractor, Mulle & Swanson 
2011). KARs form functional receptors in homo- or heteromeric combinations. GluR5-7 are 
capable of forming both homo- and heteromeric channels (Lerma 2006). The structure of 
KARs is homologous to other iGluRs. The extracellular N-terminal domains of KARs 
including the S1 and S2 (the loop between M3 and M4) regions form the glutamate binding 
site while the C-terminal intracellular domain is responsible for receptor targeting and signal 
transduction (Fig 5). The transmembrane domains; M1, M3 and M4, with the re-entrant 
membrane loop M2 line the channel pore (Fig 5).  
RNA editing of GluR5 and GluR6 at the Q/R site in the M2 domain by RNA deaminase gives 
rise to further structural variety. Substitution of glutamine (Q) by arginine (R) decreases the 
calcium permeability of the receptor and ultimately its conduction properties (Swanson et al. 
1996). The physiological relevance of the Q/R site has remained unclear, but there seems to 
be developmental control that might contribute, for instance, to remission from childhood 
epilepsies (Vincent, Mulle 2009) (Fig 5). GluR6 has additionally two editing sites in the M1 
domain that affect the ion selectivity of the receptor (Kohler et al. 1993).  
Furthermore, GluR5-7 subunits undergo alternative splicing that affects their cytoplasmic C-
terminal domains. Splice variants include GluR5a-c, GluR6a-b, and GluR7a-b (Barbon, 
Barlati 2000, Barbon, Vallini & Barlati 2001, Jaskolski et al. 2005). All splice variants vary 
in their amino acid sequences of the C-terminal domains, which in turn affects their 
interactions with stabilizing and trafficking proteins. Thus, the splice variants may show very 
different properties in trafficking to the cell surface or subcellularly, and even activity of the 
KARs. The two splice variants of GluR6, GluR6a and GluR6b, differ by two distinct 
sequences of their C-terminal domains (Barbon, Vallini & Barlati 2001). GluR6a has been 
shown to be highly expressed in the plasma membrane of neurons and also affect the surface 
targeting of other KARs thus being critical in targeting of heteromeric KARs (Jaskolski et al. 
2004). GluR6a carries a high surface expression determinant of four charged amino acids that 
is indispensable in membrane targeting. In addition, GluR6a has a PDZ (postsynaptic density-
95/discs large/zona occludens-1) interaction motif that allows interaction with e.g. PSD95, 
GRIP and PICK1. PDZ proteins can regulate trafficking of receptor proteins from the ER to 
the plasma membrane, however, for KARs they seem to function only as to stabilize their 
postsynaptic localization (Garcia et al. 1998, Hirbec et al. 2003).  
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Figure 5 Schematic structure of KARs. Extracellular, intracellular and transmembrane domains found in KARs, with sites 
of known interactions and amino acid substitutions important for the receptor function. Abbreviations: M1-4: transmembrane 
domains 1-4; Q/R: glutamine/arginine substitution site; PDZ: postsynaptic density-95/discs large/zona occludens-1; PKC: 
protein kinase C; S1-2: extracellular domains 1-2.  
Kinetic profiles of postsynaptic KARs vary from extremely low to rapid responses (Castillo, 
Malenka & Nicoll 1997, DeVries, Schwartz 1999). In the hippocampus, KARs are involved 
in direct excitatory post-synaptic currents (EPSCs) between synapses of mossy fibers and 
CA3 pyramidal cells (Castillo, Malenka & Nicoll 1997, Vignes, Collingridge 1997). KA-
mediated EPSCs are lower in amplitude as compared to AMPA-mediated EPSCs and show 
slower rise and decay times. The slow kinetics result in summation of repetitive stimuli and 
may also arise from non-saturation of postsynaptic KARs (Jaskolski, Coussen & Mulle 2005). 
CA3 pyramidal cell dendrites show KAR (GluR6, KA2, and KA1) expression and EPSCs 
specifically in the stratum lucidum region where they contact with mossy fiber axons 
(Castillo, Malenka & Nicoll 1997). GluR6-/- mice are devoid of the KAR component of the 
mossy fiber EPSCs as well as the presynaptic actions (Mulle et al. 1998, Contractor, Swanson 
& Heinemann 2001). Other neurons, such as the CA1 pyramidal neurons and striatal medium 
spiny neurons exhibit unconventional synaptic transmission (Bureau et al. 1999, Chergui et al. 
2000). Studies indicate that these KARs localize extrasynaptically and can also be activated 
by glutamate release from astrocytes (Liu et al. 2004). The CA1-localized KARs possibly 
increase neuronal excitability through a metabotropic function (Melyan, Wheal & Lancaster 
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2002). Presynaptic KARs have been detected for instance in the mossy fiber-CA3 synapses 
and function as autoreceptors sensing glutamate release. This function increases the 
likelihood of future release of glutamate thus modifying the strength of the synaptic 
stimulation and short-term synaptic plasticity (Contractor, Swanson & Heinemann 2001, 
Lauri et al. 2001). 
Activation of KARs is modulated by ions and and small molecules. Different from other 
iGluRs, KARs are dependent on both Na+ and Cl- in the extracellular solution (Paternain et al. 
2003, Plested, Mayer 2007). Interestingly, Cl- ions play an essential role by binding between 
subunits and stabilizing the dimer structure while in the absence of Cl- ions the receptors are 
desensitized and glutamate-induced activation diminished (Plested, Mayer 2007).  
Desensitization mechanisms are not fully clear for iGluRs but most is known of AMPARs 
and includes rearrangements in dimer interfaces of the receptors as well as transmembrane 
AMPAR regulator proteins (Hansen, Yuan & Traynelis 2007). KARs were shown to have 
similar mechanism of desensitization that seems to be conserved among AMPARs and KARs. 
Desensitization requires the domain 1 surfaces of a dimer and large conformational 
rearrangements (Weston et al. 2006). KAR desensitization can be relieved by concanavalin A 
treatment that is achieved possibly via interaction with surface sugar chains of KARs 
(Fletcher, Lodge 1996). 
In addition to the repertoire of different KARs and their variants, combinations of different 
subunits to functional channels as well as other proteins can affect the properties of the KARs. 
Previously an auxiliary protein, Neto1, was shown to interact and affect GluR6 expression in 
the hippocampal PSDs (Straub et al. 2011, Tang et al. 2011). 
KARs are widely distributed throughout the nervous system (Wisden, Seeburg 1993) (See 
table 4). Their function in both pre- and postsynaptic neurons allows diverse roles in 
glutamatergic signaling; facilitating glutamate release, influencing other glutamate receptors 
and GABAergic signaling. In addition, variations in subunit composition and KAR 
expression levels may influence their impact on the glutamatergic signaling. Expression of 
different KARs occurs in complex patterns, indicating that there are numerous functionally 
diverse receptor complexes in the CNS. For instance, KARs have been implicated in mood 
regulation, for GluR5 being encriched in the amygdala (Li et al. 2001b) as well as GluR6 and 
KA1-2 prominently expressed in the dentate gyrus and hippocampal CA3 area (Wisden, 
Seeburg 1993). (Table 4)  In addition, presynaptic KARs can regulate GABA release in the 
hippocampus and amygdala (Rodriguez-Moreno, Herreras & Lerma 1997). To further 
complicate their involvement in neuronal systems, they seem to produce metabotropic actions 
via interaction with G-proteins (Melyan, Wheal & Lancaster 2002, Melyan, Lancaster & 
Wheal 2004). Thus, KARs seem to be involved in a vast array of modulatory functions in the 




Table 4 Expression of high -affinity KAR mRNAs in the rat brain. The areas of highest expression are highlighted. 
KAR subtype Expression (Wisden, Seeburg 1993) 
GluK1/ 
GluR5 
Neocortex, pyriform cortex, septum, anterior ventral thalamus, hypothalamus, 
pontine and rhabdoid nuclei of the hindbrain, cerebellar purkinje cells 
GluK2/ 
GluR6 
Neocortex, pyriform cortex, hippocampus, caudate putamen, dorsal raphe 
nucleus, cerebellar granule cells  
GluK3/ 
GluR7 
Neocortex, cingulate cortex, dentate gyrus, caudate putamen, septum, reticular 
and anterior ventral nuclei of the thalamus, hypothalamus, dorsal raphe and pontine 
nuclei of the hindbrain, cerebellar stellate/basket cells 
GluK4/ 
KA1 
Neocortex, hippocampus, globus pallidus, medial septum, medial preoptic 
hypothalamus, hindbrain, corpus callosum, cerebellar purkinje cells 
GluK5/ 
KA2 
Neocortex, hippocampus, caudate putamen, septum, medial habenula, anterior 
ventral thalamus, hypothalamus, hindbrain, cerebellar granule cells, pineal gland 
 
KAR signaling can be divided into two characteristic forms; the canonical pathway involves 
ion flux, and the noncanonical pathway links KAR activation to G protein activation and 
GABA release in GABAergic interneurons (Melyan, Lancaster & Wheal 2004, Rodriguez-
Moreno, Lerma 1998, Rozas, Paternain & Lerma 2003). In addition, KARs can be divided to 
having both pre- and postsynaptic functions. In other words, the presynaptic functions include 
modulation of release of neurotransmitters while postsynaptically KARs mediate synaptic 
currents as ion channels like the NMDA and AMPA receptors.  
KARs have been implicated in synaptic plasticity and regulation of synaptic transmission in 
both inhibitory and excitatory synapses (Lerma 2003). Moreover, knowledge of KAR 
functions has been provided by their implications in several neurological disorders, including 
AD, HD, schizophrenia and related disorders such as bipolar disorder (Lerma 2006). An 
increasing understanding about the function of KARs and signaling mechanisms in neurons 
may help to better understand various neurological disorders accompanied by excitotoxic 
damage.  
GluR6 
As shown in GluR6 deficient mice, the GluR6 receptors are important for the KA-mediated 
epileptiform seizure and cell death in the CA3 area of the hippocampus (Mulle et al., 1998). 
Despite this, no clear genetic association for GluR6 and epilepsy has been found in humans. 
However, polymorphisms in the GluR6 gene has been linked to a number of mental disorders, 
for instance, schizophrenia and bipolar disorder (Beneyto et al. 2007, Blackwood et al. 2007). 
Levels of GluR6 were shown to be elevated in schizophrenia (Bullock et al. 2008), and 
downregulated in bipolar disorder, especially during manic symptoms (Dick et al. 2003, 
Shaltiel et al. 2008, Malkesman et al. 2009). Moreover, GluR6 KO mice exhibited specific 
behavioral features resembling those seen in mania, including hyperactivity, aggressiveness, 
decreased anxiety, and sensitivity to psychostimulants, such as amphetamine (Shaltiel et al. 
2008). In addition, several studies have implicated GluR6 polymorphism association in 
autism (Strutz-Seebohm et al. 2006, Jamain et al. 2002). Linkage of a mutation in GluR6 
gene to autosomal recessive mental retardation in a consanguineous Iranian family provided 
proof of GluR6 being indispensable in higher cognitive functions in humans (Motazacker et 
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al. 2007). Some evidence has also been provided of GluR6 polymorphism affecting the age-
of-onset in HD (Rubinsztein et al. 1997). 
As other glutamate receptors, the KARs at the postsynaptic density are regulated by binding 
to PSD proteins, including PSD95, GRIP and PICK1 (Hirbec et al. 2003). The activity of 
KARs is also regulated by modification of the polypeptide, for instance, by phosphorylation. 
GluR6 has been indicated in ischemic neuronal death via activation of the JNK pathway 
through GluR6-PSD95-MLK3 signaling module (Pei et al. 2004, Pei et al. 2005, Chen et al. 
2009). Activation of p38 resulted from signaling cascade involving MLK3 (Mixed lineage 
kinase 3; mitogen activated protein kinase kinase kinase (MAPKKK)) and downstream 
MAPKKs MKK3/MKK6/MKK4 (Chen et al. 2009). MAP kinases are involved in multiple 
biological responses from proliferation to cell death and are activated by various extracellular 
signals (Irving, Bamford 2002). Previously, CaMKII, being the most abundant signaling 
protein at the PSD, was implicated in GluR6 phosphorylation during ischaemia (Hao et al. 
2005). CaMKII is activated by autophosphorylation during NMDAR activation and travels to 
plasma membrane where it can activate a myriad of substrates, including the AMPAR, GluR1 
(Tan, Wenthold & Soderling 1994). In physiological conditions, CaMKII is essential in 
hippocampal learning and LTP formation (Soderling 1993). Recently, it was shown that 
GluR6 phosphorylation by CaMKII occurred via GluR6-PSD95-CaMKII signaling module 
formation during ischaemia injury (Xu et al. 2010). This resulted in JNK activation and could 
be inhibited by CaMKII inhibitor KN-93. Despite these, it is likely that several other kinases 
in addition to the aforementioned, play a role in GluR6 modulation.  
Apart from phosphorylation, proteins can be posttranslationally modified by various other 
tags, including ubiquitin, SUMO (small ubiquitin-like modifier), nitrosyl- and acetyl-groups. 
The actin-binding protein present in neuronal PSDs, actinfilin, was shown to bind and link 
GluR6 to the UPS-mediated degradation via presentation of GluR6 to the ubiquitin E3 ligase 
Cullin 3 (Salinas et al. 2006). Moreover, SUMOylation was shown to take part in kainate-
mediated GluR6 endocytosis and resulting in decrease in postsynaptic currents (Martin et al. 
2007). In relation to ischemic injury, it was also represented that nitrosylation, the addition of 
NO group, takes part in GluR6 modulation (Yu et al. 2008). This modification was presumed 
to facilitate the GluR6-PSD95-MLK3 signaling module formation. Among others, the S-
nitrosylation pathway presents a possible target for drug develoment in ischaemia since 
inhibition GluR6 nitrosylation attenuated the GluR6-PSD95-MLK3 signaling module activity 
(Yu et al. 2008).  
1.5.2.5 Metabotropic glutamate receptors 
Metabotropic glutamate receptors are coupled to G-proteins and their activation leads to 
regulation of cAMP levels and calcium release from intracellular stores. Contrary to 
ionotropic glutamate receptors, mGluRs mediate mostly slow synaptic responses and 
modulate the activity of the glutamatergic circuits (Conn, Pin 1997). The categorizations of 
mGluRs to groups I-III are based on their pharmacological properties, sequence similarity, 
and signal transduction mechanisms. Group I mGluRs are usually located in the post-synaptic 
neuron and regulate ion channels and NMDA and AMPA receptor, for instance, by 
potentiating NMDA receptor activation and thus calcium influx (Bruno et al. 1995). Group I 
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mGluRs are linked to phopspholipase C activation and downstream inositol triphosphate (IP3) 
production that can induce intracellular calcium movements thus providing means for 
NMDA/AMPA receptor activation (Abe et al. 1992, Aramori, Nakanishi 1992).  Group II and 
III mGluRs are often presynaptic and inhibit certain calcium channels and neurotransmission 
via regulation of neurotransmitter release.   
1.5.3 Mechanisms of excitotoxicity  
Excitotoxicity has been proposed as a separate form of cell death (Kroemer et al. 2005); 
however, it seems to involve a mixture of cell death pathways such as apoptosis and necrosis 
depending on the intensity of the stimulus and was not coined as one (Kroemer et al. 2009). 
As mentioned above, excitotoxicity can be triggered both in acute hypoxic and ischemic 
conditions as well as chronically in neurodegenerative diseases, where the neurons are 
exposed to excitotoxic signals over a long period of time. In chronic conditions, the damage 
accumulates and the symptoms emerge gradually, e.g. gradual memory loss in AD. Despite 
the difference in exposure, both acute and chronic excitotoxicity are caused by prolonged 
excitation by glutamate and share similar molecular mechanisms. 
During ischemic stroke, for instance, the blood flow to certain brain areas seizes and results 
in glucose and oxygen deprivation (Ames et al. 1968). In low energy (ATP) conditions 
neurons are unable to maintain the ionic gradients across their cell membrane, which leads to 
depolarization and release of neurotransmitter vesicles. As a consequence, also the 
neurotransmitter uptake machinery is stunned and more neurotransmitters accumulate to the 
extracellular space. Although the precise molecular mechanisms in excitotoxicity are still 
somewhat unclear, it is clear that rise in intracellular calcium plays a key role in subsequent 
events. Other events taking place during excitotoxicity include organelle dysfunction, and 
increased nitric oxide and free radical production as well as activation of proteases and 
kinases. For instance, excitotoxicity involves activation of calpains (Wu, Lynch 2006) as 
previously described. 
Calcium has numerous important functions in normal cellular homeostasis and signaling. 
Involvement in toxicity was noted in the late 1970s when several toxins were found to 
effectively kill cells in the presence of calcium but not without it (Schanne et al. 1979).  Cells 
are surrounded by calcium-rich extracellular fluid with a concentration of approximately 2 
mM. To control calcium-dependent proteins and processes, the concentration of calcium in 
the cytoplasm is maintained in 10-100 nM range by actively pumping out Ca2+ from cytosol 
to extracellular space, or intracellular organelles, including the endoplasmic reticulum, Golgi 
apparatus and mitochondria. Certain signals can trigger opening of calcium channels and 
pumps at the plasma membrane or the ER leading to sudden rise in intracellular calcium. 
Excitotoxicity often results in excessive calcium rise and activation of cell death pathways. It 
has been shown that the route of calcium entry is the main determinant in calcium-induced 
neurotoxicity (Sattler et al. 1998) since different micro- and nanodomains around the specific 
receptors or channels contain different proteins that may induce totally diverse signaling 
pathways. Thus, calcium entry via voltage-gated Ca2+-channels did not alter cell morphology 
even with high calcium load. However, glutamate-induced NMDA receptor opening has a 
calcium threshold above which calcium readily induces cell death (Sattler et al. 1998). 
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One toxic function of excessive calcium is the induction of free radical production from 
mitochondria (Dykens 1994). The mitochondria are responsible for most reactive oxygen 
species (ROS) produced in cells and taken into account the post-mitotic nature of neurons it 
is of outmost importance to clear these harmful species. Calcium increase in excitotoxicity 
has several consequences that induce ROS production; activation of phospholipase A2, nNOS 
(neuronal nitric oxide synthase) and xanthine oxidase, that further induce acide arachidonic 
cascade (Emerit, Edeas & Bricaire 2004).  
NMDAR activation and subsequent calcium flow has been shown to regulate nitric oxide 
(NO) production via coupling of PSD95 and nNOS (Sattler et al. 1999). NO toxicity was 
reduced by PSD95 antisense downregulation and was specific for only NMDAR stimulation 
since KA-induced toxicity was unaffected in PSD95 -depleted cells. Thus, PSD95 is a 
potential target in treatment of excitotoxic diseases involving NMDAR-mediated toxicity. 
Like ROS, NO acts as a rective nitrogen species (RNS) and together with superoxide anion 
(O´2-), NO forms peroxynitrite (ONOO-) that is highly reactive and harmful for cell functions 
(Emerit, Edeas & Bricaire 2004).  
1.6 KA model to study excitotoxic cell death 
Systemic or intracerebral injection of KA has been long used as a model of temporal lobe 
epilepsy (TLE) (Ben-Ari 1985, Nadler 1981). Epilepsy in general is a common neurological 
disorder characterized by spontaneous recurrent seizures consisting of excessive 
synchronized neuronal activity. TLE is a common form of epilepsy in humans manifesting 
recurrent partial seizures originating from the hippocampus. In some cases the epileptiform 
activity can propagate also to other structures of the limbic system, such as amygdala and 
medial entorhinal cortex inducing secondary generalized tonic-clonic seizures (Lothman, 
Bertram & Stringer 1991). A hallmark of TLE is a specific type of hippocampal damage, 
called hippocampal sclerosis, characterized by extensive neuronal loss (>50%) in the CA3 
and CA1 areas and the dentate hilus (Engel 1996).  
KA provokes acute seizures in model animals originating in the hippocampal CA3 region 
(See fig 6) and selectively destroys these neurons along some other regions depending on the 
route of KA administration. Systemic (intraperitoneal, intravenous or subcutaneous) 
administration of KA triggers limbic seizures lasting for several hours. After a few days to 
weeks the animals usually exhibit a chronic phase of spontaneous limbic seizures that 
increase in frequency without remission (Ben-Ari 1985). KA-provoked seizures produce 
brain damage closely resembling the neuropathology characteristic of TLE, involving loss of 
CA1 and CA3 pyramidal neurons and interneurons of the dentate hilus (Fig 6). 
Intraventricular KA injections mainly cause degeneration of the CA3 pyramidal neurons 
while intraperitoneal administration is often accompanied with CA1 degeneration (Nadler, 
Perry & Cotman 1978, Sperk 1994). Besides region-selective pattern of damage, age of the 
model animal contributes greatly to the degenerative effects of KA. For instance, P9 rats 
show no clear degeneration of the hippocampal CA1 or CA3 areas while P21 and older rats 
show damage of the CA1 and CA3 (Holopainen 2008) as described earlier. Postnatal rat brain 
shows also age-dependent differences in microglial activation and inflammatory processes 
(Holopainen 2008). 
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KA model was developed well before the identification of KARs. Subsequent studies 
revealed KA binding sites in the CNS, especially enriched in the hippocampal CA3 area, 
consistent with the low dose of KA triggering epileptic activity in hippocampal slice 
preparations (Monaghan, Cotman 1982, Robinson, Deadwyler 1981). The CA3 pyramidal 
neurons are most vulnerable, exhibiting 10- to 30-fold higher sensitivity to KA as compared 
to CA1 pyramidal cells. Furthermore, concentrations below 3µM (20mg/kg) selectively 
activate KARs containing the GluR6 subtype in the CA3 neurons, while higher 
concentrations also activate other KARs and AMPARs (Mulle et al. 1998). As reviewed 
earlier, the GluR6 subtype of KARs was shown to be responsible for the epileptogenic effect 
of KA on CA3 pyramidal cells when applied at small concentrations (<3µM) (Mulle et al. 
1998). The CA3 pyramidal neurons are also vulnerable to repetitive high-frequency 
stimulation and network hyperactivity per se. 
KA-mediated synaptic responses have been characterized for GluR6 and KA2 –containing 
synapses between CA3 pyramidal cells and Mossy fibers (Castillo, Malenka & Nicoll 1997, 
Mulle et al. 1998) (Fig 6). Postsynaptic KARs seem to have restricted and specific subcellular 
localization patterns, since many other areas, including CA1 pyramidal neurons fail to fire 
KAR-mediated EPSCs despite expressing functional KARs (Bureau et al. 1999).  
The chronic phase of epileptogenic activity has been proposed to arise from axonal sprouting 
of the dentate granule cells. The mossy fibers have been shown to form new synapses to 
aberrant targets, including CA3 pyramidal cells and granule cells, thus recreating recurrent, 
synchronized excitatory circuits that include KAR EPSCs and exhibit reduced seizure 
threshold (Epsztein et al. 2005).  
 
Figure 6 Hippocampal connections. KARs at the MF synapses are often located to the post-synaptic density while SC 
synapses have been found to contain extrasynaptic KARs. In addition, KARs can be found from the presynaptic areas where 
they might function as autoreceptors. The lower figure shows the Mossy fiber and Scaffer collateral pathways. Abbreviations: 
CA: Cornu Ammonis; DG: Dentate Gyrus; KAR: Kainate receptor; MF: Mossy fiber; PSD: Post-synaptic density; SC: 
Schaffer collateral. 
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Apart from its epileptogenic properties KA can be considered as a model for excitotoxicity. 
KA-induced excitotoxicity triggers at least apoptotic and necrotic cell death as well as PCD 
and autophagy (Wang et al. 2005). The type of cell death and damage caused by KA is dose-
dependent as well as influenced by the extent and duration of seizures (Tokuhara et al. 2007). 
Higher doses tend to induce necrosis while lower doses are characterized by PCD without 
apoptotic morphology. Moreover, kainate has been shown to mediate PARP-mediated cell 
death, parthanatos, in rat striatum and spinal cord neurons (Kuzhandaivel, Nistri & Mladinic 
2010, Cosi et al. 2000). As mentioned earlier, AIF has been implicated in KA-mediated 
neuronal injury in the hippocampus. “Harlequin” (Hq) mice with reduced expression of AIF 
were studied for neuroprotection against NMDA- and KA-excitotoxicity (Cheung et al. 2005). 
AIF was shown to be involved in both NMDA- and KA-mediated cell death in cortical 
neurons and in hippocampal CA3 area in vivo as Hq mice showed increased resistance 
against hippocampal damage (Cheung et al. 2005). These data indicate strong involvement of 
AIF-mediated cell death pathway in KA excitotoxicity. Table 5 summarizes the involvement 
of certain cell death mediators in KA-induced excitotoxic cell death in the hippocampus. 
Table 5 Selected cell death effectors and modulators in the KA model. The cell death mediators and effects studied in the 
hippocampal CA3 area unless otherwise stated.  
Apoptotic 
effectors 





Caspase-3 Cleaved/activated 4-48h 
after KA in the 
hippocampus 
Execution of apoptosis, 
colocalization with TUNEL 
positive neurons 





 AIF Translocates to the 
nucleus  
Reduction of AIF reduces 
hippocampal damage in Hq 
mice 
(Cheung et al. 2005) 
 Cytochrome c Released from 
mitochondria 2-24h after 
KA  
Activation of caspase cascade (Henshall, Chen & 
Simon 2000, 
Henshall et al. 
2001a) 
 Caspase-2 Cleaved/activated 
immediately after KA in 
the hippocampus 
Linkage to surface death 
receptor? 
(Henshall et al. 
2001) 
 RAIDD Increased after KA Caspase-2 interacting death 
receptor adaptor 
(Henshall et al. 
2001) 
 Caspase-8 Cleaved/activated after 
KA similar to caspase-2 
Extrinsic apoptotic pathway 
Caspase-8 inhibitor reduced 
caspase-8, -9 and -3 activites 
(Henshall et al. 
2001, Henshall et al. 
2001b) 
 Fas Upregulated after 4-24h 
KA 
Death receptor pathway (Henshall et al. 
2001b) 
 FADD Upregulated after 4-72h 
KA 
Fas/caspase-8 adaptor (Henshall et al. 
2001b) 
 Bid Cleaved immediately after 
KA (upto 72h) 
Caspase-8 mediated cleavage 
– integration to cytochrome c 
release 
(Henshall et al. 
2001b) 
 Caspase-9 Cleaved/activated 4-72h 
after KA 
Initiator caspase, activated by 
the apoptosome 
(Henshall et al. 
2001a) 
 Apaf-1 Binds to cytochrome c 
after KA, 0-24h 
Apoptosome formation and 
caspase-9 activation platform 
(Henshall et al. 
2001a) 
 Caspase-6 Cleaved/activated after 2-
72h KA 
Executor caspase, proteolyses 
e.g. lamin A 
(Henshall et al. 
2002) 
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 Bad Dissociates from the 
molecular chaperone 14-
3-3 after KA 
Free Bad binds Bcl-XL that 
binds and neutralizes Bax in 
unstressed conditions 
(Henshall et al. 
2002) 
 Bax Relocalizes to 
mitochondrial membrane 
after KA, increased after 
KA 
Facilitation of cytochrome c 
release 
(Henshall et al. 
2002, Korhonen et 
al. 2003) 
 Bim Upregulated 4-8h after 
KA-induced seizure/ 
downregulated 12h after 
KA (Korhonen et al. 
2003) 
Binds the anti-apoptotic Bcl-w (Shinoda et al. 2004, 
Korhonen et al. 
2003) 
 Hrk/DP5 Reduced after KA Interacts with Bcl-2 and Bcl-
XL 
(Korhonen et al. 
2003) 
 Puma Inreased after 1h KA Binds anti-apoptotic Bcl-2 
binds and activates Bax. 
Deletion of puma protects 
against KA-induced 
hippocampal damage 
(Engel et al. 2010) 
 JNK, p38 
MAPKs 
Increased activation in the 
early time points upto 2h 
after KA 
MAPK family kinases 
involved in cell death 




in the cortex 
May induce Bad 
phosphorylation and 
sequestration by 14-3-3, 
providing protection in 
surrounding tissue  
(Henshall et al. 
2002) 
 Bcl-w/Bcl2L2 Decrease after 6-24h KA  Pro-apoptotic BH3-only Bim 
binds and inactivates Bcl-w 
(Murphy et al. 2007, 
Korhonen et al. 
2003) 
 Bcl-XL Downregulated after 6-
24h KA 
Normally binds and 
neutralizes pro-apoptotic Bcl-2 
family proteins 
(Korhonen et al. 
2003) 
 Bcl-2 Increased levels and 




(Korhonen et al. 
2003) 
 XIAP Biphasic regulation by 
KA; initial increase in 
CA3 after KA, absence 
from dying neurons 
Protect against caspase-3, -7 






Biphasic regulation by 
KA; initial increase in 
CA3 after KA, absence 
from dying neurons 
Protect against caspase-3, -7 
and -9 activation 
(Belluardo et al. 
2002) 
 Bruce/Apollon Downregulated by KA Protects against cell death and 
caspase-3 activation  
(Sokka et al. 2005) 
 BDNF Increased production after 
KA 
Neuroprotective effect (Castren et al. 1998) 
 ERK1, 2  Increased activation upto 
6h after KA 
MAPK family kinases 
involved in survival 
(Kim et al. 1994) 
Abbreviations: AIF: Apoptosis Inducing Factor; Apaf-1: Apoptotic Protease-Activating Factor-1; Bad: Bcl-2 antagonist of 
cell death; Bax: Bcl-2-Associated X protein; Bcl-2: B cell lymphoma-2; Bcl-w/Bcl2L2: Bcl-2 like 2; Bcl-XL: Bcl-extra long; 
BDNF: Brain Derived Neurotrofic Factor; Bid: BH3 interacting domain death agonist; Bim: Bcl-2 interacting mediator of 
cell death; CA3: cornu ammonis 3; c-IAP-1/RIAP-2: Cellular Inhibitor of Apoptosis Protein-1/Rat Inhibitor of Apoptosis 
Protein-2; ERK: Extracellular signal-Regulated Kinase; FADD: Fas-associated protein with death domain; Hrk/DP5: 
HaRaKiri; JNK: c-Jun N-terminal Kinase; MAPK: Mitogen-Activated Protein Kinase; Puma: p53 promoter Upregulated 
Modulator of Apoptosis; RAIDD: Receptor interacting protein (RIP)-associated Ich-1/CED-3 homologous protein; TUNEL: 
Terminal deoxynucleotidyl transferase-mediated biotinylated UTP Nick End Labeling; XIAP: X-linked Inhibitor of 
Apoptosis Protein. 
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1.7 Cdk5 and cell death 
Cyclin-dependent kinases (Cdk1-9) are a family of nine small (30-35kDa) serine/threonine 
kinases (Morgan 1997). Their functions are vast and diverse; however, most of the Cdks are 
closely related to cell cycle control. Dysregulation of Cdk function in proliferating cells can 
induce tumor formation, while terminal differentiation of neuronal cells is associated with 
Cdk inhibition and disappearance (Okano, Pfaff & Gibbs 1993). Distinctive features of Cdk 
activity include dependence on association with regulatory proteins, called cyclins, as well as 
regulatory phosphorylations and dephosphorylations (Morgan 1997). 
Unlike most Cdks, Cdk5 (alternatively called neuronal cdc2-like kinase, tau protein kinase II, 
PSSALRE) is not directly involved in cell cycle; on the contrary, it has a myriad of functions 
in differentiated cells, especially in neurons (Dhariwala, Rajadhyaksha 2008). As other Cdks, 
Cdk5 activity is dependent on regulatory subunits. These activator proteins are, however, not 
cyclins, but neuronally expressed activator proteins, p35 and p39 (Tsai et al. 1994, Tang et al. 
1995). In addition, truncated forms of the activator proteins, produced by calpain, p25 and 
p29 are strong Cdk5 activators (See chapter 1.7.5. Deregulation of Cdk5). Furthermore, as 
other Cdks, Cdk5 can be phosphorylated at Tyr-15 resulting in several-fold increase in the 
activity of Cdk5 (Zukerberg et al. 2000), however, this is not a functional necessity as for 
other Cdks. Active Cdk5 phosphorylates serine/threonine residues located just N-terminal to 
a proline-residue (belonging to a kinase family of proline-directed serine/threonine protein 
enzymes) in its substrates.  
Although Cdk5 seems to have widespread expression, p35 and p39 show complementary 
spatial and temporal expression in the CNS (Zheng, Leung & Liem 1998) thus governing the 
prominent activity of Cdk5 in the CNS. p35 appears to be essential in the cerebral cortex, 
governing the laminar organization of neurons, while p39 has important roles in the 
cerebellum (Ko et al. 2001). In addition, p35 can substitute the absence of p39 whereas p39 
can only compensate for some functions of p35. On the contrary, deletion of Cdk5 results in 
perinatal lethality, abnormal corticogenesis and cerebellar defoliation (Ohshima et al. 1996). 
Studies using conditional knockout of Cdk5 have provided more insights into Cdk5 functions 
in the adult CNS and indicated Cdk5 essential in neuronal migration in certain brain areas, 
including the cortex and cerebellum (Hirasawa et al. 2004).  
Subcellular localization of Cdk5 and its activators contribute essentially to the substrate pool 
and, interestingly, p35 and p39 possess N-terminal myristoylation sites that link Cdk5 to the 
membranes (Asada et al. 2008). In addition, lysine cluster in the N-terminal p10 regions was 
also shown to act as a nuclear localization signal (NLS) when p35 and p39 are not 
myristoylated. Importantly, p35 and p39 exert major regulatory influence on Cdk5 activity 
due to their short half-lives of approximately 20-30 min in neuronal cultures (Patrick et al. 
1998). p35 and p39 are degraded by the UPS and degradation involves an autoregulatory 
function mediated by Cdk5 kinase activity. Inhibition of Cdk5 activity by roscovitine, 
proteasome blockers or phosphorylation mutant of p35 increased the half-life of p35 
underlining the importance of Cdk5 feedback loop (Patrick et al. 1998). Phosphorylation of 
p35 has been shown to affect the membrane association of Cdk5/p35 complex (Sato et al. 
2007). Another important aspect of membrane association is that membrane-bound Cdk5/p35 
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complex seems to be inactive while cytosolic form is the active form (Zhu et al. 2005). In 
addition, membrane association appears to facilitate p35 and p39 degradation (Minegishi et al. 
2010). On the contrary, p35 expression can be induced by neurotrophic factors, including 
nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and glial cell line-
derived neurotrophic factor (GDNF) (Harada et al. 2001, Bogush et al. 2007, Ledda, Paratcha 
& Ibanez 2002).  
1.7.1 Cdk5 in the synapse  
During development, Cdk5 has been proposed to have pro-differentiation and anti-cell cycle 
roles (Cicero, Herrup 2005). Mechanistically, it appears that Cdk5 activity and/or Cdk5 
subcellular localization are important for preventing re-activation of the cell cycle in 
postmitotic neurons. However, in the adult animals, the kinase has diverse roles in the 
synapses affecting a myriad of synaptic proteins (Rosales et al. 2000, Fu et al. 2001, Fu et al. 
2005, Fu et al. 2007, Morabito, Sheng & Tsai 2004, Tomizawa et al. 2002, Tomizawa et al. 
2003, Zhang et al. 2008, Hawasli et al. 2007). In higher level, Cdk5 has been proposed to 
control synaptic plasticity, learning, and memory (Hawasli, Bibb 2007, Lai, Ip 2009). In 
physiological conditions, Cdk5 regulates numerous proteins both at the pre- and postsynaptic 
parts of the synapses and, for instance, the cholinergic and the glutamatergic neurotransmitter 
systems (Fu et al. 2001, Hawasli et al. 2007).  Cdk5 deregulation has been linked to 
neurodegenerative diseases such as AD (Weishaupt, Neusch & Bahr 2003, Kanungo et al. 
2009).  
Presynaptic regulation by Cdk5 
The presynaptic terminal is the neuronal output station, where neurotransmitters are packed 
to synaptic vesicles, released to the synaptic terminal by exocytosis of the vesicles followed 
by endocytosis of the vesicles for local recycling. Cdk5 has been implicated as a major 
controller of the neurotransmitter release and determinant of silent synapses since silencing 
the synapse severely depletes Cdk5 levels (Kim, Ryan 2010). Endocytosis of synaptic 
vesicles is triggered by dephosphorylation of a group of phosphoproteins at the nerve 
terminals, collectively called the dephosphins (Cousin, Robinson 2001). This is accomplished 
by a single phosphatase, the Ca2+-calmodulin dependent phosphatase, calcineurin (CaN). The 
reversal, namely phosphorylation of dephosphins, is regulated by Cdk5 that phosphorylates at 
least dynamin 1, synaptojanin, and phosphatidylinositol phosphate kinase Iγ (PIPK Iγ) 
(Tomizawa et al. 2003, Lee et al. 2005, Lee et al. 2004). This generates a cytosolic pool of 
dephosphins and prevents premature interactions with the plasma membrane (Cousin, 
Robinson 2001). Thus, phosphorylation of dephosphins by Cdk5 is needed to repress 
endocytosis and necessary for continued vesicle recycling and neurotransmitter release, in 
other words, resetting the mechanism for new rounds of activity (Tan et al. 2003).  
In addition, synapsin I and MUNC18 have been characterized as Cdk5 substrates thus 
broadening Cdk5-dependent regulation of presynaptic nerve terminal to the control of 
exocytosis (Matsubara et al. 1996, Shuang et al. 1998).  
Postsynaptic regulation by Cdk5 
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The dendritic spines make contacts with axonal terminals forming the input station or 
postsynaptic density at the synapse. The postsynaptic density is involved in postsynaptic 
potential formation and is composed of neurotransmitter receptors, ion channels, signaling, 
scaffolding, as well as cytoskeletal proteins facilitating in the process of neurotransmission. 
Cdk5 signaling has been implicated in numerous signaling pathways involved in synaptic 
plasticity in the dendritic spines (Barnett, Bibb 2011).  
The postsynaptic density is an insoluble intracellular matrix rich in scaffolding proteins, such 
as PSD95, Shank, GKAP and Homer, involved in anchoring and clustering neurotransmitter 
receptors and modulation of the structure of the PSD (Sheng, Hoogenraad 2007). Cdk5 has 
been identified to phosphorylate PSD95 resulting in inhibition of ion channel and NMDA 
receptor multimerization and clustering (Morabito, Sheng & Tsai 2004). Cdk5-mediated 
phosphorylation suppressed PSD95 multimerization thus affecting the composition of the 
PSD. Recently, reduced Cdk5 activity was shown to induce PSD95 monoubiquitination and 
interaction with β-adaptin AP-2/clathrin adaptor complex (Bianchetta et al. 2011). PSD95 
ubiquitination has been implicated to regulate NMDAR-induced AMPAR endocytosis, 
interaction of PSD95 with AP-2 providing a previously missing link in AMPAR regulation. 
In addition, these results link Cdk5 in AMPAR internalization and synaptic plasticity. 
Furthermore, Cdk5 was shown to regulate AMPA receptors via phosphorylation of the 
neuronal adherens junction protein δ-catenin (Poore et al. 2010), which is involved in 
cadherens-cytoskeletal interaction at the plasma membrane (Lu et al. 1999). Cdk5-mediated 
phosphorylation of δ-catenin affected its cellular localization and morphology of the synapse 
while inhibition of Cdk5 or expression of phosphorylation mutants of δ-catenin resulted in 
increase in GluR2 membrane localization and AMPAR/NMDAR ratio.  
Apart from AMPAR regulation, Cdk5 is involved in NMDAR modulation. Cdk5 was shown 
to facilitate NR2B degradation by calpain while conditional Cdk5 knockout mice showed 
improved learning and plasticity resulting from increase in synaptic NR2B levels (Hawasli et 
al. 2007). The mechanism was further studied to involve PSD95-Src kinase interaction. Src-
mediated phosphorylation of NR2B was shown to decrease its binding to AP-2 and inhibit 
endocytosis of NR2B-containing NMDARs (Zhang et al. 2008). Moreover, the NR2A 
subunit, important mediator of LTP, is a direct target for Cdk5 (Li et al. 2001a). Inhibition of 
Cdk5-mediated NR2A phosphorylation reduced LTP formation and inward currents induced 
by NMDA. In another study, NR2A phosphorylation by Cdk5 was shown to enhance 
NMDAR currents and inhibition of Cdk5 protected against ischemic insults decreasing 
ischaemia-induced EPSCs (Wang et al. 2003). 
Furthermore, the type I mGluRs, mGluR1 and mGluR5, have been shown to be 
phosphorylated by Cdk5 (Orlando et al. 2009). The localization of mGluRs in the periferal 
parts of PSD is managed by their interaction with the scaffolding Homer –proteins (Fagni, 
Worley & Ango 2002). Cdk5 phosphorylates the Homer-binding domains of mGluR1 and -5 
and this phosphorylation enhances their binding to Homer thus increasing their localization at 
the PSD and Homer-regulated trafficking (Orlando et al. 2009). 
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Another important protein present in the postsynaptic density is the Ca2+/calmodulin-
dependent kinase (CaMKII) that has been implicated as a Cdk5 target (Hosokawa et al. 2006). 
CaMKII is an important mediator of LTP and decreased Cdk5 activity was shown to facilitate 
CaMKII activation and long-term potentiation.  
Cdk5 phosphorylates protein phosphatase inhibitor-1 (PPI) as well as its homolog DARPP32 
that are activated by cAMP/PKA (Bogush et al. 2007, Bibb et al. 2001). Recently, Cdk5 was 
shown to regulate the cAMP signaling cascade and synaptic plasticity via modulation of 
cyclic nucleotide phosphodiesterase (PDE) that catalyzes the conversion of cAMP and cGMP 
to AMP and GMP, respectively (Guan et al. 2011). In this study, conditional knockout of 
Cdk5 in mice resulted in upregulation of PDE isoforms and inhibition of cAMP pathway. The 
deficiencies were, however, rescued by treating the mice with a PDE4-specific inhibitor, 
Rolipram, indicating an important role for Cdk5-dependent modulation of PDEs. 
Taken together, Cdk5 regulates numerous receptors at the post-synaptic neuron and presents 
an essential control switch in synaptic function. 
1.7.2 Cdk5 in the nucleus 
Besides its synaptic functions, Cdk5 has been implicated in nucleus. The first nuclear 
substrate of Cdk5 was found to be the pro-survival transcription factor myocyte enhancer 
factor 2 (MEF2) (Gong et al. 2003) that is involved in reduction of dendritic spines (synaptic 
pruning) in interneurons in activity-dependent fashion (Flavell et al. 2006). Importantly, 
excitotoxicity-induced Cdk5 deregulation results in hyperphosphorylation of MEF2, which in 
turn induces its calpain-dependent cleavage followed by neuronal death (Gong et al. 2003).  
Furthermore, MEF2 inhibition by Cdk5/p25 has been proposed to mimic the autistic 
phenotype of Fragile X syndrome, an inherited disorder causing autism and intellectual 
disability, where loss of fragile X mental retardation protein (FMRP) is associated with 
reduction of MEF2-dependent synaptic pruning (Barnett, Bibb 2011). 
Another nuclear target for Cdk5 is the histone deacetylace 1 (HDAC1) that catalyzes 
acetylation of histones thereby altering chromatin and access of transcription factors (Brehm 
et al. 1998). Cdk5/p25 expressing transgenic mice show inactivation of HDAC1 and cell 
cycle re-entry in combination of double-strand DNA breaks (Kim et al. 2008). On the 
contrary, gain-of-function of HDAC1 was neuroprotective against p25-induced neurotoxicity. 
1.7.3 Deregulation of Cdk5 
Activation of calpain occurs when intracellular calcium levels increase above controllable 
levels, for instance, after overactivation of glutamate receptors or by exposure to Aβ (Rami, 
Ferger & Krieglstein 1997, Saito et al. 1993b). Active calpain cleaves the Cdk5 activator 
proteins p35 and p39 generating C-terminal p25 and p29 peptides, respectively, that lack the 
myristoylation sites (Kusakawa et al. 2000, Patzke, Tsai 2002, Lee et al. 2000). These new 
forms of activators have distinct properties as compared to their full-length precursors, 
mainly, longer half-lives, stronger association with Cdk5 and resulting increased activity of 
Cdk5/p25 (or Cdk5/p29) complex (100% vrs 80% for p25 and p35 complexes, respectively) 
(Patrick et al. 1998, Amin, Albers & Pant 2002). Interestingly, p35 has three domains 
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involved in Cdk5 interaction and inactivation of any of these domains inhibited Cdk5 kinase 
activity (Amin, Albers & Pant 2002).  Furthermore, p25 and p29, lacking the myristoylation 
sites, distribute to different subcellular sites in the cell, from periphery to the more 
perinuclear regions (Kusakawa et al. 2000, Asada et al. 2008, Patrick et al. 1999). Although 
certain Cdk5 substrates, such as tau, are increasingly phosphorylated in p25-transgenic 
(overexpressing) mice, the phosphorylation of the physiological substrates of Cdk5 is not 
increased (Cruz et al. 2003). In addition, mice expressing p25 for long periods showed 
impairment of hippocampal long-term potentiation (LTP) and memory deficits combined 
with neuronal loss (Cruz et al. 2003). These effects were reversed by transient expression of 
p25 in mice actually facilitating learning and memory (Fischer et al. 2005). Taken together, 
prolonged activity of Cdk5/p25 seems to underlie the switch from physiological to 
pathological function.  
1.7.4 Cdk5 in neuronal cell death 
Cdk5 has been implicated in cell death in AD as responsible for, for instance, 
hyperphosphorylation of the microtubule-associated protein (MAP) tau (Baumann et al. 
1993). Hyperphosphorylation of tau causes its detachment from microtubules and 
accumulation in the cytoplasm as filaments and tangles (Alonso et al. 2001). An interesting 
link between Cdk5, tau phosphorylation and calcium transfer from the ER to mitochondria 
was made in a study showing that Cdk5-mediated phosphorylation of tau at T231 during 
ceramide neurotoxicity enhanced its detachment from microtubules resulting in microtubule-
dependent clustering of the ER and mitochondria in the centrosome region (Darios et al. 
2005). Close contacts between the organelles allowed calcium transfer from the ER to 
mitochondria resulting in neurotoxic levels and cell death activation (Darios et al. 2005). This 
study showed a In addition, p25 has been shown to accumulate in AD brains (Patrick et al. 
1999). In PD the Lewy bodies have been shown to contain Cdk5 and p35 (Nakamura et al. 
1997). Cdk5 deregulation has been shown to occur in HD; in mutant HdhQ111 mice as well as 
human postmortem brain (Paoletti et al. 2008). Importantly, inhibition of Cdk5 was 
neuroprotective against neuronal loss in mutant HdhQ111 mice (Paoletti et al. 2008). 
Cdk5 is a major regulator of cell survival and cell death. Inhibition of Cdk5 during 
development results in failure to neuronal differentiation and migration (Cicero, Herrup 
2005). In addition, these cells, despite having neuronal morphology, expressed both cell cycle 
and cell death markers indicating that Cdk5 deficiency accompanies failure to exit the cell 
cycle. Thus, Cdk5 seems to play both the roles of maintenance of mitotic arrest and 
progression of neuronal differentiation. The mechanism by which Cdk5 regulates cell cycle 
has been linked to its binding of several cyclins and the retinoblastoma protein (Lopes, 
Oliveira & Agostinho 2009). 
Cell cycle reentry has been observed in several neurological disorders, including AD, ALS, 
and stroke (Andorfer et al. 2005, Ahn et al. 2008, Nguyen et al. 2003, Wen et al. 2005). 
Excitotoxicity, oxidative stress and DNA damage are linked to re-expression of cell cycle 
proteins (Lopes, Agostinho 2011) and it remains to be determined how powerful player Cdk5 
is in all these diseases and cell death mechanisms. One link might be previously described 
Cdk5-mediated HDAC1 inactivation in p25-transgenic mice (Kim et al. 2008) since p25 
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accumulation coincides many neurodegenerative disorders. Moreover, for instance, in a 
mutant SOD1 mouse model of ALS, Cdk5 was linked to increased Cdk4 expression via 
induction of Aβ, while the changes were prevented when Cdk5 was inhibited (Nguyen et al. 
2003).  
1.7.5 Inhibition of Cdk5 as a therapeutic tool 
Taken its important and broad functions in neurons, Cdk5 has been a subject of a number of 
studies aiming to modulation of its activity. Many investigations are based on 
pharmacological or genetic inhibition of Cdk5. Generally used inhibitors, Roscovitine and 
Olomoucine resemble ATP and antagonize its binding to Cdks, especially Cdk2, Cdk1 and 
Cdk5 (Schmid, Strosznajder & Wesierska-Gadek 2006). In neurons, where expression and 
function of cell cycle-related Cdks are minimal roscovitine can be used to primarily target 
Cdk5. However, for in vivo studies, more drugs selectively targeting Cdk5 are required. 
Despite this, roscovitine has shown potential neuroprotective effects in in vitro (Maas et al. 
1998) and in vivo studies of tauopathies and stroke (Wen et al. 2007, Menn et al. 2010). 
Indolinone A is another Cdk inhibitor implicated in neuroprotection via prevention of 
mitochondrial dysfunction (Weishaupt et al. 2003). Indolinone-mediated Cdk5 inhibition was 
effective against various cell death models, including growth factor withrawal and 
staurosporine treatment (Weishaupt et al. 2003). 
Genetic inhibition of Cdk5 includes antisense and siRNA-based methods as well as 
expressing dominant negative mutant of Cdk5 (DN-Cdk5) (Tsai et al. 1994, van den Heuvel, 
Harlow 1993). Furthermore, inhibition of Cdk5/p25 complex by an inhibitory peptide (CIP; 
Cdk5 inhibitory peptide) has shown promising results in cultured neurons and is also studied 
for in vivo applicability (Kanungo et al. 2009, Zheng et al. 2002). 
1.8 Huntington’s disease and cell death  
HD is a progressive neurodegenerative disorder characterized by motor, cognitive and 
psychiatric disturbances, first described by George Huntington in 1872 (reprinted in 
Huntington 2003). HD is caused by an unstable CAG expansion in the exon-1 of the 
huntingtin gene (HTT, IT-15) inherited in an autosomal dominant manner. In humans, the 
non-disease causing number of CAG repeats varies between 6 and 35 whereas in HD patients 
the number raises usually over 40 repeats (The Huntington's Disease Collaborative Research 
Group 1993). Due to the unstable nature of the mutation, the disease progression, age of 
onset, and severity varies greatly between individuals but correlates inversely to the size of 
the expansion. The size explains approximately 70% of the variance of the age of onset 
(Brinkman et al. 1997) and several other genes have been proposed to modulate the disease 
onset (Li et al. 2003, Wexler et al. 2004). Analysis of postmortem brains of HD patients 
shows neuropathological changes particularly in the striatum (Reiner et al. 1988) but also in 
other brain areas, such as the cortex, thalamus and cerebellum (Walker 2007).   
The HTT gene encodes for a 350kDa protein, huntingtin (Htt), that has several subdomains 
and functions, although the precise physiological role of the protein remains unclear (Bano et 
al. 2011) (Fig 7). Htt is ubiquitously expressed, however, particularly in mature postmitotic 
neurons (Strong et al. 1993). In neurons, Htt is found in the nucleus, Golgi, ER, neuronal 
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body, synapses and dendrites (DiFiglia et al. 1995). Characterization of the structure and 
function of huntingtin and mutant huntingtin have revealed important functional properties 
that underlie the disease pathogenesis. In humans, the CAG repeat encoding for a 
polyglutamine (polyQ) stretch has a potential to associate with membranes (Atwal et al. 
2007). In addition, the polyQ stretch associates with the ER and Htt was predicted to be 
released from the ER in response to ER stress (Atwal et al. 2007). The polyQ-domain is 
followed by a polyproline sequence that has a stabilizing function in the protein structure. 
Furthermore, the N-terminal part of the protein contains three clusters of HEAT repeats 
(acronym for proteins that include the domain: Huntingtin, Elongation factor 3 (EF3), Protein 
phosphatase 2A (PP2A), and the yeast PI3-kinase TOR1) that interact with other proteins and 
are involved in intracellular transport (Fig 7).  
 
Figure 7 Schematic presentation of huntingtin domains and sites for calpain and caspase cleavage. Abbreviations: 
HEAT: Huntingtin, Elongation factor 3, Protein Phosphatase 2A, yeast PI3-kinase TOR1; polyQ: polyglutamine repeat, 
polyP: polyproline repeat. 
The normal function of Htt has been studied, for instance, by deleting the gene in mice. Full 
deletion results in embryonic lethality due to extensive apoptosis indicating an anti-apoptotic 
function for Htt (Nasir et al. 1995). In addition, heterozygous knockout animals are 
characterized by increased apoptosis of neurons in the basal ganglia combined with cognitive 
deficits (Nasir et al. 1995). Later it was shown that Htt binds and inhibits caspase-3 and also 
activates the pro-survival pathway mediated by the serine/threonine kinase Akt (Zhang et al. 
2003, Humbert et al. 2002). 
The expansion of the polyQ stretch alters the properties of Htt. This mutation is a 
characteristic gain-of-function mutation, since the mutant Htt (mHtt) downregulates the wild-
type Htt functions. Why has the polyQ expansion evolved in the first place? Evidence for 
evolutionary positive selection for expansion of the polyQ stretch came from studies where 
the murine Htt gene carried only seven CAG repeats (Clabough, Zeitlin 2006). These mice 
exhibited slight memory and learning deficits combined with alterations in mitochondrial 
energy metabolism, indicating that elongation of the polyQ stretch is essential for the protein 
activity.  
Pathological elongation of the CAG repeat in the Htt gene renders the mHtt protein 
aggregation-prone and HD is characterized by intracellular inclusions containing mostly N-
terminal fragments of the mHtt protein (DiFiglia et al. 1997). These inclusions intriguingly 
affect mostly the GABAergic medium spiny neurons of the striatum (Martindale et al. 1998, 
Ferrante et al. 1985). Degeneration of these neurons is thought to underlie the development of 
uncontrolled movements during the disease progression. The biochemical properties of the 
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medium spiny neurons make them vulnerable to cell death in HD; in addition to GABA, these 
neurons express, for instance, NMDA, AMPA and KA receptors and receive glutamatergic 
inputs from the motor cortex and thalamus (Mori et al. 1994, Stefani et al. 1998). 
Consequently, one of the contributors of the disease pathogenesis is thought to be 
excitotoxicity, as will be explained in more detail. 
1.8.1 Cell death mechanisms and contributors of HD pathogenesis 
Several mechanisms have been proposed to mediate cell death in HD. These include, among 
others, excitotoxicity, disturbances in the function of the UPS and mitochondrial energy 
production, autophagy, inflammation, defective trophic factor support and ER stress.  
Before the underlying cause of HD was characterized, one of the hypotheses behind the 
disease was proposed to be excitotoxicity (Coyle, Schwarcz 1976, McGeer, McGeer 1976). 
Treatment of rats or mice with KA developed motor abnormalities and memory deficits 
accompanied with striatal lesions resembling those seen in human HD patients (Sanberg, 
Lehmann & Fibiger 1978, Mason, Fibiger 1979). Later, the excitotoxin quinolinic acid was 
found to produce even more resembling characteristics of HD (Beal et al. 1986). Despite the 
errorneous assumptions of these excitotoxins being the cause of HD, glutamate excitotoxicity 
is still considered a major mechanism in the course of HD pathogenesis.  
As previously explained, excitotoxicity induces calcium influx that can further activate 
calpain. Calpain has been shown to proteolyse Htt into a series of fragments (Gafni, Ellerby 
2002).  It was also noted that the cleavage of Htt is dependent on the polyQ repeat length.  
These fragments, along others produced by caspases (Wellington et al. 2002) and matrix 
metalloproteinase (MMP) (Miller et al. 2010) are found in the intracellular inclusions in the 
affected neurons (Bano et al. 2011). However, the more toxic functions of these fragments 
are thought to be produced during their monomeric states and the aggregates serve more 
likely as to scavenge the toxic oligomers.  
The ubiquitin-proteasome system (UPS), being responsible for protein degradation of 
numerous proteins, especially, those abnormally assembled, was found to be dysfunctional in 
HD (Bence, Sampat & Kopito 2001). Cells expressing high levels of a Htt construct encoding 
a polyQ stretch of 103Q accumulated high molecular weight ubiquitin conjugates indicating 
inhibition of the proteasomal machinery (Bence, Sampat & Kopito 2001). One reason for this 
is the scavenging properties of the inclusion bodies, found to contain ubiquitin, other 
components of the UPS, in addition to molecular chaperones, cytoskeletal proteins and even 
transcription factors (DiFiglia et al. 1997, Davies et al. 1997). Thus, dysfunction of the UPS 
and accumulation of proteins that normally would be degraded by the proteasome definitely 
influence the pathogenesis of HD. Furthermore, the activity of the UPS slows down simply 
during ageing (Keller, Hanni & Markesbery 2000, Keller, Huang & Markesbery 2000) and 
might thus contribute to the age of onset of the disease.  
Mitochondrial deficiency has been implicated in HD. Investigations have revealed that the 
aggregates are associated with organelles, especially, with mitochondria resulting in 
disruption of the organelle homeostasis (Li et al. 2001). Dysregulated mitochondria show 
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reduction in Ca2+ uptake (Panov et al. 2002) possibly enhancing the activation of calpains and 
other calcium-regulated pathways. 
Neurotrophic factor support is an essential survival mechanism for neurons and has been 
considered as a treatment for neurological diseases, including HD (Sari 2011). Mutant Htt has 
been shown to disrupt BDNF signaling both in transcriptional level as well as via altered 
axonal transport (Zuccato et al. 2001, Gauthier et al. 2004). BDNF transport from cortical 
afferents to the striatum is impaired in HD and, thus, considered as one important mediator of 
striatal cell death in HD. 
Despite enormous efforts made to clarify the mechanisms behind HD pathogenesis, it 
remains to be shown how all the participating factors contribute to the disease. Although the 
medium spiny neurons of the striatum are the most clearly affected, they are not the only 
ones. Other areas of the brain might be better protected due to the lack of, for example, 
receptor proteins that might contribute to the excitotoxic effects of neurotransmitters. In fact, 
it was hypothesized that striatal neurons are vulnerable due to a striatal-specific processing 
machinery (Li et al. 2000). Furthermore, the expression of Htt is high in the striatum and in 
the cortico-striatal pathway and is likely especially important for these particular neurons.  
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2 Aims 
The general aim of this study was to characterize the molecular mechanisms of organelle 
specific cell death initiation. Special attention was paid to the roles played by the ER and 
involvement of Cdk5 in signalling pathways. The specific aims were: 
• To study the role of the ER in KA-induced excitotoxic cell death (I) 
• To characterize synaptic degeneration and regulation of GluR6 in KA-induced 
excitotoxic cell death and the role of Cdk5 in regulation of these processes (II)  
• To study the role of the ER in a cell model of Huntington’s disease (III) 
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3 Materials and methods 
3.1 Animals and kainic acid injections (I-II) 
The animal experiments were approved by the ethical committee and carried out in 
accordance with the European Communities Council Directive (86/609/EEC). Adult male 
Wistar rats weighing 200-300 g (B&K, Hull, UK) were used in experiments. Prior to KA 
injections the rats were anaesthetized with ether and placed in a David Kopf stereotaxic 
apparatus using coordinates AP=-0.85, L=4.3 from the Bregma. Status epilepticus was 
induced by injecting 0,175 µg KA (0.35 µg/µl in saline; Sigma, Finland) into the lateral 
ventricles of the rat in a total volume of 0.5 µl per side. The rats were subsequently killed by 
decapitation in deep anesthesia at time-points ranging from 3 to 72 h. Control rats received 
equal volume of saline. All experimental groups consisted of at least quadruplets. The brains 
were rapidly dissected, frozen in isopentane, cooled in liquid nitrogen and stored at −70 °C 
until analysis. The right side of the brain was used for histology and the left for Western blot 
analyses. 
In some experiments, Salubrinal (Sal) was given prior to KA injections (I). Sal (Calbiochem) 
was dissolved in dimethylsulfoxide (DMSO; Sigma, Finland) and diluted in saline. Sal was 
given either intracerebroventricularly (1 µl) with a 75 µM solution or intraperitoneally (0.1 
ml) with 1 mg/kg. Control groups were given equal amounts of DMSO. 
3.2 Hippocampal neuronal cultures, treatments and transfections (I-II) 
Hippocampal neurons were prepared from embryonic, E17-old Wistar rats (Harlan, Holland). 
Pregnant rats were anaesthetized by carbon dioxide and killed by cervical dislocation or 
decapitation. The embryos were immediately collected to sterile phosphate buffered saline 
(PBS) and placed on ice. The hippocampi were isolated from the brains and incubated with 
papain and cystine (0,5 mg/ml and 0,2 mg/ml respectively; Sigma; in PBS containing 1 
mg/ml BSA) at +37 °C for 15 min. The cells were gently triturated in RT in the presence of 
20 µg/ml DNase (Sigma), pelleted by centrifugation and resuspended in Neurobasal medium 
(Invitrogen) containing 0.5 mM GlutaMAX (Invitrogen), 1 % PenStrep and 2 % B27 
supplement (Gibco). The initial plating medium contained 25 µM glutamate to induce neurite 
outgrowth and was replaced with normal medium after 4-6 h. The neurons were plated on 
poly-ornithine (Sigma) coated 6-well plates at a density of 1.8×106 cells or 150-180x103 cells 
on poly-ornithine coated cover slips on 24-well plates, and cultured for 7 days. 
KA treatment. Neurons were treated with different concentrations of KA for varying periods 
of times as indicated (I-II). Cell death was induced preferentially with 100 µM KA that 
induces death of approximately 40-50 % of the neurons within 24 h.  
Treatments with other chemicals. I: In addition to KA, neurons were in some cases stimulated 
with glutamate (75-300 µM; Sigma) for various time periods. In some experiments the ER 
stress inhibitor Sal (50 µM), the glutamate receptors inhibitor, Kynurenic acid (1 mM; 
Sigma), and the NMDA receptor blocker MK801 (10 µM; Sigma) were added to cells 30 min 
before KA. To reduce calcium increase after KA 50 and 20 µM BAPTA-AM (1,2-bis(o-
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aminophenoxy)ethane-N,N,N',N'-tetraacetic acid acetoxymethyl ester; Sigma) was added 2 h 
and 30 min before KA, respectively. In some experiments, Brefeldin A (0,5 µg/ml, 1h; Sigma) 
was used as a positive control for ER stress. II: In some experiments, 1-10 µM BAPTA-AM, 
2 mM EGTA (glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid; Sigma), the Cdk5 
inhibitor roscovitine (20 µM; Sigma), the calpain inhibitor XI (20 µM; Z-Leu-Abu-
CONH(CH2)3-morpholine; Calbiochem) were added 10-60 min before KA.  
Modulation of Cdk5 in neurons (II). To downregulate Cdk5, 5×106 neurons were transfected 
with 100 nM siRNA constructs against Cdk5 (On TargetPlus Smartpool, Dharmacon) using 
the Amaxa Rat Neuron Nucleofector system (Amaxa GmbH, Germany) according to 
manufacturer’s protocol. As control, a negative control siRNA (Mission® siRNA; Sigma) 
was used. Cdk5 activity was alternatively inhibited using expression plasmids containing 
dominant-negative construct of Cdk5, DN-Cdk5, with a mutation in the active site (D144N) 
and linked to HA (hemagglutinin) epitope (van den Heuvel and Harlow, 1993; Addgene) or 
to EGFP (enhanced green fluorescent protein; courtesy by Dr Tsai; Addgene). The DN-Cdk5-
HA or DN-Cdk5-EGFP were transfected into hippocampal neurons as above, and the vectors 
containing HA- or EGFP were used as controls. siRNA-treated neurons were cultured for 3 d, 
while DN-Cdk5 –transfected neurons were cultured for 5-7 d and stimulated with KA. 
3.3 PC6.3 cell cultures, transfections and treatments (III) 
PC6.3 is a neuronal-like subline of rat PC12 pheochromocytoma cell line that can be 
differentiated by and made dependent on NGF. PC6.3 cells were cultured on Nunc dishes in 
RPMI-1600 (Biochrom) medium supplemented with 10 % horse serum and 5 % fetal calf 
serum, 7.5 % NaHCO3, 100 mM GlutaMAX (Gibco) and 100 mM penicillin-streptomycin 
(Gibco).  
Transfections. Cells were transfected with expression vectors encoding for different CAG-
repeat lengths (18, 39, 53 or 120) of huntingtin exon-1 fused to EGFP (Hasholt et al. 2003). 
Transfectin reagent (BioRad) was used following the instructions provided by the vendor 
using 0.5 µg DNA per 24 well plates, and 4 µg per 6 well plates. Controls were transfected 
with EGFP expression plasmid (Clontech) and cells were incubated for 24–30 h prior to 
analysis. In some experiments 5 µM Sal was added 2 h after transfection. In addition, 200 
ng/ml cycloheximide (CHX, Calbiochem), inhibiting protein synthesis was used in certain 
experiments. For positive controls, ER stress was induced by 0.5 µg/ml Brefeldin-A (Sigma) 
or cellular stress with the general kinase inhibitor Staurosporine (1 µM; STS, Sigma). 
3.4 Calcium imaging (I, II) 
I: Transient Ca2+ responses were studied with conventional wide-field fluorescence 
microscopy integrated in CellR Olympus (Tokyo, Japan) microscopy station. Cells were 
pretreated with vehicle (1% dimethylsulfoxide) or 50 µM Sal for 30 min (short-term 
treatment) or for 20–24 h (long-term treatment). After washing the cells were loaded with 
fura-2 acetoxymethyl ester (2 µM; Sigma) for 40 min at RT. 50 µM KA or 50 µM glutamate 
was applied for 1 min through a bath perfusion system. Ca2+ transient responses were 
measured after background subtraction as the ratio between the fluorescence intensity at 340 
and 380 nm, respectively. Plots were made using Microcal (Northampton, MA) Origin 6.0 
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software. Peak amplitude of Ca2+ responses was calculated as mean amplitude of the five 
time points after agonist application.  
II: Hippocampal neurons were loaded with 4 µM fura-2 acetoxymethyl ester (Invitrogen, 
Carlsbad, CA, USA) for 20 min at 37 °C in Hepes-buffered medium (HBM: 137 mM NaCl, 5 
mM KCl, 1 mM CaCl2, 1.2 mM MgCl2, 0.44 mM KH2PO4, 4.2 mM NaHCO3, 10 mM 
glucose, 20 mM Hepes, pH7.4), rinsed once, and studied immediately. Ca2+ measurements 
were performed at 35 °C using Nikon TE2000 fluorescence microscope (20×/0.75 air 
objective) and Andor iXon 885 EM-CCD camera under the control of Nikon NIS Elements 
AR software with 6D extension. For Ca2+ imaging, the cells were excited with alternating 340 
and 380 nm light (Sutter DG4 Plus) and the emitted light collected through a 400 nm dichroic 
mirror and a 450 nm long-pass filter. DN-Cdk5-EGFP transfected cells were selected based 
upon GFP-fluorescence. Different concentrations of KA were added by constant perfusion 
(HBM). Regions of interest (cell bodies) were defined in NIS software and the data extracted 
to Microsoft Excel for visualization and quantitation. 19-70 cells were measured in each 
experiment, and each experiment was repeated altogether 4 times or more. 
3.5 Antibodies (I-III) 
Target protein Species Dilution  Origin 
Actin (I-III) Rabbit 1:2000-5000 (WB) Sigma 
AIF (I, III) Goat 1:1000 Santa Cruz 
Biotechnologies 
ATF6 (I, III) Mouse 1:100 (ICC) Pierce 
BiP (I, III) Mouse 1:1000 (WB); 1:100 
(ICC) 
BD Biosciences 
Caspase-12 (I, III) Rabbit 1:1500 Chemicon 
Caspase-3 (I, III) Rabbit 1:400 (WB) Cell Signaling 
Cdk5 (II) Mouse 1:2000 (WB) Millipore/Upstate 





caspase-3 (I, III) 
Rabbit 1:150-200 (ICC) Cell Signaling 
Cytochrome c (III) Mouse 1:1000 (WB); 1:200 
(ICC) 
BD Biosciences 
eIf2α  (Ι ,  ΙΙΙ)  Rabbit 1:1000 (WB) Cell Signaling 
GFP (III) Mouse 1:5000 (WB) Roche 
GluR6/7 (II) Rabbit 1:1000 (WB); 1:100 
(ICC) 
Millipore/Upstate 
Hsp60 (III) Mouse 1:1000 BD Biosciences 
NeuN (II) Mouse 1:100 (ICC) Millipore/Chemicon 
p-c-jun (I, III) Rabbit 1:1000 Cell Signaling 




p-eif2α  (Ι ,  ΙΙΙ)  Rabbit 1:1000 (WB); 1:200 
(ICC) 
Cell Signaling 
p-JNK (III) Rabbit 1:250 (WB) Cell Signaling 




p35/25 (II) Rabbit 1:1000 (WB) BD Biosciences 
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PARP (III) Rabbit 1:2500 Cell Signaling 
PERK (I, III) Rabbit 1:500 Santa Cruz 
Biotechnologies 
PSD95 (II) Mouse 1:2000 (WB); 1:500 
(ICC) 
BD Biosciences 
Synapsin I (II) Rabbit 1:500 (ICC) Nordic Biosite/Covance 
α-Spectrin (II, III) Mouse 1:2000 (WB) Chemicon 
 
3.6 Western Blotting (I-III) 
For Western blotting, hippocampal tissue, neurons or PC6.3 cells were rinsed twice with ice-
cold PBS and lysed in RIPA buffer (150 mM NaCl, 1 % Triton-X-100, 0.5 % sodium 
deoxycholate, 1 % SDS, 50 mM Tris-HCl pH 7.4) supplemented with protease inhibitor 
cocktail (Roche, Espoo, Finland) and phosphatase inhibitors (PhoStop; Roche, Espoo, 
Finland). Equal amounts of protein were subjected to SDS-PAGE and blotted onto 
nitrocellulose filters (Amersham, Helsinki, Finland), which were incubated for 1 h in 5% 
skimmed milk or BSA, in TBS-T (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1 % Tween 20), 
and then with primary antibodies overnight at 4 °C. After washing the filter was incubated 
with horseradish peroxidase-conjugated secondary antibodies (1:2,500; Jackson 
ImmunoResearch Laboratories, Espoo, Finland), followed by detection using enhanced 
chemiluminescence (Pierce, Helsinki, Finland). Quantifications were done using the ImageJ 
software (version 1.41o).  
3.7 Immunochemistry (I-IV) 
In vivo: 10 µm rat brain sections were fixed for 10 min at −20 °C using acetone-methanol 
(1:1). Slides were incubated for 1 h with phosphate-buffered saline (PBS)-5 % Bovine Serum 
Albumin (BSA; Sigma) -0.1 % Triton-X-100 at room temperature, and then overnight at +4 
°C with primary antibodies. The nuclei were counterstained with bisbenzimide/Hoechst 
33258 (Sigma). 
In vitro: Neurons and PC6.3 cells were fixed for 20 min using 4 % paraformaldehyde, 
incubated for 1 h using PBS-5 % BSA-0.1 % Triton-X and stained as above with primary and 
secondary antibodies followed by counterstaining of the nuclei with Hoechst 33258. 
Stainings were visualized by fluorescent microscope (Leica DM4500B, Espoo, Finland). 
3.8 Cell degeneration assays (I-III) 
In vivo:  
(I-II) Fluoro-Jade staining. Frozen 10 µm sections were immersed for 5 min in 1 % sodium 
hydroxide/80 % ethanol, rinsed for 2 min in 70 % ethanol, and then rinsed in distilled water. 
Potassium permanganate solution (0.06 %) was added for 10 min, followed by a 10 min 
incubation in 0.0001 % Fluoro-Jade C (Chemicon). After washing, the sections were air dried 
for 10 min at 50 °C, cleared in xylene, and mounted in dibutyl phthalate xylene (Sigma).  
(I) Terminal deoxynucleotidyl transferase-mediated biotinylated UTP nick end labeling 
(TUNEL) staining. Frozen sections were fixed for 10 min with acetone : methanol (1:1) at 
−20 °C and permeabilized with 0.1 % Tween-20/1 % bovine serum albumin/phosphate-
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buffered saline on ice. Fluorescein-labelled UTP (Roche, Germany) was added and sections 
incubated for 1 h at +37 °C, washed and studied under a microscope. 
In vitro: 
(I-II) Hoechst staining. Neuronal cell death after 24 h treatment with 100 µM KA was 
determined by staining hippocampal neurons with Hoechst blue (Sigma) and counting nuclei 
with fragmented/condensed nuclei. Similarly, neurons expressing DN-Cdk5-EGFP or EGFP 
were studied for nuclear condensation/fragmentation (II). Alternatively, neurons were stained 
with propidium iodide (Sigma), which penetrates cells with plasma membrane breaks (I).  
 
(I) MTT assay. In some experiments, MTT (Sigma) assay was used for cell viability. Cells on 
96-well plates were incubated for 2 h at +37 °C in the presence of MTT solution (Thiazolyl 
blue tetrazolium bromide; Sigma) after which the medium was removed. 40 mM HCl in 
isopropanol was added to solubilize the dye absorbed by the cells. The amount of the dye was 
measured by absorbance at 560 nm with Labsystems Multiskan MS spectrophotopmeter. The 
absorbance was linear to cell viability. 
 
(III) PC6.3 cells transfected with huntingtin exon-1 –EGFP contructs. Cells were examined 
under a Zeiss fluorescence microscope and the number of transfected cells with fragmented 
or condensed nuclei was counted as an estimate of cell death. In each experiment, 
approximately 100 cells in four different fields per well using triplicates cultures were 
counted, and experiments were repeated at least three times. Results are expressed as 
percentage of mock-transfected controls. 
3.9 Confocal imaging (II-III) 
Neurons were analyzed at RT with a confocal microscope (LSM 510 Meta; Carl Zeiss, Inc.) 
using LSM AIM software and 63×/1.4 Plan-Apochromat oil objective. Images were 
processed using ImageJ and Adobe Photoshop CS softwares.  
3.10 PCR and Quantitative PCR (I, III) 
RNA was prepared from hippocampal neurons and cDNA synthesized using 50 U of 
SuperScript II reverse transcriptase and components given by the vendor (Invitrogen). 
Quantitative PCR was performed using LightCycler (Roche) and the following primers:  
BiP (I, III):   forward 5′-AAG GTG AAC GAC CCC TAA CAA A-3′,  
                      reverse 5′-GTC ACT CGG AGA ATA CCA TTA ACA TCT-3′;  
Chop (I, III): forward 5′-GCC TTT CGC CTT TGA GAC AGT-3′,  
                      reverse 5′-TGA GAT ATA GGT GCC CCC AAT T-3′;  
ATF4 (I):  forward 5′-CTA CTA GGT ACC GCC AGA AG-3′,  
                      reverse 5′-GCC TTA CGG ACC TCT TCT AT-3′;  
β-actin (I, III): forward 5′-CAC ACT GTG CCC ATC TAT GA-3′,  
                      reverse 5′-CCA TCT CTT GCT CGA AGT CT-3′.  
Amplification was performed using an initial 10 min step at 95 °C, followed by 50 cycles 
with 15 s at 95 °C, 5 s at 60 °C, and 4–12 s at 72 °C, and with a final extension for 10 min at 
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72 °C. Specificity of the product was confirmed by melting-curve analysis. Quantification 
was done from data on the reaction kinetics, and expression levels were related to β-actin. To 
study splicing of XBP, reverse transcription-PCR and the following primers were used: 
forward 5′-AGAGTAGCAGCACAGACTGCGCG-3′; reverse 5′-GGAACTGG-
GTCCTTCTGGGTA-3′. 
3.11 Analysis of ER fragmentation (I) 
Hippocampal neurons were loaded for 30 min with 100 nM	  Blue-white ER-tracker 
(Invitrogen, Espoo, Finland). Different concentrations of KA or glutamate were added for 60 
min after medium change. Cells were studied under a fluorescent microscope (Leica, Espoo, 
Finland) using UV filters. In addtion, cells were also stained using an anti-inositol-3-
phosphate receptor (IP3-R) antibody as described in immunochemistry (1:100; Chemicon). 
3.12 Solubility assay (III) 
Cells were lysed in buffer containing 50 mM Tris–HCl, pH 7.5, 100 mM NaCl, 3 mM EGTA, 
0.5 % Triton X and protease inhibitors (Roche) and kept for 5 min on ice and suspended in 3 
volumes of SDS loading buffer to obtain the total cell lysate as described previously. In order 
to detect high molecular weight forms of the huntingtin fragment proteins, we also blotted the 
stacking gel after the run by which protein aggregates in cells can be resolved. 
3.13 Subcellular fractionation (III) 
PC6.3 cells were harvested by scraping, washed twice in ice-cold PBS, and resuspended in 
600 µl of homogenization buffer (20 mM HEPES-KOH, pH 7.5, 10 mM KCl, 1.5 mM MgCl2, 
1 mM NaEDTA, 1 mM NaEGTA, and 1 mM dithiothreitol) containing 250 mM sucrose and 
a mixture of protease inhibitors (Roche). After 30 min of incubation on ice, cells were 
homogenized using a Dounce homogenizer (type B pestle, 30 strokes). Unbroken cells, and 
nuclei were collected by low speed centrifugation, and the resulting supernatant was 
centrifuged at for 20 min at 10,000 g to obtain mitochondria, followed by centrifugation of 
the supernatant for 1 h at 100,000 ×g. The membrane fraction obtained called P3 contains the 
ER and other cell membranes, and the remaining supernatant represents the cytosolic fraction. 
The mitochondrial and P3 membrane fractions were washed three times in homogenizing 
buffer, and then solubilized in a buffer containing 10 mM Tris acetate, pH 8.0, 0.5 % Nonidet 
P-40, 5 mM CaCl2 and protease inhibitors. The purity of cell fractions was analyzed using 
antibodies against Hsp60 as a marker for mitochondria, and against inositol- (1,4,5) 
triphosphate receptor (IP3-R) as a marker for ER. 
3.14 Surface biotinylation assay 
Cell surface proteins were studied using EZ-Link® Sulfo-NHS-SS-Biotin (Pierce) label. 
Hippocampal neurons were treated with KA and in some experiments roscovitine or 
transfected with DN-Cdk5. Treated neurons were transferred on ice to stop endocytosis. After 
washing with PBS, the cells were biotinylated with freshly prepared, membrane impermeant 
Sulfo-NHS-SS-Biotin (0,2 mg/ml in PBS) for 1 h. Excess Sulfo-NHS-SS-Biotin was 
quenched by washing three times in 50 mM Tris, pH 8,0. Cells were then lysed in extraction 
buffer containing 10 mM Tris-HCl, pH 7,5, 10 mM EDTA, 1 % Triton X-100, 0.1 % SDS, 
supplemented with protease and phosphatase inhibitors (Roche). After brief sonication and 
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centrifugation (14 000 rpm, 10 min at +4 °C) the supernatants were collected. Equal amounts 
of proteins were incubated 1 h with streptavidin beads (Pierce) to pull down biotinylated 
proteins. After washing extensively with extraction buffer, reducing sample buffer was added 
to the streptavidin beads and boiled for 5 min to elute bound proteins. The samples were 
analysed by Western blotting with antibodies for GluR6/7. GluR6/7 levels were compared to 
the levels of GluR6/7 vs Actin in total samples. All experiments were repeated > 4 times.  
3.15 Statistical analyses (I-III) 
Statistical analyses were performed using one-way ANOVA followed by Bonferroni or 
Tukey’s (> 5 groups) post-hoc test. Student’s t-test was used for experiments with two groups. 
For all experiments n= > 3 and p <0.05 was considered significant. Data from Western blots 
were quantified by ImageJ software. All values are expressed as percentage of controls as 
mean + SEM. 
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4 Results 
4.1 KA induces neuronal degeneration in hippocampal neurons (I-II) 
4.1.1 In vivo 
KA treatment in rodents has been used as model of temporal human lobe epilepsy as well as 
excitotoxicity. KA induces excitotoxicity via prolonged excitatory activation of KAR subtype 
of glutamate receptors that are especially abundant in the hippocampal CA3 area. The CA3 
pyramidal neurons are extremely vulnerable to excitotoxicity due to high density of 
postsynaptic KARs and network-like assembly of glutamatergic collaterals able to 
synchronize their discharges (Ben-Ari, Cossart 2000). We studied the effect and extent of 
degeneration caused by intraventricular injections of KA in the rat, known to preferentially 
target the CA3 neurons with little effect on the CA1 area (Nadler, Perry & Cotman 1978).  
Fluoro-Jade, a fluorescent compound that penetrates and stains specifically degenerating 
neurons, was used to assess the extent of degeneration in the hippocampus (I-II). After 24 h 
of KA injection, the CA3 area of treated rats showed degenerating neuronal somas in the 
CA3 area (I: Fig 2a and 5d, II: Fig 1a). In addition, the method was able to stain also 
degenerating neurites (II: Fig 1a). TUNEL staining indicated similar cell death pattern that 
was seen with Fluoro-Jade staining (I: Fig 5e).  
To further assess the cell death in the hippocampus, we studied activation of the major 
execution caspase, caspase-3, by immunostaining the brain slices of KA-treated rats with an 
antibody recognizing the cleaved (activated p17) form of caspase-3. Caspase-3 activation was 
present in neuronal nuclei at the CA3 area similar to Fluoro-Jade and TUNEL stainings (I: 
Fig 5e). The number of TUNEL and activated caspase-3 positive neurons at 24 h after KA 
treatment were quantified and exhibited similar pattern, being around 65 % for both at this 
time-point (I: Fig 5e).  
Early signs of neuronal cell death include protraction and degeneration of neurites that can 
propagate the injury further to the whole cell. In addition, axonal degeneration is a hallmark 
of neuronal death in some neurological disorders, such as ALS (Dadon-Nachum, Melamed & 
Offen 2011). Dendritic spine loss occurs, for instance, in AD (Spires-Jones, Knafo 2012). We 
studied the effects of KA treatment on the post-synaptic neurons (II). The major constituent 
of the post-synaptic density is PSD95, a scaffold protein involved in correct targeting and 
clustering of ion channels and neurotransmitter receptors at the postsynaptic neuron. As early 
as after 3 h post treatment, KA had induced loss of PSD95 in the neurites of the CA3 region, 
innervated by the Mossy fiber axons (II: Fig 1b). Whole hippocampal lysates of KA-treated 
rats indicated that initially (12 h KA) PSD95 is dramatically decreased, however, the levels 
were somewhat recovered after longer periods post treatment (II: Fig 1c), possibly due to 
newly synthesized protein. In addition, the lysates included the whole hippocampus, making 
it possible that the downregulation of PSD95 seen by WB was an understatement of the 
localized situation at the CA3 area, as immunolabeling showed a specific effect on PSD95 
levels at the neurites of the CA3 area (II: Fig 1b).  
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4.1.2 In vitro 
To more specifically study the effects of KA at molecular level, we used hippocampal 
neurons isolated from E17 rats. Isolated neurons develop networks when cultured in vitro and 
can be used to study neuronal functions in more detail (Korhonen, Belluardo & Lindholm 
2001, Banker, Cowan 1977). Importantly, cultured hippocampal neurons abundantly express 
the KAR subtype GluR6 (II: Fig 2c-d). We first tested whether the KA concentration of 100 
µM that is known to cause delayed neuronal degeneration (Korhonen, Belluardo & Lindholm 
2001) is suitable for our studies. The concentrations from 25 µM up to 200 µM had little 
effect on plasma membrane in 1 h as assessed by propidium iodide (PI) staining and excluded 
the possibility for rapid necrotic effects of KA (I: Supplementary fig 1b). For comparison, 
high levels of glutamate (300 µM) increased PI positive neurons in cultures (I: 
Supplementary fig 1b). We then studied the levels of cell death caused by 100 µM KA on 
hippocampal neurons. The number of condensed or fragmented nuclei, indicative of ongoing 
cell death, in KA-treated hippocampal neurons was around 45 % at 24 h post treatment as 
compared with basal level of cell death of around 10 % seen in cultures (I: Fig 5a). 
Respectively to the in vivo assessment of cell death, hippocampal neurons positive for active 
caspase-3 were determined. Active caspase-3 was found in around 40% of neurons following 
the pattern of cell death determined by nuclear morphology (I: Fig 5c).  
The levels of PSD95 in cultured hippocampal neurons decreased rapidly in response to KA 
(II: Fig 2b). In addition, the amount of synaptic networks declined already in 3 h in KA-
treated cultures indicative of synaptic degeneration (II: Fig 2a). Double labeling with PSD95 
and synapsin I, a presynaptic marker, displayed reduction in co-labeling and thus in amount 
of synaptic contacts in KA treated cultures in a time-dependent mechanism (Fig 8).  
 
Figure 8 Double labeling of PSD95 and synapsin I indicating sites of contacts. Neurons were cultured for 7 div, treated 
with KA, fixed and stained as described in Materials and methods. Confocal images were captured from areas with average 
density of neurites using the same adjustments for different treatments. Images of PSD95 (red) and synapsin I (green) 
stainings were deconvoluted and analyzed with a Colocalization finder –plugin using ImageJ. Colocalized areas are shown in 
white. KA treatment showed a reduction in the amounts of synaptic contacts. 
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4.2 KA induces ER stress in hippocampal neurons in vitro and in vivo (I) 
ER stress involvement was indicated in neurological disorders, including PD and ALS, in the 
middle 2000s (Wootz et al. 2004, Lindholm, Wootz & Korhonen 2006). Apart from being an 
indispensable factory of proteins and lipids, the ER is also a major regulator of calcium 
homeostasis (Sammels et al. 2010). One of the most acknowledged consequences of 
excitotoxicity is increased calcium flow from extracellular space but also from intracellular 
organelles. Since ER stress was implicated in neurological disorders involving protein 
accumulation it was an interesting and presumable outcome for a disease model involving 
disturbances in calcium homeostasis. Thus, we studied the involvement of the ER in KA-
induced excitotoxicity as little was known of the ER responses in this type of brain injury.  
First, we studied whether KA (100 µM) had effects on the ER by loading cultured 
hippocampal neurons with an ER-tracker dye prior to KA-treatment. In addition, KA-treated 
neurons were stained with an antibody for an ER resident protein and calcium channel, IP3-R 
(inositol triphosphate receptor). In healthy cells, both the ER-tracker staining and IP3-R 
immunolabeling appeared continuous in the cell soma as well as in the neurites (I: Fig 1). 
KA-treatment induced disintegration of the ER and by 1h after KA treatment the staining of 
IP3-R was dramatically decreased and discontinuous in the neurites (I: Fig 1). Likewise, ER 
networks appeared fragmented after KA in neurons treated with the ER-tracker (I: Fig 1 and 
supplementary fig 1a). 
During stress, the ER responds by activating the UPR consisting of three conserved pathways 
(PERK, IRE and ATF6) aiming to restore homeostasis. Encouraged by our finding of ER 
disintegration by KA, we studied the activation of these pathways in vivo and in vitro. 
4.2.1 KA-induced ER stress response in vivo (I) 
The ER chaperone BiP is involved in binding and guarding all unfolded proteins in the ER as 
well as the stress sensors found at the ER membranes. Accumulation of unfolded proteins or 
disruption of calcium homeostasis triggers release of BiP from the membranes and stress 
sensors thereby activating the UPR cascade. Key events also include upregulation of BiP to 
overcome the growing demands for the chaperone.  
We first studied the levels of BiP in hippocampal lysates from KA treated rats. BiP levels 
increased in 12 h up to 24 h (> 1,5 fold) from KA-treatment but decreased after longer time 
points (I: Fig 2b). Immunostaining of KA-treated rat brains showed increase in BiP levels in 
surviving neurons in the CA3 region after 24 h post treatment (I: Fig 2c). Next, we analyzed 
the activation of the stress sensors, ATF6, PERK and IRE1 (See fig 3: ER stress pathways). 
The ATF6 pathway was activated in the CA3 region as shown by translocation of ATF6 
immunolabeling from the cytosol to the nucleus (I: Fig 2e), consistent with the generation of 
the transcription factor N-ATF6. Second, the PERK pathway activation was investigated by 
studying its phosphorylation status with an antibody specific for the phosphorylated form of 
PERK (p-PERK). Accumulation of p-PERK in the CA3 region was observed at 3 h post KA-
treatment (I: Fig 3c and supplementary fig 2a). The observation was transient, perhaps an 
initial activity boost, since p-PERK immunolabeling diminished in longer time-points (I: 
Supplementary fig 2a). PERK activation is responsible for phosphorylation of eIF2α that in 
 58 
turn results in generalized inhibition of translation. p-eIF2α was observed in the CA3 area 
after 3 h of KA treatment and continued with a slight reduction in longer time points (24-48 h) 
possibly due to switch of the UPR to apoptosis-promoting mode (I: Fig 3c and supplementary 
fig 2a). To assess the IRE1 pathway activation we studied expression of p-c-jun that is 
induced downstream of JNK activation. As expected, p-c-jun was increased in CA3 regions 
of KA-treated hippocampi (I: Supplementary fig 2b). 
Chop, the ER stress-inducible leucine zipper-containing transcription factor, was also induced 
in vivo at 24 h post KA treatment in hippocampal lysates (I: Fig 2b). In addition, 
immunostaining of the proapoptotic Chop was induced and localized to the nuclei of CA3 
neurons (I: Fig 2c), indicating that prolonged UPR was aiming toward apoptosis. 
4.2.2 KA-induced ER stress response in vitro 
As for in vivo, we studied the activation of ER stress pathways in cultured hippocampal 
neurons at 7 div. Consistent with the situation in vivo, BiP levels increased after 100 µM KA 
treatment (I: Supplementary fig 3). Furthermore, the increase was seen clearly also with 
lower KA doses (25 µM) (I: Supplementary fig 3). Levels of BiP mRNA were also studied 
with quantitative PCR that demonstrated time-dependent increase for up to 24 h of KA 
treatment (100 µM) (I: Fig 2d). The stress sensor pathways indicated similar activation as in 
vivo. ATF6 immunostaining showed translocation of ATF6 from cell body to the nuclei 
already in short KA stimulations (90 min) (I: Fig 2e). Both PERK and eIF2α phosphorylation 
was observed after short KA treatments (from 15 min onwards) with a transient pattern 
showing reduction in longer time points (by 3 h) (I: Fig 3a). There was also a clear increase 
in immunostaining of both p-PERK and p-eIF2α (I: Fig 3b and supplementary fig 
3a). Furthermore, we studied the specificity of KA activity on KARs by treating neurons with 
NMDA receptor blocker MK801 (10 µM) as well as a general glutamate receptor blocker 
Kynurenic acid (Kyn; 1 mM) and saw that Kyn but not MK801 could block 
eIF2α phosphorylation (I: Fig 3f). The translational block exerted by eIF2α phosphorylation 
overcomes several mRNAs, one being the transcription factor ATF4 that in turn can induce 
translation of pro-survival as well as pro-apoptotic genes, including the aforementioned Chop. 
We found by quantitative PCR that ATF4 mRNA levels increased upto 4-fold (I: Fig 3d). The 
IRE1 pathway activation was studied by PCR of the XBP1 mRNA around the splicing site (I: 
Fig 3e). Therefore, the splicing of the XBP1 mRNA could be seen by the appearance of a 
second, shorter band in addition to the full-length band. As a control, we used Brefeldin A-
treatment known to induce ER stress. The spliced isoform was readily seen in the control 
Brefeldin A-treated neurons (0,5 µg/ml). With the exception of the 16 h time point, in KA-
treated neurons the spliced isoform was harder to detect, although the mRNA level of XBP1 
increased in longer time points (I: Fig 3e), which can be a result of ATF6-induced 
transcription. The absence of the spliced isoform can be a result of rapid translation of XBP1. 
Furthermore, the splicing could occur at even earlier time points as the ones studied here 
(from 2 h upwards). Thus, the activation of IRE1 pathway cannot be overruled.  
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4.3 KA-induced ER stress mediates cell death via activation of ER resident 
caspase-12 in vivo and in vitro (I) 
The continuation of ER stress activates several mediators promoting cell death, including 
Chop and the JNK pathway. In addition, the ER resident caspase-12 has been shown to be 
activated by ER stress and promote apoptosis (Nakagawa et al. 2000). We studied rat 
hippocampi treated with KA and found that caspase-12 is upregulated and cleaved after 12 h 
KA treatment (I: Fig 4a). Furthermore, immunostaining revealed the presence of caspase-12 
in neuronal nuclei in the CA3 region (I: Fig 4b). In cultured hippocampal neurons the 
cleavage of caspase-12 was present rapidly, already after 15min of KA treatment (I: Fig 4c). 
We suspected that this fast signal could be mediated by Ca2+ and used the Ca2+ chelator 
BAPTA-AM to block the Ca2+ -activated signaling pathways. Indeed, BAPTA-AM (50 µM 
and 20 µM, 2 h and 30 min prior to KA, respectively) could reduce the KA-induced 
formation of cleaved form of caspase-12 in neuronal cultures (I: Fig 4d).  
4.4 Inhibition of ER stress by Salubrinal decreases cell death in hippocampal 
neurons in vitro and in vivo (I) 
Salubrinal (Sal) inhibits the dephosphorylation of p-eIF2α and has been shown to reduce ER 
stress-induced cell death (Boyce et al. 2005, Wiseman, Balch 2005). To test whether Sal 
affects KA-induced cell death we studied its effects on cultured hippocampal neurons. Sal (50 
µM) significantly reduced KA-induced cell death by a 70 % reduction in condensed and 
fragmented nuclei in Sal pretreated cultures (I: Fig 5a). In addition, we saw that Sal readily 
counteracted KA-induced increase in BiP levels, cleavage of caspase-12 as well as the 
number of active caspase-3 –positive cells in cultured neurons (I: Fig 5b-c). To exclude the 
possibility that Sal affects Ca2+ movements in neurons we studied calcium movements using 
the calcium-binding fluorescent dye, fura-2, reflecting the amounts of free calcium in the 
cells. The results indicated no differences between Sal-treated and -untreated neurons on KA 
and glutamate-mediated calcium movements (I: Supplementary fig 4).  
Next, we studied if Sal was able to protect KA-induced cell death in vivo. Rats were given 
intracerebroventricular (icv) or intraperitoneal (ip) injections of Sal prior to KA-treatment as 
described in materials and methods. Both delivery methods significantly reduced KA-induced 
cell death in CA3 neurons (75 % for icv, 60 % for ip) shown by TUNEL and active caspase-3 
staining (I: Fig 5e). Thus, Sal had a significant neuroprotective effect against neuronal cell 
death in vivo. These data represent a novel and important pathway to consider in developing 
drugs against excitotoxic brain damage. 
4.5 KA-induced deregulation of Cdk5 (II) 
It has previously been shown that Cdk5 is involved in various neurological disorders, 
including AD, where deregulation of Cdk5 has been shown to contribute at least to 
hyperphosphorylation of tau (Weishaupt, Neusch & Bahr 2003, Kanungo et al. 2009). 
Deregulation of Cdk5 is brought up via calpain-mediated truncation of the Cdk5 activator 
protein p35 to p25 (Kusakawa et al. 2000). Importantly, calpain-mediated p35 cleavage was 
detected in neurons treated with glutamate as well as the excitotoxins NMDA, AMPA and 
KA (Kerokoski et al. 2004). Cdk5 has been implicated in regulation of numerous neuronal 
functions including the clustering of certain NMDA receptor subtypes and the scaffolding 
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protein PSD95 (Morabito, Sheng & Tsai 2004, Zhang et al. 2008, Hawasli et al. 2007, Li et al. 
2001a). In addition, Cdk5 was indicated in AMPA receptor regulation via δ-catenin (Poore et 
al. 2010). These studies intrigued us to investigate possible involvement of Cdk5 in 
regulating the KAR subtypes of glutamate receptors. GluR6, being the most important KAR 
in mediating KA excitoxicity in the hippocampus (Mulle et al. 1998), was chosen for more 
detailed studies.  
First, we analyzed the expression of GluR6 in hippocampal neurons (II). We used an 
antibody for GluR6/7 recognizing both KAR subunits. Hippocampal expression of GluR7 is, 
however, extremely low and most immunolabeling represents the GluR6 subtype, especially 
in the CA3 area of the hippocampus (Bureau et al. 1999, Wisden, Seeburg 1993). 
Immunostaining of the rat hippocampus indicated specific and concentrated expression of 
GluR6/7 in the CA3 region in neurites from the pyramidal cell layer (II: Fig 1d). Analysis of 
hippocampi from KA-treated rats revealed massive reduction in GluR6/7 immunostaining 
that was evident after 12 h after KA and almost totally absent by 24 h (II: Fig 1d). Similarly, 
the levels of GluR6/7 were reduced in WB with lowest levels at 3-6 h and a rebound in longer 
times, possibly representing newly synthesized protein (II: Fig 1f).  
Next, we studied the GluR6/7 levels in cultured hippocampal neurons and observed a 
dramatic and long lasting reduction of GluR6/7 without similar rebound as seen in vivo (II: 
Fig 2d-e). Immunostaining of GluR6/7 showed how the receptor initially disappears 
specifically from the neurites (II: Fig 2c). GluR6 has been shown to be modulated by 
phosphorylation, ubiquitination and sumoylation, among others, affecting its trafficking and 
function. 
4.5.1 KA treatment induces activation of the calcium-dependent protease calpain (II) 
As already described above, KA induces dose-dependent calcium movements in neurons. 
Calpain is a calcium-activated protease that has functions both in physiological as well as in 
pathological conditions (Goll et al. 2003). Calpain mediates proteolysis of a vast variety of 
substrates, including spectrin and the Cdk5 activator protein p35 (Kusakawa et al. 2000, 
Harris, Morrow 1988). We first studied the activation of calpain by KA-induced increase in 
intracellular Ca2+ (II: Fig 3c). Analysis of spectrin breakdown products by WB was done as 
described in materials and methods. KA treatment induced accumulation of calpain 
breakdown product of 150 kDa and 145 kDa, representing calpain activation (II: Fig 3d). 
Next, we studied the effects of KA on p35 using an antibody that recognizes both p35 and the 
cleaved form, p25. KA treatment induced rapid p35 cleavage in hippocampal neurons already 
in 15 min, with time-dependent increase in p25 levels and decrease in p35 levels (II: Fig 3a-
b). The decrease in p35 levels were probably the result of Cdk5-dependent phosphorylation 
that enhances p35 degradation via the UPS as has been previously shown (Patrick et al. 1998). 
Furthermore, we wanted to verify the activation of calpain also in vivo. Western blotting 
experiments revealed p25 formation after 3 h KA treatment (II: Fig 4f-g). The levels of p25 
increased and peaked at 12 h post treatment and decreased in longer time points (48-72 h) (II: 
Fig 4f-g). In contrast, p35 levels dropped only slightly 3-12 h after KA but were significantly 
reduced (by 50 %) in longer time points (24, 48 and 72 h after KA) (II: Fig 4f-g).   
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To investigate the mediators of calpain activation and p35 cleavage, we used calcium and 
calpain inhibitors to verify the KA-mediated calpain activation and resulting effects on p35. 
Both BAPTA-AM (1-10 µM), chelating intracellular calcium, and EGTA (2 mM), stripping 
the extracellular calcium, successfully inhibited KA-mediated cleavage of p35 to p25 (II: Fig 
3e-h). Moreover, the calpain inhibitor XI (20 µM) also inhibited p25 formation providing 
evidence of its involvement in the proteolytic event (II: Fig 3g-h). The levels of p35 in these 
experiments, however, decreased, possibly reflecting to Cdk5-aided p35 degradation.  
4.5.2 Cdk5 is phosphorylated after KA treatment (II) 
Cdk5 can be phosphorylated at tyrosine 15 (Y15) and thereby achieve increased activity, 
although it is not a necessity for its function (Zukerberg et al. 2000). We investigated if KA-
induced phosphorylation of Y15 in cultured hippocampal neurons. Specific antibody 
recognizing Cdk5 phosphorylated at Y15 (p-Cdk5) revealed that Cdk5 indeed was 
phosphorylated in response to KA. The level of p-Cdk5 was present after 30 min KA (II: Fig 
4a-b). Immunostaining with p-Cdk5 antibody revealed intensified staining in KA-treated 
neurons within the soma as well as in the neurites (II: Fig 4c). The phosphorylation of Cdk5 
occurred later than formation of p25 indicating that the Cdk5/p25 complex might achieve its 
full activation in longer time points (30 min onwards). The levels of Cdk5 remained 
unchanged even in longer KA treatments (II: Fig 4a) reflecting that its activity is mainly 
regulated by the activator proteins.  
In addition, the presence of p-Cdk5 was studied in vivo. As in cultured neurons, the levels of 
Cdk5 remained almost constant (II: Fig 4f-g). We saw p-Cdk5 appear after 3 h KA treatment 
and peak at 12 h after KA (II: Fig 4f-g). The levels decreased by 24 h but showed a rebound 
in longer times (72 h), which was, however, not significant (II: Fig 4f-g). The 
phosphorylation was dependent on calcium as both calcium blockers, BAPTA-AM and 
EGTA prevented the KA-induced phosphorylation of Y15 in Cdk5 (II: Fig 4d-e).  
4.5.3 Inhibition of Cdk5 in hippocampal neurons prevents KA-induced decreases in 
GluR6 and PSD95 (II) 
Since many receptors and other proteins involved in glutamatergic signaling have been 
implicated as Cdk5 targets, we wanted to study if Cdk5 is involved in KA-induced GluR6 
downregulation. Phosphorylation of PSD95 by Cdk5 inhibits its multimerization and 
regulates the clustering of cell surface receptors (Morabito, Sheng & Tsai 2004). In addition, 
Cdk5 has been implicated in receptor endocytosis and degradation (Hawasli et al. 2007, 
Poore et al. 2010). Since both NMDARs and AMPARs are Cdk5 targets, it is possible that 
KARs are modulated by this kinase as well.  
Cdk5 activity can be modulated in neurons with the chemical inhibitor, Roscovitine, which 
also inhibits some other Cdks, however, these are mostly absent from postmitotic neurons. 
Thus, we studied the effect of Roscovitine pretreatment (20 µM, 1h) on KA-induced GluR6 
downregulation. Moreover, we also studied the levels of known Cdk5-substrate, PSD95. The 
levels of GluR6/7 in neurons treated with Roscovitine did not decrease in response to KA (II: 
Fig 5a-b). Interestingly, the levels of PSD95 in Roscovitine treated neurons increased after 
KA (II: Fig 5a-b). This might indicate activity-dependent translation of PSD95 that normally 
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is regulated and stabilized by Cdk5. Immunostaining of Roscovitine-treated neurons showed 
increase in GluR6/7 staining intensity that was even sharper after KA-treament (II: Fig 5c). 
Next, we used dominant-negative Cdk5 (DN-Cdk5) construct that is defective for its kinase 
activity. Expression of DN-Cdk5 in neurons reduced KA-induced downregulation of GluR6/7 
and PSD95 as seen with Roscovitine (II: Fig 5d-e). Moreover, we silenced Cdk5 expression 
in hippocampal neurons by siRNA construct and found that this also was successful in 
counteracting the effect of KA on GluR6/7 and PSD95 (II: Fig 5f-g). Taken together, 
inhibition of Cdk5 reduced the KA-mediated downregulation of GluR6/7 and PSD95 that 
could be due to ineffective endocytosis or degradation. In addition, it is not clear whether 
Cdk5 directly targets GluR6/7 or if the effect is indirect, via a regulatory protein or perhaps 
PSD95.  
We hypothesized that stabilization of GluR6/7 protein levels and increase in staining intensity 
seen in Roscovitine-treated neurons could be the result of defective endocytosis of the 
receptor. Thus, using sulfo-NHS-biotin we labeled surface proteins at different time points 
after KA and/or Roscovitine. Labeled proteins were pulled down and assayed by WB as 
described in Materials and methods. KA treatment induced reduction in cell surface GluR6/7 
while pre-treatment with Roscovitine counteracted this effect (Data not shown). Similar 
results were obtained with Cdk5 siRNA and DN-Cdk5-transfected neurons (See Fig 9 for 
results obtained using DN-Cdk5 construct). These data provided evidence of Cdk5 
involvement in GluR6/7 endocytosis.  
 
Figure 9 Biotinylation of cell surface GluR6/7 in hippocampal neurons. Hippocampal neurons were transfected with 
HA-DN-Cdk5 construct or empty plasmid. Neurons were treated with for 1-60min and biotinylated with Sulfo-NHS-Biotin 
reagent as described in materials and methods. Immunoprecipitated cell surface proteins (IP), unbound intracellular proteins 
(IC) and total samples (T) were studied by WB. A. Upper panel shows cell surface GluR6/7 decreasing after KA treatment in 
neurons transfected with empty plasmid. Lower panel shows how cell surface GluR6/7 levels decrease slower in HA-DN-
Cdk5 expressing neurons. DN-Cdk5 is presented by another, higher molecular weigth band in the lower panel Cdk5. B. 
Quantification of data from biotinylation experiments, n=4. Notice high GluR6/7 levels in 10-60min after KA. C. Schematic 
presentation of receptor labeling with sulfo-NHS-biotin in normal (left) and KA-treated (right) conditions.  
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4.5.4 Inhibition of Cdk5 protects against cell death induced by KA in vitro (II) 
Function of Cdk5 is essential for the development and proper functioning of the CNS 
(Ohshima et al. 1996). Deregulation of Cdk5, however, changes its physiological functions 
towards pathological and are associated with cell death. Studies have shown that inhibition of 
Cdk5/p25 can be protective in several pathological conditions (Kanungo et al. 2009). 
Roscovitine has been documented to have toxic effects in cell cultures during prolonged 
incubations and we also saw decrease in cell viability in MTT experiments with longer 
Roscovitine treatments (Data not shown). Thus, for further study of the effect of Cdk5 
inhibition on cell death, we used the DN-Cdk5 construct. Neurons were transfected with DN-
Cdk5-GFP constructs and control GFP vector. Cell death was assessed by calculating GFP-
expressing neurons exhibiting condensed or fragmented nuclei as described in Materials and 
methods. The results indicated that DN-Cdk5 protected neurons from KA-induced cell death 
after 24 h (55 % cell death for GFP vrs 35 % for DN-Cdk5-GFP) (II: Fig 5h). The results 
were verified and in line with MTT experiments for the same conditions (Data not shown). 
This shows that catalytic activity of Cdk5 is involved in KA-induced cell death in 
hippocampal neurons and preventing its function has beneficial properties, making it a 
possible drug target in neuropathological conditions.  
To investigate the possible mechanisms behind the protective effect of Cdk5 inhibition we 
decided to study ER stress markers. One study has shown that Cdk5/p25 translocates to the 
nucleus and promotes cell death in response to ER stress (Saito et al. 2007). We found that 
expression of DN-Cdk5 or Roscovitine upregulated BiP levels (unpublished data). 
Upregulation of BiP by an inducer compound, BIX, has been reported to protect against ER 
stress induced cell death (Kudo et al. 2008). On the other hand, phosphorylation of eIF2α was 
counteracted by Cdk5 inhibition. This might suggest that upregulation of BiP by Cdk5 
inhibition has a protective, buffering effect on ER functions and, second, Cdk5 might take 
part in promoting excitotoxicity induced ER stress. It remains to be studied if Cdk5 mediates 
signaling from the receptor to the ER. In regards to calcium signaling, we also studied if 
Cdk5 inhibition affects KA-induced calcium movements since the expression of GluR6 on 
the cell surface was altered by Cdk5 inhibition. DN-Cdk5 expression or roscovitine treatment 
did not significantly alter KA-mediated calcium movements indicating that Cdk5 could be 
involved in signaling pathways leading to cell death and promotion of ER stress. One 
possibility is that the protective effect on cell death by Cdk5 inhibition occurs by decreasing 
ER stress. 
4.6 ER stress is involved in a cell model of Huntington’s disease (III) 
Huntington’s disease is a neurodegenerative disorder caused by the expansion of N-terminal 
poly-CAG repeat in the huntingtin gene. This results in translation of aggregation-prone 
huntingtin (htt) protein that selectively destroys striatal neurons in affected individuals. Cell 
death mechanisms in HD has been suggested to involve excitotoxicity, mitochondrial 
dysfunction and disturbed neurotrophic support. We suspected that accumulation of mutant 
htt could also induce ER stress as the ER is essentially involved in proper folding of proteins.  
It has been shown that the bare N-terminal fragment of mutant htt is sufficient to induce cell 
death (Mangiarini et al. 1996). To study mutant htt-mediated effects on ER functions and cell 
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death, we transfected PC6.3 cells with N-terminal htt-EGFP constructs encoding for different 
polyQ lengths (18Q, 39Q, 53Q and 120Q) (Hasholt et al. 2003) as described in Materials and 
methods. Expression of different mHtt constructs was determined by Western blotting and 
immunofluorescence microscopy (III: Fig 1a, c-d). Cells expressing Htt fragment proteins 
with 39Q or more showed aggregates both in the nucleus and perinuclear regions (III: Fig 1c). 
Cell death was assessed by measuring nuclear condensation or fragmentation and revealed 
increase in polyQ length-dependent manner (III: Fig 1b).  
Next, we studied the ER stress proteins in cells expressing Htt proteins. BiP protein levels 
were increased in cells expressing Htt constructs 24 h after transfection (III: Fig 2a). BiP 
mRNA levels were also increased in polyQ length-dependent manner (III: Fig 2b). 
Phosphorylation of eIF2α also took place in transfected cells, especially, in cells with 53Q- 
and 120Q-containing Htt fragment proteins (III: Fig 2a). Immunostaining of p-eIF2α showed 
increase in cells expressing 120Q-containing Htt fragment protein (III: Fig 2c). Moreover, 
ATF6 was shown to translocate to the nucleus in cells expressing the 120Q-containing Htt 
fragment protein (III: Fig 2c). To assess the cell death mediators activated by mutant Htt we 
studied proteins involved in ER stress-evoked cell death pathway, namely, Chop, JNK and 
caspase-12. Chop was induced in cells expressing the 53Q and 120Q-containing Htt fragment 
proteins (III: Fig 2c). The JNK-pathway was activated as well, shown by appearance of 
phosphorylated JNK in cells expressing 53-120Q-containing Htt fragment proteins (III: Fig 
2a). Also the downstream transcription factor c-jun was phosphorylated (III: Fig 2a). In 
addition, caspase-12 was cleaved and translocated to the nucleus in cells expressing 53-
120Q-containing Htt fragment proteins (III: Fig 2d-e). 
Activation of ER stress and downstream cell death mediators led us to study further cell death 
mediators. Caspase-3, the key effector caspase, was activated in cells expressing the 53-120Q 
containing Htt fragment proteins shown by immunostaining and cleavage of the full-length 
protein by WB (III: Fig 3a-b). In addition, PARP, being a substrate for caspase-3 was cleaved 
in these cells (III: Fig 3c). As mitochondrial cell death pathway has been implicated in HD 
pathogenesis we then studied if it is involved in our cell model. Cytochrome c and AIF, 
released from mitochondria during MOMP, were studied by immunostaining, WB as well as 
fractionation of cells expressing Htt fragment proteins. We did not observe cytochrome c or 
AIF release in our cell model after 24-30 h transfection (III: Fig 4), indicating that ER stress 
is playing a prominent role in this model as the activator of caspase-3 pathway.  
4.6.1 Inhibition of ER stress by Salubrinal reduces cell death and aggregation of 
mutant huntingtin fragment proteins (III) 
ER stress inhibition by Sal was successful in decreasing KA-induced cell death in 
hippocampal neurons in vitro and in vivo (I). Therefore, we were intrigued to study its effects 
on our cell model of HD. Sal-treatment (5 µM) of PC6.3 cells 2 h after transfection with Htt 
fragment protein-constructs showed that inhibition of ER stress reduced cell death by 40 % 
caused by 39-120Q -containing Htt fragment proteins (III: Fig 5a). Calculating the number of 
aggregates in htt-expressing cells showed increase in polyQ length- dependent manner and 
was also significantly reduced in cells treated with Sal (III: Fig 5b). The level of aggregated 
proteins was additionally studied by immunoblotting the membrane fractions (P3) of cells 
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expressing 53Q and 120Q containing Htt fragment proteins. 120Q containing Htt fragment 
protein was clearly present in the P3 fraction and was reduced by Sal –treatment (III: Fig 5c). 
This was not due to reduction in total expression level of the 120Q-containing Htt fragment 
protein but could reflect to Sal-mediated inhibition of aggregate formation or breakdown of 
the aggregates (III: Fig 5d).  
Furthermore, we studied the effect of Sal on ER stress proteins in Htt fragment protein-
expressing cells. As expected, the levels of BiP and p-eIF2α were increased in 53Q-
containing Htt fragment protein treated with Sal, as compared to Sal-untreated cells (III: Fig 
5e). In addition, caspase-12 levels were increased by 53Q- containing Htt fragment protein 
expression but the cleavage was significantly reduced in Sal-treated cells (III: Fig 5e). These 
data clearly implicate ER stress involvement in the cell damage caused by mutant Htt 
fragment proteins. Inhibition of the PERK pathway by Sal greatly reduced cell death and 
might be beneficial also in postmitotic striatal neurons expressing mutant Htt.  
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5 Discussion and future prospects 
5.1 KA induced excitotoxicity, cell death pathways and organelle dysfunction 
Kainic acid is a well-known agonist for non-NMDA glutamate receptors targeting specific 
brain regions enriched in KA receptors in vivo (Bahn, Volk & Wisden 1994). The data 
obtained in this thesis with in vivo i.cv. injections of KA are consistent with previous studies 
(Ben-Ari 1985, Nadler, Perry & Cotman 1978, Bahn, Volk & Wisden 1994) showing 
localized degeneration of neurons in the CA3 area of the hippocampus (I-II).  
The cell death triggered by KA excitotoxicity appears to be a continuum of different cell 
death modalities, including necrosis, apoptosis, and autophagy, depending on the duration 
and extent of the seizures (Vincent, Mulle 2009, Wang, Qin 2010). For in vitro experiments, 
we used a concentration of KA shown to induce delayed neuronal degeneration with 
approximately 45-50 % cell death in 24 h (I) and (Korhonen, Belluardo & Lindholm 2001). 
This type of treatment also excluded the induction of necrosis in the early time points after 
KA (I). 
The cell death proteins involved in neuronal degeneration after KA treatment have previously 
been shown to involve Bcl-2 and IAP family proteins (Korhonen, Belluardo & Lindholm 
2001, Belluardo et al. 2002, Sokka et al. 2005, Korhonen et al. 2003). KA-induced 
excitotoxicity was shown to accompany upregulation and punctate staining indicative of 
mitochondrial localization of the pro-apoptotic Bax as well as increased phosphorylation of 
the anti-apoptotic Bcl-2, which abrogates its normal functions (Korhonen et al. 2003). Unlike 
Bax, the pro-apoptotic BH3-only proteins Bim and Hrk/DP5 showed decrease after KA 
(Korhonen et al. 2003). This indicates that Bax is an important pro-apoptotic mediator in KA 
excitotoxicity, however, other factors regulating KA-induced cell death remain to be studied. 
The inhibitor of apoptosis proteins XIAP, RIAP-2 and BRUCE, normally antagonizing cell 
death mediators, are downregulated by KA specifically in areas vulnerable for KA (Korhonen, 
Belluardo & Lindholm 2001, Belluardo et al. 2002, Sokka et al. 2005). As also previously 
shown, KA induces cleavage and activation of the executor caspase-3 in vivo and in vitro (I) 
and (Korhonen, Belluardo & Lindholm 2001, Becker et al. 1999). Inhibition of caspase-3 has 
neuroprotective effects against KA toxicity (Becker et al. 1999) and decreases degradation of 
XIAP and BRUCE (Korhonen, Belluardo & Lindholm 2001, Sokka et al. 2005). According 
to their neuroprotective roles, it would an intriguing possibility to prevent neuronal death by 
overexpressing or preventing the degradation of IAP proteins. 
The main trigger of cell death pathways in KA excitotoxicity is thought to be calcium influx 
via ionotropic glutamate receptors and secondarily through voltage-gated channels activated 
by depolarization (Koh et al. 1990). We also observed calcium movements caused by KA in 
cultured hippocampal neurons and saw that blocking calcium movements by BAPTA-AM or 
EGTA inhibited activation of caspases and calpains indicating that calcium mediates the 
primary neurotoxic effects by KA.  
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Apart from the influx from extracellular spaces, calcium movements are also regulated by 
intracellular organelles. The main calcium store in cells is found in the ER. In addition, 
mitochondria and the Golgi apparatus play roles in calcium regulation. The ER contains 
numerous Ca2+  -binding proteins and Ca2+ pumps, including sarcoplasmic-endoplasmic 
reticulum Ca2+ ATPase (SERCA), ryanodine reseptor (RyR) and IP3R, transporting Ca2+ in to 
the ER (SERCA) or outwards to the cytosol (RyR and IP3R) (Stutzmann, Mattson 2011). 
Importantly, apoptotic Ca2+ efflux was regulated by Bcl-2 and upregulation of Bcl-2 reduced 
thapsigargin-induced Ca2+ release (Stutzmann, Mattson 2011, Lam et al. 1994). Bcl-2 binds 
IP3R and controls its Ca2+ release. Apoptotic activation of JNK, however, results in Bcl-2 
phosphorylation and release of the IP3R that apparently facilitates calcium release (Stutzmann, 
Mattson 2011). From the ER, calcium can be transferred to mitochondria at specific contact 
sites, called mitochondria associated membranes (MAMs) (Hayashi et al. 2009). 
Mitochondrial calcium overload in turn can induce permeability transition pore opening and 
release of apoptotic mediators to the cytosol (Giacomello et al. 2007). In ceramide-induced 
apoptosis, it was shown that Cdk5 regulates the clustering of the ER and mitochondria via 
phosphorylation of tau, thus inducing its detachment from the microtubules that favors 
retrograde transport of organelles (Darios et al. 2005). In addition, overexpression of BiP was 
protective against ischaemic injury in primary astrocytes by slowing the mitochondrial Ca2+ 
transfer (Ouyang et al. 2011). It remains to be shown if KA has the potential to induce similar 
Ca2+ transfer and how this contributes to overall cell death induced by KA.  
Centrally involved in the secretory pathway, the Golgi also is a dynamic calcium store and 
contains, for instance, a Ca2+ ATPase SPCA1 (Secretory pathways Ca2+ ATPase) (Wootton et 
al. 2004), which is deactivated by ischaemia reperfusion injury (Lehotsky et al. 2009). In 
addition, several Ca2+ pumps also found in the ER are localized to the Golgi. These include 
SERCA and IP3Rs (Pizzo et al. 2011). In keeping with this, it is understandable that any 
disturbances in calcium homeostasis in the cell affect the functions of the Golgi and vice 
versa. Indeed, we have observed a fairly rapid dose- and time-dependent fragmentation of the 
Golgi after KA treatment (unpublished data). Regarding the important role of calcium in 
cellular homeostasis and its regulation by intracellular organelles, we studied the involvement 
of the ER in KA excitotoxicity. In addition, it would be of importance to characterize the 
mediators and pathways involved in excitotoxic Golgi fragmentation. 
5.2 ER stress in KA excitotoxicity 
Studies concerning the ER showed that KA excitotoxicity involves activation of ER stress 
sensors PERK, ATF6 and IRE1 in combination with BiP upregulation. ER stress signaling 
was previously detected in neurological disorders, including ALS as well as in human TLE 
patients (Wootz et al. 2004, Yamamoto et al. 2006). In human TLE, expression of the ER 
chaperones BiP/GRP78, GRP94 and calnexin were upregulated in combination with 
localization of the pro-apoptotic Bid, Bim and caspase-3 to the ER fraction (Yamamoto et al. 
2006). Adaptive changes including XIAP binding to caspase-7 was detected indicating that 
anti-apoptotic signaling minimizes seizure-induced cell death in TLE (Yamamoto et al. 2006). 
Evidence of ER stress signaling in increasing number of disorders and especially in 
neurological diseases involving KAR activity makes it a significant area of study for both 
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clinical means as well as as a target for drug development. Subsequently to our study, ER 
stress has been characterized after KA treatment also by others (Chihara et al. 2009, Murphy 
et al. 2008) and it was shown that in addition to hippocampal pyramidal neurons, also 
astrocytes show activation of ER stress markers such as BiP (Chihara et al. 2009). 
Inhibition of ER stress with the small molecular compound, Sal, decreased cell death caused 
by KA treatment in vitro and in vivo (See fig 10). This occurred via decrease in activation of 
caspase -12 and caspase-3. These data indicated strong involvement of ER stress in KA-
mediated excitotoxicity and proves that ER homeostasis is very important in normal neuronal 
functions. Sal, inhibiting the dephosphorylation of eIF2α (Fig 10) acts to prolong the levels 
of phosphorylated eIF2α and thereby halting protein synthesis (Boyce et al. 2005). This is 
accomplished by inhibition of the protein phosphatase 1 (PP1) in a complex with the growth 
arrest and DNA damage gene (GADD34) that dephosphorylates eIF2α during ER stress 
giving negative feedback for the PERK pathway (Novoa et al. 2001). It has also been shown 
that Sal binds Bcl-2 and protects cells from pro-apoptotic and pro-autophagic effects 
mediated by Bcl-2 inactivation (Kessel 2006). Bcl-2 inactivation occurs also after KA 
treatment (Korhonen, Belluardo & Lindholm 2001). PD and α-synucleinopathies involving 
mutant α-synuclein (αS) accumulation was recently shown to involve ER stress in transgenic 
mouse models with A53T mutant human αS (A53TαS) (Colla et al. 2012a, Colla et al. 2012b). 
Moreover, Sal was used to inhibit ER stress pathways and found to reduce disease 
manifestation, αS accumulation (Colla et al. 2012a, Colla et al. 2012b) as well as to extend 
the lifespan of the A53TαS Tg mice and decrease Golgi fragmentation of dopaminergic 
neurons (Colla et al. 2012a). Interestingly, we have also seen a decrease in levels of 
fragmented Golgi in KA treated hippocampal neurons when pretreated with Sal (data not 
shown). Sal was also used in a study with mouse model of familial ALS (FALS) where the 
vulnerable motor neurons manifest with ER stress (Saxena, Cabuy & Caroni 2009). 
Superoxide dismutase-1 (SOD1)-mutant/FALS mice treated with Sal showed reduction in 
loss of muscle force and extension of their lifespan as well as reduced axon pathology and 
denervation (Saxena, Cabuy & Caroni 2009). Sal was neuroprotective both when applied in 
early and later time points of the disease (Saxena, Cabuy & Caroni 2009) with the indication 
that attenuating ER stress would greatly benefit ALS patients. Previously, Aβ neurotoxicity 
and microglial activation were shown to be attenuated by Sal via activation of NFκB pathway 
(Huang et al. 2012). These data enlighten the mechanisms by which Sal protects neuronal 
cells from injury and make it an interesting drug to study in more detail for neurological 
disorders. However, Sal has also been implicated to promote apoptosis in certain cancer cells 
when used in high doses bringing up the possibility for its use as anti-cancer drug (Park et al. 
2011). Furthermore, Sal was shown to potentiate ER stress caused by fatty acids in pancreatic 
beta cells, indicating that different cell types might have very different responses to this drug 
(Cnop et al. 2007). Taken together, Sal shows promising effects against neuronal cell death 
and it would be interesting to study if it has protective effects in other neuronal diseases 
involving excitotoxic damage, such as ischaemia.  
BiP/GRP78 is an important protective chaperone in regards to ER stress and its depletion 
under stressful conditions sets the ER vulnerable for prolonged ER stress and subsequent cell 
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death activation. Upregulation thus occurs as a first aid mechanism, however, other signals 
can overcome the protective effect of BiP. It was recently found that a new compound, 
named BiP inducer X (BIX), is able to induce BiP via the ATF6 pathway (Kudo et al. 2008). 
BIX-mediated induction of BiP protected neuroblastoma cells against ER stress in vitro and 
reduced cell death in mice after focal cerebral ischaemia (Kudo et al. 2008). Compounds 
inducing BiP could therefore be of therapeutic relevance. In regards to our studies with Cdk5, 
we observed upregulation of BiP in neurons when Cdk5 was downregulated (unpublished 
data). Cdk5 inhibition also reduced the PERK pathway -mediated phosphorylation of eiF2α 
that occurs after KA in mock cells (data not shown). ER stress has been shown to induce 
calpain-mediated cleavage of p35 to p25 and deregulation of Cdk5 that promoted cell death 
(Saito et al. 2007). This study also pointed out that inhibition of Cdk5 protected against ER 
stress-induced cell death (Saito et al. 2007). It remains unclear, if Cdk5 also plays other roles 
directly in ER stress and if Cdk5 regulates ER-to-mitochondria Ca2+ transfer during KA 
excitotoxicity as was shown in ceramide-induced cell death (Darios et al. 2005). In future 
studies it should be verified whether also Cdk5 could be a target for excitotoxic cell death 
involving ER stress as Cdk5 inhibition has shown promising neuroprotective effects in 
several neurological disorders.  
In addition, ER stress and Golgi fragmentation induced by Brefeldin A treatment has some 
intriguing properties and these organelles might have more common factors causing organelle 
dysfunction that spreads via cross talk of the organelles. Brefeldin A targets the Golgi-
localized guanine nucleotide exhange factors (GEFs) for the ADP-ribosylation factor 1 (Arf1) 
that is involved in coat protein recruitment and transport vesicle formation at the Golgi 
(Klausner, Donaldson & Lippincott-Schwartz 1992, Donaldson, Finazzi & Klausner 1992). 
These GEFs include three large factors that are localized to different Golgi compartments: 
Golgi-specific BFA resistance factor 1 (GBF1), BFA-inhibited GEF (BIG1) and BIG2 (Zhao, 
Lasell & Melancon 2002). Interestingly, siRNA depletion of GBF1 resulted in Golgi 
dispersion and UPR induction that resulted from mixing of the Golgi membranes with the ER 
(Citterio et al. 2008). BFA has been shown to cause similar redistribution of Golgi 
membranes with the ER (Klausner, Donaldson & Lippincott-Schwartz 1992). GBF1 
depletion caused relocation of the site 2 protease (S2P) that is responsible for ATF6 cleavage 
during the UPR thus resulting in activation of the ATF6 pathway and increase in ER 
chaperones (Citterio et al. 2008). The close relationshop of Golgi and ER makes it a 
fascinating target of study how the organelles talk together in different cellular stress 
conditions. It remains to be studied, for instance, how KA affects these organelles, which is 
affected first or are the insults simultaneous.  
Deletion of caspase-12 from mice resulted in resistance to ER stress induced apoptosis, for 
instance, triggered by Aβ toxicity (Nakagawa et al. 2000). The absence of caspase-12 from 
humans suggests that it might have evolved to prolong the survival of human cells from ER 
stress. This also might underlie the development of degenerative diseases involving 
accumulation of un- or misfolded proteins with defective clearance of affected cells. 
However, in light of neuronal irreplaceable nature it might have been important to save as 
many as possible. Humans that have been found to have functional caspase-12 have not been 
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reported to have more neurodegenerative diseases, although they are more susceptible for 
sepsis (Saleh et al. 2004). 
 
Figure 10 Summarizing figure of I. 
5.3 KA-induced activation of Cdk5 and cell death 
KA induced fast deregulation of Cdk5 in hippocampal neurons that was also apparent in vivo. 
Deregulation of Cdk5 was verified by the appearance of calpain cleavage product of the Cdk5 
activator protein p35 (See fig 11). Modification of p35 occurs in neurological disorders 
including AD and HD (Paoletti et al. 2008, Kobayashi et al. 1993, Noble et al. 2003). 
Modification p35 to p25 results in detachment from membranes due to the loss of the 
myristoylation site at the N-terminal part of p35 (Kusakawa et al. 2000). Apart from 
relocalization of the activator protein, p25 achieves increased stability and activity due to the 
loss of Cdk5 phosphorylation site responsible for p35 degradation (Patrick et al. 1998, Patrick 
et al. 1999). KA readily induced p25 formation indicating that deregulated Cdk5/p25 
complex is involved in KA excitotoxicity. In addition to the modification of the activator 
protein, Cdk5 activity can be increased by phosphorylation of the tyrosine residue Y15 
(Zukerberg et al. 2000). We saw phosphorylation of this residue occurring in cultured 
neurons after KA treatment after p25 appearance.  Moreover, phospho-Cdk5 was also present 
in vivo after KA treatment. Cdk5 phosphorylation is mediated at least by Src, c-Abl, Fyn and 
semaphorin A (Zukerberg et al. 2000, Qiao et al. 2008, Sasaki et al. 2002). It would be 
interesting also to characterize the kinase involved in KA-mediated Cdk5 phosphorylation as 
it was not studied here.  
Cdk5 activation has also been implicated in ischaemic injury (Wen et al. 2007, Menn et al. 
2010). Inhibition of Cdk5 by the chemical compound Roscovitine was neuroprotective in 
animal models of ischaemia and tauopathies (Wen et al. 2007, Menn et al. 2010, Zhu et al. 
2007). It remains to be determined, whether Roscovitine exerts protection against KA 
excitotoxicity or other excitotoxic events. We used the dominant negative Cdk5 construct to 
determine the effect of Cdk5 inhibition on KA induced cell death in vitro. DN-Cdk5 
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decreased KA-induced cell death significantly indicating that Cdk5 plays an important role in 
mediating cell death after KA treatment (Fig 11).  
The GluR6 KA receptor has been implicated as the mediator of hippocampal damage in 
rodents treated with KA (Mulle et al. 1998). We saw robust reduction in GluR6 levels 
accompanied with reduction in the scaffold protein PSD95 in the Mossy fiber area of the 
CA3 of the hippocampus after KA. This reduction was apparent also in vitro. We found that 
inhibition of Cdk5 greatly affected the levels of these proteins (Fig 11). PSD95 has been 
previously reported as a target of Cdk5 regulating PSD95 multimerization and clustering 
abilities of neurotransmitter receptors (Morabito, Sheng & Tsai 2004, Zhang et al. 2008, 
Bianchetta et al. 2011). The effect of Cdk5 inhibition on KARs has not been studied before 
and this study sheds light for Cdk5 being a grand modulator of even larger variety of 
glutamate receptors, as it has been previously implicated in NMDAR, AMPAR and mGluR 
regulation (Morabito, Sheng & Tsai 2004, Zhang et al. 2008, Poore et al. 2010, Wang et al. 
2003, Orlando et al. 2009). It remains to be studied how Cdk5 exerts its effect on GluR6 
levels; via PSD95 or directly phosphorylating GluR6. It is of notice that GluR6 has a 
predicted Cdk5 site in its amino acid sequence. However, this site localizes in the 
extracellular S2 domain excluding the possibility of Cdk5 phosphorylating GluR6 localized 
at the cell membrane. It still might have other functions, for instance, regulating the surface 
translocation of stored GluR6. We saw increased surface localization of GluR6 both by 
immunostaining and using a surface biotinylation assay in neurons treated with Roscovitine 
or expressing DN-Cdk5. A hypothesis could state that in cells with normal or deregulated 
Cdk5 activity (caused by KA) GluR6 levels are regulated by Cdk5 phosphorylation that 
inhibits excess GluR6 targeting to the cell surface. Inhibition of Cdk5 could therefore result 
in free movement of GluR6 from intracellular sites to the cell surface. However, we also saw 
that the endocytosis of GluR6 was reduced with prolonged surface expression as compared to 
control. This might be due to another mechanism involving other Cdk5 targets. As earlier 
mentioned, Cdk5 was recently linked closely to regulation of endocytosis via phosphorylation 
of dephosphins that are essential for continued vesicle recycling (Tan et al. 2003). It cannot 
be overruled, however, that GluR6 has a Cdk5 phosphorylation site in its C-terminal domain 
that in many GluRs contains binding sites for signaling proteins. Moreover, as likely is that 
general Cdk5 inhibition affects numerous other proteins in neurons as has been reviewed 
earlier, and that multiple mechanisms exist for GluR6 modulation by Cdk5, one possible 
modulator being PSD95. We were also curious about the prolonged surface localization of 
GluR6 in neurons treated with roscovitine or expressing DN-Cdk5 and asked if this affects 
the calcium movements after KA treatment. We concluded that there was no significant effect 
of Cdk5 inhibition on KA-induced calcium movements. 
Cdk5 has been implicated in Golgi fragmentation with deregulation of Cdk5 inducing robust 
Golgi disassembly after glutamate or Aβ treatment (Sun et al. 2008). Moreover, the Golgi 
matrix protein, GM130 (Golgi matrix protein of 130kDa) was found to be a substrate for 
Cdk5 and the phosphorylation of GM130 by Cdk5 may be a key link in Golgi fragmentation 
(Sun et al. 2008). As Cdk5 has also been linked to ER stress it would be interesting to clarify 
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its overall involvement in cell death pathways involving different organelles and pathways 
controlling organelle dysfunction.  
As the most dangerous effect of Cdk5 is exerted by its association with p25, it is an intriguing 
target for drug development. Optimized targeting would save normal Cdk5/p35 functions 
important for the cell. Furthermore, drugs targeting Cdk5, such as Roscovitine, have toxic 
effects possibly due to inhibition of Cdc2 and Cdk2 indicating that there is a need for more 
specific drugs. A Cdk5 inhibitory peptide (CIP) was recently developed that specifically 
targeted the Cdk5/p25 formation, however, this method is presently not tested in vivo 
although has shown promising results in vitro (Kanungo et al. 2009, Zheng et al. 2002). The 
authors have recently constructed a smaller 24-residue peptide, p5, that is efficient inhibitor 
of Cdk5/p25 with no effect on Cdk5/p35 and also has potential for therapeutic trials in animal 
models (Zheng et al. 2010). It will be interesting to see if this approach develops to be of 
clinical applicability.  
 
Figure 11 Summarizing figure of II.  
5.4 Huntington’s disease, ER stress and cell death 
HD is a debilitating inherited disorder caused by an expansion of the N-terminal CAG repeat 
in the huntingtin gene (The Huntington's Disease Collaborative Research Group 1993). It has 
been shown that the bare N-terminal fragment of huntingtin protein with an enlarged polyQ 
stretch is enough to induce cell death and that aggregates seen in HD pathology mainly 
consists of N-terminal fragment (DiFiglia et al. 1997). Thus, we studied HD pathogenesis 
with Htt constructs consisting of different polyQ repeats; 18Q, 39Q, 53Q and 120Q (Hasholt 
et al. 2003). We saw that cell death was induced in PC6.3 cells expressing these Htt fragment 
proteins in a polyQ length dependent fashion. Moreover, as HD involves aggregation of the 
mutant protein we hypothesized that the ER of mutant Htt expressing cells might exhibit 
stress reactions. As assumed, ER stress pathways were induced in our HD cell model with the 
activation of caspase-12 and caspase-3. Previously, it has been shown that caspases in 
addition to calpains are involved in cleaving Htt (Gafni, Ellerby 2002, Wellington et al. 2002). 
It would be of interest to see if caspase-12 is also able to cleave mutant Htt. Later it has been 
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shown also by others that ER stress indeed plays an important role in HD (Duennwald, 
Lindquist 2008) and it presents an important target for drug development for HD. 
Excitotoxicity was implicated early in HD pathogenesis. Although it does not have a direct 
role in our cell model it is a real event in human patients and can also be studied in animal 
models of HD. Striatum is rich in KARs and thus our findings with the KA model might 
share similar cell death mechanisms.  
We also studied if Sal mediates protection against cell death caused by Htt in PC6.3 cells. Sal 
reduced cell death in mutant Htt-expressing cells, although the protection was partial and 
could mean involvement of other cell death mechanisms. Moreover, Sal-treated cells 
exhibited less aggregation of mutant Htt suggesting that it mediates either more efficient 
breakdown of the proteins or inhibition of aggregate formation since the overall translation of 
Htt proteins was not significantly reduced. These data further indicate that Sal or other 
compounds targeting ER stress have possible therapeutic value in neurological disorders.  
5.5 Therapeutic considerations on Salubrinal 
Since its discovery, Salubrinal has been studied in multiple conditions involving ER stress. 
As earlier mentioned, Sal has exerted both protective effects against ER stress-induced cell 
death but also potentiating ER stress in certain cell types. At the moment its therapeutic 
potential in healing bone wounds is under investigations (Zhang et al. 2012).  
Sal has been shown to protect against cell death in several in vivo –studies involving neuronal 
damage. These include our study on KA excitotoxicity (I), mouse models of PD and α-
synucleinopathy, and familial ALS (Colla et al. 2012a, Colla et al. 2012b, Saxena, Cabuy & 
Caroni 2009), described earlier. On the contrary, in an in vivo study of prion 
neurodegeneration, Sal treatment accelerated the disease progression and the opposite 
approach, sustaining the translational capacity of the neurons was protective (Moreno et al. 
2012). Interestingly, in this study a reduction in synaptic proteins caused by prions was even 
aggravated when Sal was used, causing further repression of translation (Moreno et al. 2012). 
Salubrinal was indicated as a potential cancer drug in a study on multiple myeloma where the 
proteasome inhibitor bortezomib (Velcade) has been a successful therapy (Schewe, Aguirre-
Ghiso 2009). Some multiple myeloma cells treated with bortezomib have been shown to enter 
quiescence and survive by attenuating eIF2α phosphorylation, resulting in recurrence of the 
disease. Thus, using a combinatorial approach of bortezomib and Sal to counteract the 
dephosphorylation of eIF2α in these cells, the authors could minimize the survival of 
multiple myeloma cancer cells (Schewe, Aguirre-Ghiso 2009). Another study, investigating 
Sal as a possible protective agent against renal damage induced by the tumour drug, Cisplatin, 
showed that Sal actually enhanced Cisplatin-induced oxidative stress and nephrotoxicity in 
mouse (Wu et al. 2011).  
Taken together, Sal might prove a possible target for certain disorders involving ER stress. 
However, detailed studies are needed to determine its suitability in each condition, as there is 
a possibility for bidirectional effects depending on cell types and stress pathways. In addition, 
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This thesis is based on three individual studies aimed to clarify cell death involved in 
excitotoxicity and in a cell model of Huntington’s disease with a focus on organelle specific 
mechanisms. The studies showed that ER stress plays an important role in both KA-induced 
excitotoxic damage as well as in the HD model. Inhibition of ER stress by Sal was protective 
against cell death caused by KA and mutant Htt fragment proteins. Furthermore, we saw that 
Cdk5 is involved in KA excitotoxicity and is deregulated by calpain-mediated cleavage of the 
Cdk5 activator protein p35. Inhibition of Cdk5 by different means was able to reduce KA-
induced GluR6 downregulation and cell death.  
These studies strongly support the dysfunction of the ER and other organelles in neuronal cell 
death. Moreover, the multitasking protein, Cdk5, was here for the first time indicated in 
modulation of a KA receptor expression. The results show two relevant therapeutic 
approaches against neuronal cell death, namely inhibition of ER stress and inhibition of Cdk5. 
More studies are needed to verify and pinpoint the temporal applicability of these possible 
approaches in order to continue with further drug design and development. 
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